≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Lung diseases due to external agents

DOID EFO Endpoint Browser PheWeb

J10_EXTERLUNG

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J60-J70
  • Cause of death: ICD-10 — J60-J70

2 out of 7 registries used, show all original rules.

6157

4. Check minimum number of events

None

6157

5. Include endpoints

6644

6. Filter based on genotype QC (FinnGen only)

6461

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Similar endpoints

↥

List of similar endpoints to Lung diseases due to external agents based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 65050 24383 39593
Only index persons 45747 17975 27772
Unadjusted period prevalence (%)
Whole population 0.95 0.70 1.11
Only index persons 0.90 0.66 1.06
Median age at first event (years)
Whole population 69.66 71.27 68.59
Only index persons 67.86 68.54 67.42

-FinnGen-

Key figures

All Female Male
Number of individuals 6461 2094 4367
Unadjusted period prevalence (%) 1.59 0.74 2.00
Median age at first event (years) 68.16 62.34 70.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
6644
Matched controls
66432
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
319.6
2338
10808
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
313.2
1134
3468
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
+∞
307.7
293
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.0
307.7
788
1739
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.0
307.7
561
858
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
8.7
307.7
457
557
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
831.3
307.7
804
11
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2620.9
307.7
3546
29
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
307.7
3326
16177
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
9.0
307.7
621
749
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
307.7
2177
8402
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
2856.3
295.8
284
*
J69.8
ICD-10 Finland
Pneumonitis due to other solids and liquids
2276.1
238.8
230
*
WX730
NOMESCO Finland
Conventional respirator
8.0
235.8
328
430
TGC00
NOMESCO Finland
Bronchial lavation
5.9
223.6
415
738
J67.0
ICD-10 Finland
Farmer lung
+∞
213.7
204
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.8
196.9
1192
4852
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.4
194.3
256
314
AA1AD
NOMESCO Finland
CT of head and brain
2.2
191.6
2599
15139
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
1800.3
191.4
185
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.4
188.5
388
758
N03AG01
ATC
valproic acid; systemic, rectal
3.7
173.1
589
1699
GD1AD
NOMESCO Finland
Thorax CT examination
3.3
171.8
705
2295
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.1
157.0
240
349
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.6
156.6
548
1608
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
155.4
1128
4977
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
153.3
3659
25514
N05AH04
ATC
quetiapine; oral
2.3
141.5
1305
6383
H02AB06
ATC
prednisolone; systemic
1.9
141.3
3440
23896
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.3
140.2
557
1770
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.0
134.2
405
1071
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.1
131.6
614
2145
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
129.2
1179
5721
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.2
124.2
263
525
J01MA12
ATC
levofloxacin; systemic
2.0
123.0
1617
9029
4950A
ICD-9 Finland
Extrinsic allergic alveolitis, Farmers' lung
+∞
121.2
116
*
WX892
NOMESCO Finland
Monitored bed care
2.7
120.5
741
2996
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
119.9
694
2720
N03AX14
ATC
levetiracetam; systemic
4.2
117.1
323
799
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.3
116.8
308
736
R13
ICD-10 Finland
Dysphagia
2.7
115.8
686
2719
TJD20
NOMESCO Finland
Change of gastrostomy tube
14.2
115.1
105
75
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
4.1
109.0
307
771
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
107.4
1061
5286
WX872
NOMESCO Finland
Intensive care
2.9
107.0
527
1892
J96.0
ICD-10 Finland
Acute respiratory failure
5.2
106.8
222
436
N05AH03
ATC
olanzapine; systemic
3.1
105.6
482
1658
G41.9
ICD-10 Finland
Status epilepticus, unspecified
10.6
104.1
114
109
N03AX09
ATC
lamotrigine; oral
3.8
103.9
333
917
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.8
103.4
554
2081
N05AH02
ATC
clozapine; systemic
6.4
101.3
169
269
N05AA02
ATC
levomepromazine; systemic
3.4
100.2
385
1194
XG410
NOMESCO Finland
Flow-volume spirometry
3.3
99.3
404
1297
J01MA14
ATC
moxifloxacin; systemic
2.4
99.1
776
3499
ZXD05
NOMESCO Finland
Urgent procedure
1.8
97.6
2146
13990
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.6
96.7
233
518
R06.0
ICD-10 Finland
Dyspnoea
1.8
94.1
2040
13215
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
6.1
93.9
166
280
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.2
93.1
891
4366
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.3
92.3
246
592
4959X
ICD-9 Finland
Extrinsic allergic alveolitis, Unspecified allergic alveolitis and pneumonitis
+∞
91.9
88
*
51610
ICD-8 Finland
Other pneumoconiosis and related diseases, Due to inhalation of other dust
+∞
91.9
88
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
90.5
2122
14028
A06AD11
ATC
lactulose; oral
1.9
90.2
1435
8434
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
89.8
962
4921
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
+∞
88.7
85
*
R03BB04
ATC
tiotropium bromide; inhalant
2.1
88.0
1004
5256
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
4.4
87.7
227
534
N05BA01
ATC
diazepam; systemic, rectal
2.1
87.5
973
5044
GBB00
NOMESCO Finland
Tracheostomy
5.5
87.3
169
311
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.5
86.7
604
2577
N05AX12
ATC
aripiprazole; systemic
4.0
86.4
249
635
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.0
86.4
1105
6025
R50.9
ICD-10 Finland
Fever, unspecified
2.0
85.9
1172
6534
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
85.8
736
3441
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
84.7
474
1817
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.3
84.6
222
528
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
83.6
2370
16422
5070A
ICD-9 Finland
Pneumonitis due to solids and liquids, Due to inhalation of food or vomitus
+∞
83.5
80
*
J62.8
ICD-10 Finland
Pneumoconiosis due to other dust containing silica
+∞
83.5
80
*
C03CA01
ATC
furosemide; systemic
1.7
83.5
2867
20878
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.2
82.8
123
173
Z2446
NOMESCO Finland
Social worker
2.6
80.6
504
2041
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.5
79.7
199
455
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.6
79.7
194
435
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
79.4
1602
10076
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
79.0
535
2250
N07BB01
ATC
disulfiram; oral
3.3
78.4
313
992
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
77.5
1103
6217
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.6
77.5
467
1856
R4130
NOMESCO Finland
Speech therapy
3.6
77.0
267
774
N05AX08
ATC
risperidone; systemic
2.1
76.9
800
4032
J66.8
ICD-10 Finland
Airway disease due to other specific organic dusts
+∞
76.2
73
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
7.0
75.6
115
166
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.7
75.5
177
385
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
+∞
74.1
71
*
R03AC02
ATC
salbutamol; inhalant
1.6
73.3
3229
24718
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
5.0
72.8
158
322
J96.1
ICD-10 Finland
Chronic respiratory failure
3.2
72.4
291
926
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
72.2
376
1386
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.5
71.3
174
391
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
71.2
3027
22923
N04AA02
ATC
biperiden; systemic
4.4
70.4
178
411
N06AX11
ATC
mirtazapine; oral
1.6
70.1
2110
14692
WX882
NOMESCO Finland
High dependency care
3.3
70.0
277
873
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
69.1
424
1699
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
68.8
1255
7620
N06AB04
ATC
citalopram; systemic
1.8
68.1
1314
8110
N05BA04
ATC
oxazepam; oral
1.7
68.0
1711
11363
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
67.8
472
2007
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
67.5
1111
6535
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
5.2
67.3
140
275
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
66.6
1283
7908
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
66.2
464
1979
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
10.9
66.1
71
66
J68.0
ICD-10 Finland
Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours
330.4
65.6
66
*
N03AE01
ATC
clonazepam; systemic
2.5
65.2
425
1752
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
4.7
64.9
153
334
Z57.2
ICD-10 Finland
Occupational exposure to dust
9.0
64.9
80
90
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
64.7
1154
6948
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.3
64.7
539
2479
F10.24
ICD-10 Finland
Alcohol depence active use
4.9
63.7
142
296
B18.2
ICD-10 Finland
Chronic viral hepatitis C
6.7
63.5
101
153
N05AF03
ATC
chlorprothixene; systemic
3.8
63.5
196
525
N05CF01
ATC
zopiclone; oral
1.6
63.4
2254
16249
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
63.1
968
5560
D21
ICPC
Swallowing problem
4.0
62.9
183
470
R53
ICD-10 Finland
Malaise and fatigue
1.6
62.6
1717
11618
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
61.8
1290
8117
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.1
61.7
261
856
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.8
61.2
309
1119
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
10.9
60.8
65
60
N05AN01
ATC
lithium; oral
4.0
60.2
173
440
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
60.1
2184
15776
JN4AD
NOMESCO Finland
Body CT examination
1.9
59.5
874
4946
J68.3
ICD-10 Finland
Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours
+∞
59.5
57
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
6.1
59.1
102
168
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.3
58.8
222
679
N06AX16
ATC
venlafaxine; oral
2.0
58.4
726
3885
N05CD07
ATC
temazepam; oral
1.8
58.2
1001
5945
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
57.9
642
3297
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.1
57.9
161
400
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
6.5
57.7
94
146
J70.3
ICD-10 Finland
Chronic drug-induced interstitial lung disorders
+∞
57.4
55
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
57.3
367
1499
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
6.2
57.0
98
161
J69
ICD-10 Finland
Pneumonitis due to solids and liquids
562.9
56.7
56
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
56.7
1187
7455
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
56.4
1020
6144
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.0
56.3
163
417
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
4.3
56.2
148
353
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
5.4
56.1
112
212
N02AA05
ATC
oxycodone; systemic
1.6
56.1
1462
9724
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
5.1
55.9
118
235
P15
ICPC
Chronic alcohol abuse
3.3
55.8
217
676
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
55.5
497
2350
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.7
54.8
313
1208
A02BC02
ATC
pantoprazole; systemic
1.5
54.4
4242
35758
N03AX18
ATC
lacosamide; systemic
6.7
54.2
86
130
J62.0
ICD-10 Finland
Pneumoconiosis due to talc dust
+∞
53.2
51
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
5.0
53.0
113
227
N03AF01
ATC
carbamazepine; oral, rectal
2.3
52.1
407
1817
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
52.0
1120
7072
R40.2
ICD-10 Finland
Coma, unspecified
4.7
51.9
122
266
SPAT1254
SPAT
Administration of medicine
1.7
51.6
1098
6908
L28
ICPC
Limited function/disability (L)
1.6
50.1
1426
9655
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
+∞
50.1
48
*
J68.9
ICD-10 Finland
Unspecified respiratory condition due to chemicals, gases, fumes and vapours
491.5
49.4
49
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
12.4
48.7
48
39
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
5.4
48.6
96
180
J63.3
ICD-10 Finland
Graphite fibrosis (of lung)
481.4
48.4
48
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
48.4
1317
8812
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
3.7
48.3
154
422
J67.8
ICD-10 Finland
Hypersensitivity pneumonitis due to other organic dusts
+∞
48.0
46
*
N05AB03
ATC
perphenazine; systemic, rectal
2.9
47.9
238
854
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
8.5
47.6
61
72
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
6.6
47.5
76
116
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
5.8
47.4
86
149
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
4.5
46.8
114
256
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
46.7
1083
6955
R11
ICD-10 Finland
Nausea and vomiting
2.0
46.7
586
3136
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
46.7
1127
7313
R81
ICPC
Pneumonia
2.5
46.4
309
1284
K90
ICPC
Stroke/cerebrovascular accident
2.5
46.0
294
1198
N05AF05
ATC
zuclopenthixol; systemic
5.6
45.8
86
154
Z72.2
ICD-10 Finland
Drug use
9.2
45.6
55
60
G72.8
ICD-10 Finland
Other specified myopathies
3.2
45.1
180
570
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.9
44.9
213
745
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
4.8
44.7
102
217
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
5.9
44.3
80
138
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.0
44.2
484
2468
N03AF02
ATC
oxcarbazepine; oral
2.7
44.0
239
899
F60.9
ICD-10 Finland
Personality disorder, unspecified
5.5
43.8
85
157
F05.9
ICD-10 Finland
Delirium, unspecified
2.7
43.6
246
943
N03AX16
ATC
[U] pregabalin
1.6
43.6
1363
9393
Z3226
NOMESCO Finland
Physiotherapist
1.6
43.5
1129
7444
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.8
43.4
135
364
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
43.3
369
1708
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
43.2
862
5308
A28
ICPC
Limited function/disability NOS
1.5
42.8
1470
10341
J69.1
ICD-10 Finland
Pneumonitis due to oils and essences
+∞
42.7
41
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.7
42.6
233
880
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
8.6
42.6
54
63
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.2
42.5
374
1753
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
13.4
42.5
40
30
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
42.4
1057
6898
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
42.0
472
2428
N05AA01
ATC
chlorpromazine; systemic, rectal
4.3
41.9
110
262
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.2
41.8
363
1692
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
6.3
41.8
70
112
183
Kela drug reimbursment
Lamotrigin and topiramate
5.8
41.8
76
132
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
41.6
1116
7411
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.8
41.6
129
347
N87
ICPC
Parkinsonism
3.2
41.1
169
545
R41.0
ICD-10 Finland
Disorientation, unspecified
2.3
41.1
318
1413
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.4
40.9
151
456
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
40.7
270
1120
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
10.3
40.4
45
44
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
6.2
40.3
69
113
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
40.2
1403
9884
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
39.9
1500
10734
JN4BD
NOMESCO Finland
Extensive body CT
1.8
39.8
719
4301
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
39.6
287
1239
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.7
39.6
221
843
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.9
39.5
86
176
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.8
39.5
123
332
N05AD01
ATC
haloperidol; systemic
2.3
39.4
295
1292
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.1
39.3
391
1922
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
5.1
39.2
82
162
J96.9
ICD-10 Finland
Respiratory failure, unspecified
4.8
39.2
88
185
P16
ICPC
Acute alcohol abuse
3.8
39.1
121
325
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
13.3
39.1
37
28
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
10.8
39.1
42
39
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.7
39.0
211
792
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.0
38.6
420
2135
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.1
38.1
358
1721
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.9
38.1
184
651
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
37.9
1270
8853
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
8.0
37.9
51
64
G40
ICD-10 Finland
Epilepsy
4.9
37.8
83
171
Z3231
NOMESCO Finland
Registered nurse
1.5
37.8
1705
12638
V03AA01, ,
ATC
3.5
37.6
133
391
N05AC02
ATC
thioridazine; oral
3.4
37.5
136
406
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
37.4
362
1760
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.5
37.2
90
201
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
37.1
626
3668
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
9.4
37.1
44
47
Z72.8
ICD-10 Finland
Other problems related to lifestyle
8.0
37.0
50
63
F61.0
ICD-10 Finland
Mixed personality disorders
4.4
37.0
92
210
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
36.8
568
3240
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.7
36.8
204
776
R03AK08
ATC
formoterol and beclometasone; inhalant
2.4
36.6
267
1156
P72
ICPC
Schizophrenia
3.6
36.6
122
345
K56.0
ICD-10 Finland
Paralytic ileus
3.8
36.5
112
299
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
36.5
681
4107
R03AK03
ATC
[U] fenoterol and ipratropium bromide
1.8
36.5
550
3116
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
2.3
36.5
277
1221
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
36.4
325
1532
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
36.3
1320
9355
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.0
36.3
160
538
M03BX01
ATC
baclofen; systemic
3.2
35.7
144
459
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.5
35.4
233
963
J01FF01
ATC
clindamycin; systemic
1.5
35.3
1551
11411
WX704
NOMESCO Finland
Intubation
1.9
35.2
482
2648
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
35.1
335
1621
ZXE00
NOMESCO Finland
One hour or less
1.4
35.1
2232
17567
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.2
35.0
296
1364
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.8
35.0
527
2983
C07AB07
ATC
bisoprolol; oral
1.4
35.0
3374
28444
G20
ICD-10 Finland
Parkinson disease
2.2
34.9
300
1393
N02AX02
ATC
tramadol; systemic, rectal
1.4
34.7
2646
21458
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
34.6
513
2890
Z2445
NOMESCO Finland
Psychologist
2.6
34.6
196
754
S01.0
ICD-10 Finland
Open wound of scalp
1.8
34.4
599
3539
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
11.7
34.3
35
30
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
4.4
34.2
85
194
N06AB06
ATC
sertraline; oral
1.8
34.0
542
3122
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
33.8
471
2601
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.6
33.8
111
311
ZY000
NOMESCO Finland
Hospital inpatient
4.3
33.7
87
205
S06.0
ICD-10 Finland
Concussion
1.7
33.6
661
4040
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
33.6
393
2047
J70.9
ICD-10 Finland
Respiratory conditions due to unspecified external agent
+∞
33.4
32
*
J01DA01
ATC
[U] cefalexin
1.4
33.3
3630
31095
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.4
33.0
119
354
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
9.1
33.0
40
44
P19
ICPC
Drug abuse
5.4
33.0
65
122
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.2
32.8
86
205
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
7.8
32.7
45
58
SPAT1255
SPAT
Intravenous administration of medicine
1.9
32.7
466
2592
SPAT1263
SPAT
Sampling
1.4
32.7
2362
18935
K92.0
ICD-10 Finland
Haematemesis
2.4
32.6
225
950
A02BC05
ATC
esomeprazole; systemic
1.4
32.6
2275
18131
N06AB10
ATC
escitalopram; oral
1.6
32.5
933
6264
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
5.4
32.5
64
120
SPAT1229
SPAT
Assessment of need for aid
1.8
32.4
555
3262
51620
ICD-8 Finland
Other pneumoconiosis and related diseases, Due to inhalation of fumes
+∞
32.3
31
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
32.2
292
1384
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
3.9
31.8
92
236
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.9
31.8
152
535
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
11.4
31.8
33
29
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.9
31.6
92
237
R03BA05
ATC
fluticasone; inhalant
1.5
31.6
982
6710
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.8
31.4
158
572
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
31.3
1979
15489
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
9.1
31.2
38
42
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
5.5
30.8
59
108
SPAT1240
SPAT
Therapeutic discussion
1.9
30.7
429
2371
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
2.6
30.5
181
712
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
3.8
30.5
94
252
1240
FHL
Bronchoscopy
3.2
30.4
122
388
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
10.7
30.4
33
31
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
30.2
335
1712
WX722
NOMESCO Finland
PEEP
2.0
30.2
322
1624
N06AX21
ATC
duloxetine; oral
1.7
30.1
589
3591
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
30.1
1007
6984
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.7
29.9
160
598
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
29.9
857
5745
J01DB01
ATC
cefalexin; oral
1.4
29.8
4823
43573
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
29.7
249
1144
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
9.5
29.7
35
37
Z72.1
ICD-10 Finland
Alcohol use
3.6
29.7
97
271
T51.0
ICD-10 Finland
Toxic effect: Ethanol
7.3
29.6
43
59
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
4.3
29.6
75
174
SPAT1262
SPAT
Handing over of treatment supplies
1.5
29.5
1118
7954
N06AA09
ATC
amitriptyline; systemic
1.7
29.5
564
3418
R4110
NOMESCO Finland
Physiotherapy
1.4
29.4
1600
12182
188
Kela drug reimbursment
Psychosis requiring demanding treatment
4.7
29.4
67
143
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.2
29.4
261
1228
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.7
29.3
93
255
Z43.0
ICD-10 Finland
Attention to tracheostomy
11.6
29.1
30
26
ZX120
NOMESCO Finland
Intravenous
1.7
29.0
581
3564
OAB43, ,
SPAT
0.5
29.0
360
6413
R4190
NOMESCO Finland
Nutritional therapy
2.3
28.9
216
945
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
7.5
28.8
41
55
L04AA06
ATC
mycophenolic acid; systemic
3.1
28.8
121
396
A02BC01
ATC
omeprazole; systemic
1.4
28.7
1694
13070
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.2
28.6
256
1207
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
6.3
28.6
48
77
N05BA09
ATC
clobazam; oral
6.3
28.6
48
77
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
3.5
28.6
100
292
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
28.6
918
6306
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
2.1
28.5
276
1343
W19
ICD-10 Finland
Unspecified fall
1.6
28.3
646
4098
N05BA02
ATC
chlordiazepoxide; systemic
2.6
28.3
169
668
R55
ICD-10 Finland
Syncope and collapse
1.6
28.2
803
5370
N18
ICPC
Paralysis/weakness
2.5
28.0
171
683
Z57.3
ICD-10 Finland
Occupational exposure to other air contaminants
7.2
27.9
41
57
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.0
27.9
304
1544
SPAT1301
SPAT
No procedures
1.4
27.9
1866
14684
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.2
27.7
110
348
X84
ICD-10 Finland
Intentional self-harm by unspecified means
9.0
27.7
34
38
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
27.7
327
1709
J80
ICD-10 Finland
Adult respiratory distress syndrome
5.5
27.7
53
97
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
27.6
437
2509
AA400
NOMESCO Finland
Electroconvulsive therapy
5.1
27.5
57
112
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.5
27.5
182
755
N05BE01
ATC
buspirone; oral
2.5
27.5
172
695
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.8
27.5
139
505
Z51.5
ICD-10 Finland
Palliative care
1.6
27.4
682
4418
R03BB01
ATC
ipratropium bromide; inhalant
1.9
27.4
376
2065
N06AX12
ATC
bupropion; oral
2.1
27.3
269
1317
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.0
27.3
299
1522
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
27.2
703
4594
XA800
NOMESCO Finland
Neuropsychological investigation
2.2
27.2
229
1054
F20.0
ICD-10 Finland
Paranoid schizophrenia
5.5
27.2
52
95
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
27.2
575
3577
G41.2
ICD-10 Finland
Complex partial status epilepticus
8.8
27.1
34
39
J01FA06
ATC
roxithromycin; oral
1.3
27.0
2191
17747
P99
ICPC
Psychological disorders other
2.7
27.0
143
532
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
27.0
2068
16607
A04AA02
ATC
granisetron; systemic, transdermal
1.9
26.6
356
1939
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.2
26.6
217
986
S06.3
ICD-10 Finland
Focal brain injury
3.0
26.6
119
404
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.9
26.6
126
442
R03BA01
ATC
beclometasone; inhalant
1.5
26.3
797
5400
R03BA02
ATC
budesonide; inhalant
1.5
26.3
944
6631
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
26.2
398
2256
Z43.1
ICD-10 Finland
Attention to gastrostomy
9.4
26.2
31
33
N19
ICPC
Speech disorder
3.0
25.9
115
389
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
5.8
25.8
47
82
N03AB02
ATC
phenytoin; systemic
3.1
25.8
107
348
N29
ICPC
Neurological sympt/complt other
2.6
25.8
147
568
G41.0
ICD-10 Finland
Grand mal status epilepticus
8.5
25.7
33
39
R04.2
ICD-10 Finland
Haemoptysis
2.0
25.7
290
1492
R47.1
ICD-10 Finland
Dysarthria and anarthria
3.3
25.7
98
303
ZY010
NOMESCO Finland
Hospital outpatient
2.1
25.7
240
1152
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.0
25.7
268
1341
P18
ICPC
Medication abuse
4.7
25.6
58
123
F60.2
ICD-10 Finland
Dissocial personality disorder
9.2
25.6
31
34
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
7.1
25.4
38
54
M05BA04
ATC
alendronic acid; oral
1.7
25.3
535
3325
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
25.3
187
815
SPAT1265
SPAT
Breathalyser
4.2
25.1
67
162
N06AX03
ATC
mianserin; oral
2.0
25.1
288
1490
N30.0
ICD-10 Finland
Acute cystitis
1.5
25.0
877
6123
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.1
25.0
106
349
J63.8
ICD-10 Finland
Pneumoconiosis due to other specified inorganic dusts
+∞
25.0
24
*
A10AB05
ATC
insulin aspart; parenteral
1.7
25.0
499
3056
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.8
24.8
369
2078
J47
ICD-10 Finland
Bronchiectasis
2.6
24.8
147
579
SPAT1234
SPAT
Support of social functional capacity
1.8
24.8
394
2264
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.4
24.6
167
701
E86
ICD-10 Finland
Volume depletion
2.1
24.6
223
1058
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
7.5
24.6
35
47
SPAT1216
SPAT
Assessment of functional ability
1.4
24.5
1055
7665
RS220, ,
NOMESCO Finland
3.4
24.5
86
252
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.9
24.5
118
418
H02AB04
ATC
methylprednisolone; systemic
1.5
24.4
806
5560
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
24.3
1491
11522
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
6.4
24.3
40
63
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.5
24.3
157
645
SPAT1227
SPAT
Substance abuse rehabilitation
5.7
24.2
45
80
P29
ICPC
Psychological sympt/compl other
1.9
24.2
291
1530
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
2.5
24.2
150
604
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
7.1
24.1
36
51
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.5
24.1
150
605
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
3.2
24.1
96
305
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
24.1
348
1943
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
5.6
23.9
45
81
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.1
23.9
244
1211
R02
ICPC
Shortness of breath/dyspnoea
1.5
23.8
818
5684
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
5.9
23.8
42
71
R03AC12
ATC
salmeterol; inhalant
1.8
23.6
335
1859
IGV01
NOMESCO Finland
Psychiatric network contact
4.4
23.5
58
132
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.6
23.5
138
541
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.9
23.5
292
1552
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
5.6
23.5
44
79
B01AB05
ATC
enoxaparin; parenteral
1.3
23.4
1809
14476
A04
ICPC
Weakness/tiredness general
1.5
23.3
945
6785
AAF00
NOMESCO Finland
Ventriculostomy
4.4
23.3
57
129
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
7.3
23.3
34
47
J01MA02
ATC
ciprofloxacin; systemic
1.3
23.2
2464
20619
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.9
23.2
107
370
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
9.7
23.2
27
28
R4120
NOMESCO Finland
Occupational therapy
1.8
23.2
364
2084
L04AX01
ATC
azathioprine; systemic
2.1
23.2
220
1063
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
4.8
23.1
52
110
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.1
23.1
96
313
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
4.6
23.1
54
118
N03AX12
ATC
[U] gabapentin; oral
1.5
23.0
860
6075
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
4.2
23.0
61
147
5CM18, ,
NOMESCO Finland
5.1
23.0
48
95
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
3.0
23.0
101
340
J60
ICD-10 Finland
Coalworker pneumoconiosis
+∞
22.9
22
*
R33
ICD-10 Finland
Retention of urine
1.5
22.7
724
4953
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
5.2
22.6
46
89
H02AB07
ATC
prednisone; oral
1.5
22.5
818
5746
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
7.2
22.4
33
46
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
2.7
22.4
116
427
N99
ICPC
Neurological disease other
3.0
22.4
98
329
N06AB03
ATC
fluoxetine; oral
1.6
22.4
582
3803
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
22.3
1882
15235
UGB02
NOMESCO Finland
Tracheoscopy
8.3
22.2
29
35
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.0
22.1
96
321
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
6.6
22.1
35
53
P80
ICPC
Personality disorder
7.6
22.1
31
41
A46
ICD-10 Finland
Erysipelas
1.4
22.0
988
7226
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.7
21.9
120
455
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.7
21.9
117
438
J63.4
ICD-10 Finland
Siderosis
+∞
21.9
21
*
J92.9
ICD-10 Finland
Pleural plaque without asbestos
2.8
21.8
111
405
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.4
21.8
79
237
2959A
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]
8.1
21.7
29
36
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
8.1
21.7
29
36
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
3.6
21.7
72
204
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
21.7
786
5518
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
8.3
21.4
28
34
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.8
21.3
104
371
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
7.9
21.3
29
37
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
7.0
21.2
32
46
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.2
21.1
170
769
J46
ICD-10 Finland
Status asthmaticus
2.2
21.1
172
782
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
21.1
234
1197
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.4
21.1
150
644
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.8
21.1
333
1910
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.2
21.1
180
835
JAH00
NOMESCO Finland
Laparotomy
2.1
21.0
193
921
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
21.0
454
2837
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
20.9
837
5985
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.9
20.9
249
1306
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.3
20.9
159
703
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.7
20.8
111
416
R99
ICPC
Respiratory disease other
2.5
20.7
126
503
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
20.7
590
3934
T68
ICD-10 Finland
Hypothermia
4.2
20.7
55
133
T74.1
ICD-10 Finland
Physical abuse
3.2
20.7
80
250
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
20.7
395
2390
F31
ICD-10 Finland
Bipolar affective disorder
3.8
20.6
62
164
A07AA02
ATC
nystatin; oral
1.7
20.6
348
2034
K56.7
ICD-10 Finland
Ileus, unspecified
2.4
20.6
141
595
H02AB02
ATC
dexamethasone; systemic
1.5
20.6
615
4145
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.8
20.6
101
362
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.9
20.5
265
1427
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.6
20.5
66
183
N05AE04
ATC
ziprasidone; systemic
6.3
20.5
34
54
A02BC03
ATC
lansoprazole; oral
1.3
20.5
1646
13200
H02AA02
ATC
fludrocortisone; oral
3.1
20.5
84
272
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
3.5
20.4
70
203
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.8
20.4
101
364
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.3
20.2
152
669
P28
ICPC
Limited function/disability (P)
3.9
20.1
58
149
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
16.1
20.0
32
20
P76
ICPC
Depressive disorder
1.9
20.0
251
1340
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
4.5
19.8
48
108
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.0
19.8
216
1099
E87.6
ICD-10 Finland
Hypokalaemia
2.0
19.7
217
1108
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
19.7
1666
13448
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.7
19.6
104
388
J86.9
ICD-10 Finland
Pyothorax without fistula
3.1
19.6
83
274
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
19.6
136
578
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.2
19.6
159
723
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
2.6
19.5
113
441
J94.8
ICD-10 Finland
Other specified pleural conditions
2.4
19.5
138
592
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
3.3
19.5
73
224
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
4.4
19.4
48
110
T90.5
ICD-10 Finland
Sequelae of intracranial injury
3.0
19.3
83
276
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.6
19.3
489
3175
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.5
19.3
66
191
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.7
19.3
746
10264
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
6.5
19.2
31
48
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
7.9
19.1
26
33
F20
ICD-10 Finland
Schizophrenia
4.7
19.1
44
95
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
7.5
19.1
27
36
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
7.5
19.1
27
36
N02AA01
ATC
morphine; systemic, rectal
2.1
19.1
171
809
ZXY60
NOMESCO Finland
2-person team, nurses
6.0
19.0
33
55
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.9
19.0
86
295
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
19.0
1195
9228
J01CA04
ATC
amoxicillin; systemic
1.3
19.0
4530
41543
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
2.6
18.9
108
419
N28
ICPC
Limited function/disability (N)
2.4
18.8
130
551
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
5.5
18.8
36
66
J64
ICD-10 Finland
Unspecified pneumoconiosis
+∞
18.8
18
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
18.7
1238
15634
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.7
18.7
337
2007
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.0
18.7
83
282
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.7
18.6
313
1828
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
18.6
555
3737
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
18.6
449
2883
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
18.5
364
2219
R1260
NOMESCO Finland
Evaluation of communicative skills
2.4
18.5
123
513
OAA67, ,
SPAT
0.5
18.5
188
3578
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
2.9
18.4
83
284
127
Kela drug reimbursment
Transplant complication
2.9
18.3
85
296
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
2.7
18.2
100
380
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
6.9
18.2
28
41
N05CD08
ATC
midazolam; nasal, systemic
2.2
18.2
160
751
Z91.5
ICD-10 Finland
Personal history of self-harm
7.5
18.2
26
35
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
18.1
444
2861
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
3.6
18.1
58
161
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
18.0
1525
12283
SPAT1247
SPAT
Outpatient detoxication and monitoring
5.4
18.0
35
65
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
18.0
215
1130
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.5
18.0
60
171
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
17.8
815
5963
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
6.7
17.8
28
42
Z2221
NOMESCO Finland
Medical doctor
1.3
17.7
1432
11456
4958X
ICD-9 Finland
Extrinsic allergic alveolitis, Other specified allergic alveolitis and pneumonitis
+∞
17.7
17
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.7
17.7
339
2052
N05AX13
ATC
paliperidone; systemic
5.6
17.7
33
59
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
2.3
17.7
130
567
ZXD35
NOMESCO Finland
Usual procedure
2.0
17.6
198
1019
A03
ICPC
Fever
1.4
17.5
734
5285
AA5PD
NOMESCO Finland
CT examination of brain pefusion
3.1
17.5
74
244
N05AF01
ATC
flupentixol; systemic
2.7
17.5
92
342
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.8
17.5
272
1554
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.8
17.5
89
326
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.8
17.5
89
326
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.2
17.4
142
647
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
7.4
17.4
25
34
JDB00
NOMESCO Finland
Gastrostomy
7.4
17.4
25
34
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
17.3
527
7604
I50.0
ICD-10 Finland
Congestive heart failure
1.5
17.3
682
4854
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.9
17.3
237
1302
B01AA03
ATC
warfarin; systemic
1.3
17.3
1554
12609
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
4.5
17.2
41
91
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
17.2
227
1232
P17
ICPC
Tobacco abuse
3.1
17.2
70
226
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
17.1
493
3293
SPAT1167
SPAT
Insertion of urinary catheter
1.8
17.1
259
1467
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.3
17.1
44
104
N06AX05
ATC
trazodone; oral
2.4
17.1
119
507
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
3.2
17.0
68
217
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
3.3
17.0
62
187
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.3
17.0
63
192
P03
ICPC
Feeling depressed
1.7
17.0
346
2128
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
6.9
17.0
26
38
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
5.1
16.9
35
69
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.8
16.9
231
1269
N05BA12
ATC
alprazolam; oral
1.5
16.9
489
3272
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
3.8
16.8
51
136
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
3.9
16.8
49
127
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
2.7
16.8
90
338
TK800
NOMESCO Finland
Hemodialysis
2.2
16.8
138
631
S97
ICPC
Chronic ulcer skin
1.6
16.8
429
2790
J01AA02
ATC
doxycycline; systemic
1.3
16.8
4494
41412
N88
ICPC
Epilepsy
3.7
16.8
52
141
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.9
16.7
77
267
J68.2
ICD-10 Finland
Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified
+∞
16.7
16
*
K59.0
ICD-10 Finland
Constipation
1.6
16.7
368
2311
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.7
16.7
283
1658
SPAT1172
SPAT
Guidance concerning hydration
2.0
16.6
183
936
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
3.8
16.6
50
133
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.8
16.6
84
307
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
6.7
16.6
26
39
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
7.0
16.5
25
36
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
16.3
16.5
26
16
J70.8
ICD-10 Finland
Respiratory conditions due to other specified external agents
170.4
16.5
17
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.6
16.5
93
359
F61
ICD-10 Finland
Mixed and other personality disorders
5.9
16.5
29
49
R03AC13
ATC
formoterol; inhalant
1.7
16.5
290
1716
UJD02
NOMESCO Finland
Gastroscopy
1.7
16.5
294
1747
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.7
16.4
277
1620
XG466
NOMESCO Finland
Sleep oxymetry
2.0
16.4
183
940
SPAT1307
SPAT
Psychosocial counselling and guidance
1.9
16.4
196
1031
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
4.3
16.3
41
95
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.8
16.3
255
1458
Z50.5
ICD-10 Finland
Speech therapy
2.8
16.3
81
293
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
1.8
16.3
232
1291
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
16.3
413
2682
S72.0
ICD-10 Finland
Fracture of neck of femur
1.7
16.2
334
2062
RS221, ,
NOMESCO Finland
2.7
16.1
85
317
X78
ICD-10 Finland
Intentional self-harm by sharp object
4.9
16.1
35
72
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
3.6
16.1
52
145
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
4.8
16.1
36
76
R06.2
ICD-10 Finland
Wheezing
1.8
16.0
232
1299
TAB00
NOMESCO Finland
Lumbar puncture
1.9
15.9
202
1083
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.5
15.9
448
2977
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
15.9
153
745
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.8
15.9
239
1352
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
4.3
15.9
40
93
N04BC04
ATC
ropinirole; oral
2.8
15.8
78
281
R03AC03
ATC
terbutaline; inhalant
1.4
15.8
678
4901
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
15.7
680
4922
R47.0
ICD-10 Finland
Dysphasia and aphasia
2.7
15.7
85
322
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
15.7
564
3945
H02AB09
ATC
hydrocortisone; systemic
2.2
15.7
131
604
P01AB01
ATC
metronidazole; oral, rectal
1.3
15.7
1904
16013
J68.4
ICD-10 Finland
Chronic respiratory conditions due to chemicals, gases, fumes and vapours
+∞
15.6
15
*
Y86
ICD-10 Finland
Sequelae of other accidents
3.9
15.6
45
116
XA400
NOMESCO Finland
EEG
3.8
15.6
47
125
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.0
15.6
167
846
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
15.6
321
1982
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
2.8
15.5
78
284
GX1K5
NOMESCO Finland
Diffusion capacity
3.8
15.5
46
121
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
15.5
1744
14532
S72.1
ICD-10 Finland
Pertrochanteric fracture
1.9
15.4
189
1003
X58
ICD-10 Finland
Exposure to other specified factors
1.4
15.4
702
5130
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
15.3
965
7430
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
6.7
15.3
24
36
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.7
15.2
292
1769
UJC12
NOMESCO Finland
Flexible oesophagoscopy
3.1
15.2
63
206
N02BE01
ATC
paracetamol; systemic, rectal
1.3
15.2
5253
49529
J98.1
ICD-10 Finland
Pulmonary collapse
3.2
15.1
58
181
WW500
NOMESCO Finland
Blood transfusion
1.8
15.1
240
1380
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.7
15.1
250
1456
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.8
15.0
226
1280
GAA31
NOMESCO Finland
Thoracoscopy
4.7
14.9
34
73
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.7
14.9
79
296
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
6.8
14.8
23
34
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.0
14.8
166
854
R03DA04
ATC
theophylline; systemic, rectal
1.5
14.8
428
2860
GX1D5
NOMESCO Finland
Flow volume spirometry
5.2
14.8
30
58
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
31.7
14.8
19
6
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
5.5
14.7
28
51
Z93.1
ICD-10 Finland
Gastrostomy status
16.5
14.7
23
14
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
3.6
14.7
48
135
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.5
14.7
426
2850
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.2
14.6
128
601
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.4
14.6
96
399
193
Kela drug reimbursment
Rasagiline
3.4
14.6
51
150
G81.9
ICD-10 Finland
Hemiplegia, unspecified
2.7
14.6
76
282
PA7BD
NOMESCO Finland
CT angiography of neck and brain
2.3
14.6
106
461
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
4.0
14.5
41
104
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.0
14.5
148
737
R05
ICD-10 Finland
Cough
1.3
14.5
1061
8348
N03AX11
ATC
topiramate; oral
2.5
14.5
91
371
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.7
14.5
663
8904
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
4.6
14.4
34
75
A10AE04
ATC
insulin glargine; parenteral
1.4
14.4
577
4119
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.4
14.3
50
147
RF220, ,
NOMESCO Finland
2.5
14.3
91
373
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.7
14.3
254
1508
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.1
14.3
136
660
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.9
14.3
178
950
F39
ICD-10 Finland
Unspecified mood [affective] disorder
2.9
14.3
66
230
SPAT1260
SPAT
Consultation of another employee
1.3
14.3
910
7016
R51.80
ICD-10 Finland
Headache
1.4
14.2
652
4765
W79
ICD-10 Finland
Inhalation and ingestion of food causing obstruction of respiratory tract
4.9
14.2
31
64
K08.3
ICD-10 Finland
Retained dental root
1.5
14.2
440
2985
U04
ICPC
Incontinence urine
1.6
14.2
369
2410
WX930
NOMESCO Finland
Thepapeutic hypothermia
6.2
14.2
24
39
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
2.4
14.1
91
375
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.7
14.1
76
287
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
3.7
14.1
44
120
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
14.1
415
2785
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.2
14.1
114
519
K91
ICPC
Cerebrovascular disease
2.3
14.1
108
481
UGC02
NOMESCO Finland
Rigid bronchoscopy
5.4
14.0
27
50
RD210, ,
NOMESCO Finland
2.5
14.0
89
365
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
4.7
14.0
32
69
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
13.9
402
2688
T75.1
ICD-10 Finland
Drowning and nonfatal submersion
15.8
13.9
22
14
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.3
13.9
100
434
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
3.7
13.8
43
117
S22.4
ICD-10 Finland
Multiple fractures of ribs
2.0
13.8
148
750
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
3.8
13.8
41
108
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
20.1
13.8
20
10
K22.2
ICD-10 Finland
Oesophageal obstruction
2.7
13.7
74
280
ZXY49
NOMESCO Finland
Other health care provider
5.3
13.7
27
51
N04BD02
ATC
rasagiline; oral
3.0
13.7
59
198
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.7
13.6
237
1399
IGY02, ,
SPAT
2.9
13.6
64
225
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.7
13.6
268
1636
F34.1
ICD-10 Finland
Dysthymia
2.0
13.6
145
734
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
5.1
13.6
28
55
I95.1
ICD-10 Finland
Orthostatic hypotension
1.6
13.6
307
1940
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.1
13.6
126
606
N06AA12
ATC
doxepin; systemic
1.6
13.6
279
1722
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.2
13.6
115
534
51520
ICD-8 Finland
Pneumoconiosis due to silica and silicates, Asbestosis
+∞
13.5
13
*
J67.2
ICD-10 Finland
Bird fancier lung
+∞
13.5
13
*
J62
ICD-10 Finland
Pneumoconiosis due to dust containing silica
+∞
13.5
13
*
5088A
ICD-9 Finland
Respiratory conditions due to other and unspecified external agents, Respiratory conditions due to other specified external agents[MORBI ORGANORUM RESPIRATIONIS E PHARMACO]
+∞
13.5
13
*
TGB20
NOMESCO Finland
Tracheostomy tube replacement
14.7
13.5
22
15
G40.10
ICD-10 Finland
Simple partial seizures
3.4
13.5
47
138
J18
ICD-10 Finland
Pneumonia, organism unspecified
2.8
13.5
66
237
ZX122
NOMESCO Finland
Intra-arterial
4.0
13.5
37
92
F60.0
ICD-10 Finland
Paranoid personality disorder
5.9
13.5
24
41
ICB06, ,
NOMESCO Finland
4.6
13.5
31
67
SPAT1211
SPAT
Application of soft bandage
1.5
13.5
460
3183
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
13.5
1410
11612
N05AC01
ATC
periciazine; systemic
4.1
13.4
36
88
M05BA07
ATC
risedronic acid; oral
1.9
13.4
162
856
C10AA07
ATC
rosuvastatin; oral
0.8
13.4
1188
14542
A01AB09
ATC
miconazole; local oral
1.5
13.4
455
3145
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
13.4
486
3403
J01EA01
ATC
trimethoprim; systemic
1.3
13.4
1302
10625
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
6.1
13.4
23
38
115
Kela drug reimbursment
Breast cancer
1.6
13.3
303
1917
L01BA01
ATC
methotrexate; systemic
1.9
13.3
178
972
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.2
13.3
108
493
WZC30
NOMESCO Finland
Teaching
1.3
13.3
854
6587
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.4
13.3
90
380
A29
ICPC
General symptom/complaint other
1.4
13.3
772
5865
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.6
13.3
328
2118
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.9
13.3
166
888
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
2.3
13.2
97
424
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
3.3
13.2
48
145
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
5.3
13.2
26
49
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
5.7
13.2
24
42
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.9
13.1
167
898
P98
ICPC
Psychosis NOS/other
4.2
13.1
34
81
A04AA55
ATC
palonosetron, combinations; systemic
2.0
13.1
136
682
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
13.1
462
3219
J45.8
ICD-10 Finland
Mixed asthma
1.9
13.0
169
915
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.1
13.0
116
550
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
4.1
13.0
35
86
A10AC01
ATC
insulin (human); parenteral
1.5
12.9
480
3376
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.4
12.9
532
3814
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
6.1
12.9
22
36
SPAT1125
SPAT
Stoma care and guidance
2.1
12.9
124
605
B01AB10
ATC
tinzaparin; parenteral
1.4
12.9
543
3910
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
12.9
707
5323
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.2
12.9
1796
15277
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.1
12.8
118
566
N04BD01
ATC
selegiline; oral
2.2
12.8
105
481
IEV99
NOMESCO Finland
Other psychiatric network intervention
5.3
12.7
25
47
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
12.7
545
3937
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
3.6
12.7
41
115
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
12.7
280
1761
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.6
12.7
287
1816
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.2
12.6
105
485
IAB11
NOMESCO Finland
Psychiatric mood consultation
6.0
12.6
22
37
G56.3
ICD-10 Finland
Lesion of radial nerve
3.1
12.6
50
160
A02BA02
ATC
ranitidine; systemic
1.3
12.5
1152
9329
51500
ICD-8 Finland
Pneumoconiosis due to silica and silicates, Silicosis
+∞
12.5
12
*
K70.0
ICD-10 Finland
Alcoholic fatty liver
3.0
12.5
55
187
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
1.9
12.4
147
772
J67.1
ICD-10 Finland
Bagassosis
130.2
12.4
13
*
N06AB05
ATC
paroxetine; oral
1.7
12.4
233
1406
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.0
12.4
133
676
WX002
NOMESCO Finland
Sedation and analgesia
1.3
12.4
1024
8179
R03BA08
ATC
ciclesonide; inhalant
1.5
12.4
370
2493
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.5
12.3
364
2445
SPAT1284
SPAT
Extensive health certificate
2.0
12.3
132
670
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
4.5
12.3
29
64
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
4.5
12.3
29
64
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
3.3
12.3
44
132
ZXA00
NOMESCO Finland
Right side
1.3
12.3
1486
12432
T05
ICPC
Feeding problem of adult
3.0
12.3
52
173
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.4
12.2
684
5164
N06AB08
ATC
fluvoxamine; oral
2.0
12.2
123
611
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.5
12.2
367
2476
F13.09
ICD-10 Finland
Intoxication caused by sedative and hypnotic UNS
15.9
12.1
19
12
L04AD02
ATC
tacrolimus; systemic
3.0
12.1
51
169
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
12.1
452
3183
OAB48, ,
SPAT
0.6
12.1
203
3352
N06AA10
ATC
nortriptyline; systemic
2.2
12.1
94
422
G40.89
ICD-10 Finland
Other epilepsy
3.9
12.1
35
91
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
12.0
470
3338
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
3.3
12.0
43
129
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.0
12.0
131
670
T43.0
ICD-10 Finland
Poisoning: Tricyclic and tetracyclic antidepressants
21.3
12.0
17
8
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.3
12.0
827
6441
R06AE07
ATC
cetirizine; oral
1.2
12.0
2007
17374
J92
ICD-10 Finland
Pleural plaque
8.6
12.0
25
29
Z94.2
ICD-10 Finland
Lung transplant status
8.6
12.0
25
29
P01BA02
ATC
hydroxychloroquine; oral
1.5
12.0
349
2339
T42.4
ICD-10 Finland
Poisoning: Benzodiazepines
9.3
11.9
24
26
E46
ICD-10 Finland
Unspecified protein-energy malnutrition
5.7
11.9
22
39
F10.02
ICD-10 Finland
Alcohol-related acute intoxication with other acute clinical complications
5.7
11.9
22
39
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
11.9
324
2138
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
3.5
11.9
40
115
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
11.9
476
3394
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
4.3
11.9
30
70
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
11.9
1940
16746
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
11.9
304
1979
RL130, ,
NOMESCO Finland
4.8
11.9
26
54
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.2
11.8
92
413
H04AA01
ATC
glucagon; nasal, parenteral
2.3
11.8
88
388
X57
ICD-10 Finland
Unspecified privation
2.0
11.8
128
653
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.1
11.8
103
485
WW200, ,
SPAT
0.8
11.8
984
12163
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.8
11.8
171
960
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.0
11.7
131
675
L04AA01
ATC
[U] ciclosporin
2.5
11.7
70
279
RS121, ,
NOMESCO Finland
3.3
11.7
43
131
N07
ICPC
Convulsion/seizure
5.1
11.7
24
47
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
11.7
1958
16938
W17
ICD-10 Finland
Other fall from one level to another
1.7
11.7
214
1283
B34.9
ICD-10 Finland
Viral infection, unspecified
2.0
11.7
124
628
N05AD03
ATC
melperone; systemic
2.1
11.7
106
507
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
2.5
11.7
73
298
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
16.4
11.6
18
11
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
11.6
710
9146
S27.0
ICD-10 Finland
Traumatic pneumothorax
2.8
11.6
58
212
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
22.9
11.6
16
7
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
2.7
11.5
62
235
P77
ICPC
Suicide/suicide attempt
11.1
11.5
21
19
ZXA05
NOMESCO Finland
Left side
1.2
11.5
1387
11586
TGD00
NOMESCO Finland
Needle biopsy of lung
3.5
11.5
39
113
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.2
11.5
95
438
TK810
NOMESCO Finland
Hemofiltration
3.2
11.5
45
143
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.1
11.4
110
538
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.5
11.4
392
2717
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
1.9
11.4
142
760
R95
ICPC
Chron obstructive pulmonary disease
1.7
11.4
200
1186
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.8
11.3
155
854
TPX15
NOMESCO Finland
Removal of vascular injection port
3.9
11.3
33
86
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
2.8
11.3
54
192
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
11.3
2247
19750
A10AE05
ATC
insulin detemir; parenteral
1.6
11.3
287
1866
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
15.0
11.3
18
12
R60.0
ICD-10 Finland
Localized oedema
1.3
11.3
734
5667
F20.8
ICD-10 Finland
Other schizophrenia
4.2
11.2
29
69
N05AB01
ATC
dixyrazine; systemic
2.4
11.2
75
316
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
4.9
11.2
24
49
SPAT1060
SPAT
Administration of oxygen
3.2
11.2
42
130
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
2.1
11.2
99
469
J15.8
ICD-10 Finland
Other bacterial pneumonia
2.7
11.2
58
216
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
2.7
11.1
56
205
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.9
11.1
52
183
M05BX04
ATC
denosumab; parenteral
1.5
11.1
326
2188
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.3
11.1
82
361
UKC02
NOMESCO Finland
Cystoscopy
1.3
11.1
1152
9456
RS230, ,
NOMESCO Finland
3.4
11.1
39
116
SPAT1251
SPAT
Organisation of medication
1.6
11.0
224
1380
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
2.6
11.0
64
252
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.3
11.0
81
356
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.8
11.0
55
201
2954A
ICD-9 Finland
Schizophrenic psychoses, Acute schizophrenic episode
5.0
11.0
23
46
GBB13
NOMESCO Finland
Revision of tracheostomy
10.0
11.0
21
21
L04AD01
ATC
ciclosporin; systemic
2.3
11.0
80
350
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
11.0
484
3513
E0000UV, ,
ATC
1.2
10.9
2118
18558
N04BX02
ATC
entacapone; oral
3.4
10.9
38
112
A06AH03
ATC
naloxegol; oral
2.2
10.9
84
376
WX212
NOMESCO Finland
Femoral plexus blockade
1.8
10.9
147
807
C07AA05
ATC
propranolol; systemic
1.3
10.9
826
6517
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1.7
10.8
209
1271
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
2.9
10.8
48
164
F03
ICD-10 Finland
Unspecified dementia
1.5
10.8
374
2596
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
10.8
444
3184
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
2.1
10.8
102
496
7803A
ICD-9 Finland
General symptoms, Convulsions
2.8
10.8
53
192
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
3.0
10.8
46
154
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
8.8
10.7
22
25
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.7
10.7
174
1010
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
10.7
2197
19349
S06.2
ICD-10 Finland
Diffuse brain injury
2.5
10.7
66
268
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.8
10.7
170
981
R52.2
ICD-10 Finland
Other chronic pain
1.8
10.7
170
981
R03DC03
ATC
montelukast; oral
1.3
10.7
684
5267
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.1
10.7
42
134
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
3.3
10.6
38
114
K20
ICD-10 Finland
Oesophagitis
2.1
10.6
100
485
K22.1
ICD-10 Finland
Ulcer of oesophagus
2.0
10.6
115
587
L04AA13
ATC
[U] leflunomide
2.0
10.6
105
519
H3603, E103,
ICD-10 Finland
3.0
10.6
45
150
E87.2
ICD-10 Finland
Acidosis
3.0
10.6
44
145
130
Kela drug reimbursment
Malignant tumour
1.4
10.5
556
4158
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
3.2
10.5
40
125
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
3.3
10.5
39
120
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
4.3
10.5
26
60
N07BA03
ATC
varenicline; oral
1.7
10.5
175
1024
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
2.4
10.5
68
283
Z03
ICPC
Housing/neighbourhood problem
2.8
10.4
49
173
J01CA08
ATC
pivmecillinam; oral
1.2
10.4
1539
13119
5020A
ICD-9 Finland
Pneumoconiosis due to other silica or silicates[SILICOSIS]
+∞
10.4
10
*
J63.1
ICD-10 Finland
Bauxite fibrosis (of lung)
+∞
10.4
10
*
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
3.5
10.4
35
101
Z50.1
ICD-10 Finland
Other physical therapy
1.6
10.4
268
1749
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.3
10.4
79
352
G72.9
ICD-10 Finland
Myopathy, unspecified
2.8
10.4
50
179
A04AD12
ATC
aprepitant; systemic
2.2
10.4
81
365
J11.0
ICD-10 Finland
Influenza with pneumonia, virus not identified
3.7
10.4
32
87
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
2.4
10.4
68
284
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.6
10.3
222
1388
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
4.2
10.3
27
65
C09AA05
ATC
ramipril; oral
1.2
10.3
1628
13968
J45
ICD-10 Finland
Asthma
1.4
10.3
434
3124
N02BF02
ATC
pregabalin; oral
1.5
10.3
293
1955
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.6
10.3
222
1390
WW200
NOMESCO Finland
Immunization
1.9
10.3
131
707
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.8
10.3
153
867
NFQ20
NOMESCO Finland
Amputation of femur
2.3
10.3
75
329
J12.8
ICD-10 Finland
Other viral pneumonia
2.7
10.2
54
203
Y94.0
ICD-10 Finland
Accident at home
2.0
10.2
113
583
SPAT1310
SPAT
Counselling related to known health issue
1.2
10.1
1549
13244
I45.9
ICD-10 Finland
Conduction disorder, unspecified
2.4
10.1
67
281
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
4.1
10.1
27
66
OAB40, ,
SPAT
4.1
10.1
27
66
N06AX26
ATC
vortioxetine; oral
1.5
10.1
283
1881
A10AB01
ATC
insulin (human); parenteral
1.7
10.1
170
997
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.0
10.1
107
543
SPAT1281
SPAT
Other administrative function
1.4
10.1
375
2640
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
2.6
10.1
54
205
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
2.8
10.0
49
177
WX707
NOMESCO Finland
Fiberoscopic intubation
4.3
10.0
25
58
F1246, ,
NOMESCO Finland
5.0
10.0
21
42
B37.7
ICD-10 Finland
Candidal sepsis
5.0
10.0
21
42
R27.0
ICD-10 Finland
Ataxia, unspecified
3.5
10.0
33
94
S00.0
ICD-10 Finland
Superficial injury of scalp
1.8
10.0
143
800
SPAT1104
SPAT
Monitoring of emergency patient
1.5
10.0
343
2377
R03AK11
ATC
formoterol and fluticasone; inhalant
1.9
10.0
113
586
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
10.0
1529
13073
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.8
10.0
150
852
F11.2
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, dependence syndrome
14.6
10.0
16
11
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.9
10.0
122
650
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
2.6
10.0
54
206
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.4
10.0
476
3503
SPAT1252
SPAT
Overall medication plan or its review
1.4
9.9
401
2865
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
9.9
682
5304
R03BB02
ATC
oxitropium bromide; inhalant
2.4
9.9
66
278
N91.1
ICD-10 Finland
Secondary amenorrhoea
3.6
9.9
32
90
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
2.3
9.9
71
309
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
9.9
406
2910
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.8
9.9
155
892
L02BG04
ATC
letrozole; oral
1.6
9.9
228
1452
K22.0
ICD-10 Finland
Achalasia of cardia
3.4
9.8
34
100
IER01
NOMESCO Finland
Psychoeducation, group
3.9
9.8
28
72
G83.4
ICD-10 Finland
Cauda equina syndrome
3.9
9.8
28
72
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
8.1
9.8
21
26
F19.50
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic
26.0
9.8
13
5
T17.5
ICD-10 Finland
Foreign body in bronchus
20.0
9.8
14
7
J43.2
ICD-10 Finland
Centrilobular emphysema
3.6
9.8
31
86
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.0
9.8
41
136
JAH01
NOMESCO Finland
Laparoscopy
1.7
9.7
170
1008
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
9.5
9.7
19
20
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.5
9.7
289
1946
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.3
9.7
625
4814
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.8
9.7
139
778
7860A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]
2.5
9.7
58
232
XG405
NOMESCO Finland
Education on PEF monitoring
2.2
9.7
80
369
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
1.9
9.7
124
670
A01AB04
ATC
amphotericin B; local oral
1.6
9.7
248
1616
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
3.4
9.7
33
96
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
3.4
9.7
34
101
WX402
NOMESCO Finland
General anaesthesia
1.3
9.7
974
7953
J20
ICD-10 Finland
Acute bronchitis
1.4
9.7
455
3339
JN4CD
NOMESCO Finland
Very extensive body CT
1.6
9.7
203
1263
SPAT1360
SPAT
Extensive global examination
1.4
9.7
366
2586
HA1AA
NOMESCO Finland
X-ray mammography
1.5
9.6
273
1820
S06.4
ICD-10 Finland
Epidural haemorrhage
5.3
9.6
19
36
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
5.3
9.6
19
36
ZZA00
NOMESCO Finland
Split skin graft
1.7
9.6
169
1004
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
2.3
9.6
72
320
Z75.5
ICD-10 Finland
Holiday relief care
2.2
9.6
81
378
K29.2
ICD-10 Finland
Alcoholic gastritis
4.3
9.6
24
56
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.8
9.6
149
856
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
1.7
9.6
160
938
A10AA01, ,
ATC
1.9
9.5
113
596
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
11.4
9.5
17
15
EBA00
NOMESCO Finland
Extraction of tooth
1.2
9.5
1754
15256
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
4.8
9.5
21
44
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
2.8
9.5
45
160
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
15.0
9.5
15
10
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.5
9.5
259
1713
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
2.4
9.5
61
253
ZX080
NOMESCO Finland
Image guided radiotherapy
2.0
9.5
103
528
EB4VA, ,
NOMESCO Finland
0.7
9.5
317
4507
G12.2
ICD-10 Finland
Motor neuron disease
2.8
9.5
46
166
L03AA14
ATC
lipegfilgrastim; parenteral
2.2
9.4
77
354
RS222, ,
NOMESCO Finland
2.3
9.4
69
303
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
3.2
9.4
36
113
XW000
NOMESCO Finland
Bone marrow biopsy
1.6
9.4
228
1469
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.3
9.4
70
310
T40.1
ICD-10 Finland
Poisoning: Heroin
30.0
9.4
12
*
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
17.5
9.4
14
8
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
9.4
916
7453
5050A
ICD-9 Finland
Pneumoconiosis, unspecified[PNEUMOCONIOSIS NUD]
+∞
9.4
9
*
J66.0
ICD-10 Finland
Byssinosis
+∞
9.4
9
*
5062A
ICD-9 Finland
Respiratory conditions due to chemical fumes and vapours, Upper respiratory inflammation due to fumes and vapours
+∞
9.4
9
*
5088X
ICD-9 Finland
Respiratory conditions due to other and unspecified external agents, Respiratory conditions due to other specified external agents[MORBI ORGANORUM RESP CAUSA EXT ALIA DEFINITA]
+∞
9.4
9
*
51599
ICD-8 Finland
Pneumoconiosis due to silica and silicates, Other, including pneumoconiosis, unspecified
+∞
9.4
9
*
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.6
9.4
217
1383
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
5.1
9.3
19
37
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
3.5
9.3
31
89
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
3.5
9.3
31
89
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
8.0
9.3
20
25
IFA99, ,
SPAT
4.4
9.3
23
53
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
4.4
9.3
23
53
R28
ICPC
Limited function/disability (R)
2.1
9.3
87
422
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.2
9.3
1248
10519
29510
ICD-8 Finland
Schizophrenia, Hebephrenic type
4.9
9.3
20
41
GDC00
NOMESCO Finland
Lobectomy of lung
2.7
9.3
48
179
WX726
NOMESCO Finland
High-flow oxygen therapy
4.7
9.3
21
45
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
9.3
169
1015
A98
ICPC
Health maint/preventive medicine
0.8
9.2
4950
51711
IFC01, ,
SPAT
9.5
9.2
18
19
WX900
NOMESCO Finland
Resuscitation
3.0
9.2
39
130
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
9.2
142
814
G91.0
ICD-10 Finland
Communicating hydrocephalus
3.1
9.2
37
120
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
2.7
9.2
48
180
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.3
9.2
539
4097
XG460
NOMESCO Finland
Short time oxymetry
1.9
9.2
109
576
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.4
9.2
58
239
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
4.1
9.2
24
58
OAB95, ,
SPAT
0.5
9.1
66
1403
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.3
9.1
682
5367
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.2
9.1
75
347
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
4.4
9.1
22
50
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
11.5
9.0
16
14
WPA13
NOMESCO Finland
Palliative consultation
3.1
9.0
36
116
Y07
ICD-10 Finland
Other maltreatment
3.1
9.0
36
116
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
2.3
9.0
65
284
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
15.6
9.0
14
9
S22.3
ICD-10 Finland
Fracture of rib
1.4
9.0
403
2933
A03FA02
ATC
cisapride; oral, rectal
1.4
9.0
404
2942
GDG10
NOMESCO Finland
Bilateral transplantation of lung
9.0
9.0
18
20
E000001, ,
ATC
1.3
9.0
938
7692
NHQ40
NOMESCO Finland
Amputation of toe
1.8
9.0
118
645
G04BD04
ATC
oxybutynin; oral, transdermal
1.5
8.9
301
2080
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.6
8.9
51
200
AN1
HP
Coronary angiography
1.3
8.9
740
5900
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
8.9
764
6116
I21.97
ICD-10 Finland
Suspected acute myocardial infarction
2.1
8.9
81
389
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
2.4
8.9
56
230
P01
ICPC
Feeling anxious/nervous/tense
1.4
8.9
346
2457
IHZ05, ,
SPAT
1.9
8.9
115
625
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
3.9
8.8
25
64
K11.72
ICD-10 Finland
Xerostomia
7.9
8.8
19
24
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
4.5
8.8
21
47
S31.1
ICD-10 Finland
Open wound of abdominal wall
3.6
8.8
28
78
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
4.7
8.8
20
43
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.2
8.8
74
345
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
2.3
8.8
64
281
WYA20
NOMESCO Finland
Home visit
1.8
8.8
134
766
IEY01
NOMESCO Finland
Psychoeducation, individual
3.5
8.8
29
83
A07AA09
ATC
vancomycin; oral
2.0
8.8
87
432
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
2.2
8.8
71
326
I25.2
ICD-10 Finland
Old myocardial infarction
1.3
8.8
538
4117
R10.0
ICD-10 Finland
Acute abdomen
1.7
8.8
157
939
V01.9
ICD-10 Finland
Pedestrian injured in collision with pedal cycle, Unspecified whether traffic or nontraffic accident
3.4
8.7
30
88
M81.4
ICD-10 Finland
Drug-induced osteoporosis
3.3
8.7
32
98
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
2.9
8.7
40
140
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
1.6
8.7
195
1234
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.5
8.7
263
1780
G72.4
ICD-10 Finland
Inflammatory myopathy, not elsewhere classified
14.0
8.7
14
10
Z08
ICPC
Social welfare problem
2.3
8.7
65
289
C07AB02
ATC
metoprolol; systemic
1.2
8.7
1348
11524
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
2.8
8.7
41
146
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
2.3
8.6
60
258
R29
ICPC
Respiratory symptom/complaint other
1.5
8.6
306
2136
M60.8
ICD-10 Finland
Other myositis
4.2
8.6
22
52
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.7
8.6
149
882
WX110
NOMESCO Finland
Infiltration anesthesia
1.2
8.6
3574
33178
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
3.5
8.6
29
84
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
3.5
8.6
29
84
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
2.0
8.6
95
490
K56.2
ICD-10 Finland
Volvulus
2.5
8.6
50
198
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
8.6
214
1388
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.0
8.6
89
449
UJC01
NOMESCO Finland
Scopy of lower throat
2.3
8.6
59
253
GBB03
NOMESCO Finland
Percutaneous tracheostomy
11.6
8.6
15
13
G40.59
ICD-10 Finland
Other special epileptic syndromes
11.6
8.6
15
13
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.5
8.5
241
1607
J02AC01
ATC
fluconazole; systemic
1.2
8.5
1471
12696
9693X
ICD-9 Finland
Poisoning by psychotropic agents, Other antipsychotics, neuroleptics and major tranquillisers
16.3
8.5
13
8
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
6.9
8.5
20
29
ZYY01
NOMESCO Finland
Contact between professionals
3.8
8.5
25
66
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
2.3
8.5
59
254
F19.22
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication
27.5
8.5
11
*
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
2.4
8.5
56
236
F01.9
ICD-10 Finland
Vascular dementia, unspecified
1.7
8.4
134
775
R52.1
ICD-10 Finland
Chronic intractable pain
2.6
8.4
45
171
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
1.8
8.4
127
724
W74
ICD-10 Finland
Unspecified drowning and submersion
90.2
8.4
9
*
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
2.9
8.4
38
132
L02BG06
ATC
exemestane; oral
2.3
8.4
62
274
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
8.4
1215
10311
R42
ICD-10 Finland
Dizziness and giddiness
1.2
8.4
1291
11024
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
2.5
8.4
49
195
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
2.8
8.4
41
149
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
2.4
8.4
53
219
J43.9
ICD-10 Finland
Emphysema, unspecified
1.8
8.4
115
638
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
2.0
8.3
89
454
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
6.7
8.3
20
30
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
6.7
8.3
20
30
J63.0
ICD-10 Finland
Aluminosis (of lung)
+∞
8.3
8
*
J67.7
ICD-10 Finland
Air-conditioner and humidifier lung
+∞
8.3
8
*
J67
ICD-10 Finland
Hypersensitivity pneumonitis due to organic dust
+∞
8.3
8
*
J68.1
ICD-10 Finland
Pulmonary oedema due to chemicals, gases, fumes and vapours
+∞
8.3
8
*
F20.5
ICD-10 Finland
Residual schizophrenia
3.2
8.3
32
101
RS313, ,
NOMESCO Finland
3.7
8.3
25
67
S70.0
ICD-10 Finland
Contusion of hip
1.5
8.3
234
1560
ZX108
NOMESCO Finland
Inhalation
2.7
8.3
43
161
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
8.5
8.3
17
20
F10.07
ICD-10 Finland
Pathological alcohol intoxication
10.7
8.3
15
14
B01AC07
ATC
dipyridamole; systemic
1.4
8.3
389
2857
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
2.0
8.3
81
401
XX1XN
NOMESCO Finland
Other isotope examination
3.0
8.3
34
112
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
1.9
8.2
94
491
SPAT1244
SPAT
Occupational therapy
2.4
8.2
56
239
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
1.7
8.2
141
834
P74
ICPC
Anxiety disorder/anxiety state
1.7
8.2
138
812
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
8.2
583
4555
F25.0
ICD-10 Finland
Schizoaffective disorder, manic type
6.5
8.2
20
31
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
6.5
8.2
20
31
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
8.2
1528
13283
B01AC04
ATC
clopidogrel; oral
1.2
8.2
1102
9285
I95.9
ICD-10 Finland
Hypotension, unspecified
1.8
8.1
106
578
T18.1
ICD-10 Finland
Foreign body in oesophagus
2.4
8.1
55
234
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
4.4
8.1
20
46
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
3.0
8.1
34
113
NGQ20
NOMESCO Finland
Amputation of lower leg
2.5
8.1
47
186
N05AL01
ATC
sulpiride; systemic
2.1
8.1
73
350
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
1.8
8.1
121
688
29570
ICD-8 Finland
Schizophrenia, Schizo-affective type
4.5
8.1
19
42
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.6
8.1
205
1336
N04BC05
ATC
pramipexole; oral
1.4
8.1
380
2790
Z43.5
ICD-10 Finland
Attention to cystostomy
2.3
8.1
59
260
WX890
NOMESCO Finland
Intesive care monitoring
2.4
8.1
54
229
F05.8
ICD-10 Finland
Other delirium
2.2
8.0
61
273
D10
ICPC
Vomiting
1.6
8.0
182
1156
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.6
8.0
201
1307
SPAT1243
SPAT
Psychiatric/psychological examination
2.1
8.0
75
365
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.4
8.0
439
3303
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.4
8.0
293
2059
NFJ52
NOMESCO Finland
Internal fixation of fracture of upper femur with screws and sideplate
2.2
8.0
62
280
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
3.5
8.0
26
74
N17.8
ICD-10 Finland
Other acute renal failure
2.0
7.9
83
421
ZYC01
NOMESCO Finland
Remote contact by phone
1.5
7.9
258
1773
N05CD02
ATC
nitrazepam; oral
1.8
7.9
112
627
29580
ICD-8 Finland
Schizophrenia, Other
3.2
7.9
30
94
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
1.6
7.9
169
1059
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.7
7.9
139
829
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
6.6
7.9
19
29
IBZ14, ,
SPAT
7.7
7.9
17
22
G83.8
ICD-10 Finland
Other specified paralytic syndromes
7.7
7.9
17
22
R06.4
ICD-10 Finland
Hyperventilation
2.2
7.8
63
289
B01AB04
ATC
dalteparin; parenteral
1.5
7.8
262
1811
F33.8
ICD-10 Finland
Other recurrent depressive disorders
3.1
7.8
31
100
R40.0
ICD-10 Finland
Somnolence
3.5
7.8
26
75
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
2.3
7.8
55
239
F20.20
ICD-10 Finland
Catatonic schizophrenia continuously
10.8
7.8
14
13
B17.1
ICD-10 Finland
Acute hepatitis C
10.8
7.8
14
13
AAK00
NOMESCO Finland
Cranioplasty
10.8
7.8
14
13
NG1AA, ,
SPAT
0.6
7.8
109
1880
S82.2
ICD-10 Finland
Fracture of shaft of tibia
2.1
7.8
70
336
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
3.3
7.8
28
85
ZX095
NOMESCO Finland
Combined chemoradiotherapy
2.8
7.8
36
127
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
1.4
7.8
335
2425
GBB96
NOMESCO Finland
Other tracheostomy procedure
6.9
7.8
18
26
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.1
7.7
66
310
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
2.4
7.7
52
221
-2, ,
ICPC
2.6
7.7
43
167
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
7.7
264
1832
EB1WA, ,
NOMESCO Finland
2.8
7.7
37
133
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.7
7.7
40
150
S42.0
ICD-10 Finland
Fracture of clavicle
1.7
7.7
137
819
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.0
7.7
74
364
UJF32
NOMESCO Finland
Coloscopy
1.2
7.7
1427
12384
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.1
7.7
66
311
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.6
7.7
153
942
318
Kela drug reimbursment
Teriparatide
3.1
7.7
31
101
A01
ICPC
Pain general/multiple sites
1.3
7.7
482
3701
ZXE90
NOMESCO Finland
More than 22 hours
2.3
7.7
53
228
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
1.7
7.7
121
700
N05AX15
ATC
cariprazine; oral
5.9
7.7
20
34
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
3.1
7.7
30
96
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
3.1
7.7
30
96
W78
ICD-10 Finland
Inhalation of gastric contents
7.4
7.7
17
23
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
4.5
7.6
18
40
R64
ICD-10 Finland
Cachexia
3.7
7.6
23
62
R52.0
ICD-10 Finland
Acute pain
1.7
7.6
136
815
L04AX03
ATC
methotrexate; systemic
1.4
7.6
389
2898
C08CA02
ATC
felodipine; oral
1.3
7.6
589
4657
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.3
7.6
508
3938
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
1.9
7.6
96
520
3049X
ICD-9 Finland
Drug dependence, Unspecified drug dependence
11.8
7.6
13
11
5188X
ICD-9 Finland
Other diseases of lung
3.0
7.6
31
102
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
3.0
7.6
31
102
ZX100
NOMESCO Finland
Oral
2.0
7.6
79
401
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.2
7.5
61
281
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
2.9
7.5
33
113
M01AH05
ATC
etoricoxib; oral
0.9
7.5
2438
26699
ZXA10
NOMESCO Finland
Bilateral
1.2
7.5
960
8040
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
2.1
7.5
67
321
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
2.4
7.5
50
212
WVA20
NOMESCO Finland
Medicine administration
1.7
7.5
136
818
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.4
7.5
268
1877
PA2AD
NOMESCO Finland
CT angiography of brain
2.5
7.5
44
176
TGA30
NOMESCO Finland
Thoracocentesis
2.3
7.5
56
250
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.4
7.5
297
2121
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
7.5
1989
17788
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
2.7
7.5
39
147
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
2.2
7.4
58
263
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
1.7
7.4
140
850
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
4.4
7.4
18
41
RS122, ,
NOMESCO Finland
4.4
7.4
18
41
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.3
7.4
516
4020
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
2.1
7.4
63
296
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
2.4
7.4
49
207
A41.8
ICD-10 Finland
Other specified sepsis
1.7
7.4
120
700
G23.2
ICD-10 Finland
Multiple system atrophy, parkinsonian type [MSA-P]
13.4
7.4
12
9
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
7.6
7.4
16
21
Y96.9
ICD-10 Finland
Unspecified type of accident
1.9
7.4
91
489
WF049
NOMESCO Finland
Radiotherapy of metastasis
1.5
7.4
196
1293
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
6.0
7.4
19
32
D07AA02
ATC
hydrocortisone; topical
1.3
7.3
619
4944
A07EC01
ATC
sulfasalazine; oral, rectal
1.4
7.3
342
2509
Z94.0
ICD-10 Finland
Kidney transplant status
2.3
7.3
50
214
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
3.7
7.3
22
59
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
3.7
7.3
22
59
H25.8
ICD-10 Finland
Other senile cataract
1.3
7.3
726
5911
SPAT1139
SPAT
Nutrition survey
1.6
7.3
169
1079
M01CB01
ATC
sodium aurothiomalate; parenteral
2.1
7.3
64
304
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
2.1
7.3
67
324
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
1.7
7.3
117
680
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
1.9
7.3
84
441
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
2.7
7.3
38
143
QAB00
NOMESCO Finland
Suture of skin of head or neck
2.0
7.3
73
365
M05BB03
ATC
alendronic acid and colecalciferol; oral
1.8
7.3
111
636
T96
ICD-10 Finland
Sequelae of poisoning by drugs, medicaments and biological substances
+∞
7.3
7
*
51600
ICD-8 Finland
Other pneumoconiosis and related diseases, Due to inhalation of other inorganic dust
+∞
7.3
7
*
5060A
ICD-9 Finland
Respiratory conditions due to chemical fumes and vapours, Bronchitis and pneumonitis due to fumes and vapours
+∞
7.3
7
*
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
3.6
7.3
23
64
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
2.1
7.3
66
318
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
2.3
7.3
54
240
IFC04, ,
SPAT
9.3
7.3
14
15
QDG00
NOMESCO Finland
Debridement of bedsore of lower limb
4.1
7.3
19
46
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
4.1
7.3
19
46
H3600, E103,
ICD-10 Finland
2.6
7.2
41
161
29599
ICD-8 Finland
Schizophrenia, Unspecified type
3.2
7.2
27
84
WZA10
NOMESCO Finland
Extensive medical or dental certificate
2.2
7.2
57
260
F32.1
ICD-10 Finland
Moderate depressive episode
1.6
7.2
173
1115
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
3.0
7.2
31
105
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
4.3
7.2
18
42
J15
ICD-10 Finland
Bacterial pneumonia, not elsewhere classified
5.8
7.2
19
33
I20.09
ICD-10 Finland
Unstable angina
1.4
7.2
373
2784
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
2.3
7.2
50
216
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.4
7.2
306
2211
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.5
7.2
221
1503
N06AG02
ATC
moclobemide; oral
1.5
7.2
182
1188
T40.2
ICD-10 Finland
Poisoning: Other opioids
7.3
7.2
16
22
EDC38
NOMESCO Finland
Open reduction and fixation of fracture of body of mandible
4.5
7.2
17
38
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
4.5
7.2
17
38
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.5
7.2
193
1277
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
1.6
7.1
144
891
Z93.0
ICD-10 Finland
Tracheostomy status
20.0
7.1
10
5
JFF00
NOMESCO Finland
Catheter enterostomy
7.9
7.1
15
19
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
2.6
7.1
39
151
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
3.3
7.1
26
80
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
2.8
7.1
33
117
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1.8
7.1
106
605
G40.50
ICD-10 Finland
Epilepsia partialis continua [Kozhevnikof]
12.0
7.1
12
10
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
4.1
7.1
19
47
M33.2
ICD-10 Finland
Polymyositis
4.1
7.1
19
47
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
1.9
7.1
78
404
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.5
7.1
204
1370
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
1.8
7.1
91
496
G82.5
ICD-10 Finland
Tetraplegia, unspecified
6.0
7.1
18
30
G04BD07
ATC
tolterodine; oral
1.4
7.1
269
1907
SAA04
NOMESCO Finland
Special examination of mouth
1.5
7.1
199
1330
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
1.7
7.0
120
710
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
2.2
7.0
56
257
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
2.2
7.0
58
270
2959E
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]
4.2
7.0
18
43
C03DA01
ATC
spironolactone; oral
1.2
7.0
752
6180
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
2.9
7.0
31
107
F25
ICD-10 Finland
Schizoaffective disorders
7.0
7.0
16
23
L99
ICPC
Musculoskeletal disease other
1.8
7.0
102
578
03400
ICD-8 Finland
Streptococcal sore throat and scarlet fever, Streptococcal sore throat
3.1
7.0
27
86
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
1.6
7.0
147
920
S01.8
ICD-10 Finland
Open wound of other parts of head
1.9
6.9
87
470
K55.9
ICD-10 Finland
Vascular disorder of intestine, unspecified
3.3
6.9
25
76
RS224, ,
NOMESCO Finland
3.3
6.9
25
76
K70.1
ICD-10 Finland
Alcoholic hepatitis
2.8
6.9
32
113
SPD00
NOMESCO Finland
Mucosa borne complete denture
2.1
6.9
64
311
N05AE05
ATC
lurasidone; oral
5.4
6.9
19
35
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
5.4
6.9
19
35
R96
ICPC
Asthma
1.3
6.9
428
3283
F50.3
ICD-10 Finland
Atypical bulimia nervosa
7.5
6.9
15
20
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
7.5
6.9
15
20
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
2.8
6.9
33
119
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
2.6
6.9
37
142
G82.2
ICD-10 Finland
Paraplegia, unspecified
2.9
6.8
30
103
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
2.9
6.8
30
103
R4130, ,
SPAT
3.2
6.8
26
82
E13.1
ICD-10 Finland
Other specified diabetes mellitus, with ketoacidosis
8.2
6.8
14
17
S20.2
ICD-10 Finland
Contusion of thorax
1.4
6.8
262
1861
H03AA01
ATC
levothyroxine sodium; systemic
1.2
6.8
981
8310
N05AX16
ATC
brexpiprazole; oral
4.1
6.8
18
44
Y90.8
ICD-10 Finland
Blood alcohol level of 240 mg/100 ml or more
6.7
6.8
16
24
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
1.8
6.8
95
532
1CX08, ,
NOMESCO Finland
2.9
6.8
31
109
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
2.6
6.8
37
143
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
2.2
6.8
54
248
F12.24
ICD-10 Finland
Addiction caused by cannabis active addiction
40.1
6.8
8
*
F15.0
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication
16.7
6.7
10
6
SPE90
NOMESCO Finland
Other partial denture
1.7
6.7
110
644
ZXD00
NOMESCO Finland
Emergency procedure
1.6
6.7
156
999
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
6.7
1344
11727
T78.4
ICD-10 Finland
Allergy, unspecified
1.6
6.7
150
952
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.4
6.7
309
2264
F20.10
ICD-10 Finland
Raise schizophrenia continuously
3.5
6.7
22
63
GD1AA, ,
SPAT
0.7
6.7
360
4737
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
6.7
1958
17605
U07
ICPC
Urine symptom/complaint other
1.3
6.7
419
3218
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
7.2
6.7
15
21
F13.00
ICD-10 Finland
Intoxication caused by sedatives and hypnotics uncomplicated
7.2
6.7
15
21
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
3.2
6.7
25
78
F50.9
ICD-10 Finland
Eating disorder, unspecified
3.4
6.7
23
68
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
1.8
6.7
102
586
F44.5
ICD-10 Finland
Dissociative convulsions
22.5
6.7
9
*
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
22.5
6.7
9
*
Y34
ICD-10 Finland
Unspecified event, undetermined intent
2.8
6.7
31
110
Z10.0
ICD-10 Finland
Occupational health examination
0.6
6.7
110
1815
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
3.0
6.6
28
94
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
2.0
6.6
66
330
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.5
6.6
178
1178
QBB00
NOMESCO Finland
Suture of skin of trunk
3.7
6.6
20
54
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
3.7
6.6
20
54
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
6.6
589
4736
G41.8
ICD-10 Finland
Other status epilepticus
6.4
6.6
16
25
SPAT1097
SPAT
Recording of ECG
1.2
6.6
758
6272
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
2.2
6.6
51
231
K22.5
ICD-10 Finland
Diverticulum of oesophagus, acquired
2.6
6.6
36
139
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
2.6
6.6
36
139
IBZ15, ,
SPAT
7.8
6.6
14
18
H05AA02
ATC
teriparatide; parenteral
3.0
6.6
27
89
K70.4
ICD-10 Finland
Alcoholic hepatic failure
3.0
6.6
27
89
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
5.5
6.6
18
33
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
2.7
6.6
33
122
137
Kela drug reimbursment
Uraemia requiring dialysis
2.3
6.6
47
206
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
3.1
6.6
26
84
G91.1
ICD-10 Finland
Obstructive hydrocephalus
3.1
6.6
26
84
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.1
6.6
59
284
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
2.2
6.6
49
219
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
3.2
6.5
25
79
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
3.4
6.5
22
64
R1250
NOMESCO Finland
Evaluation of functional capability
1.7
6.5
118
710
T51.9
ICD-10 Finland
Toxic effect: Alcohol, unspecified
8.7
6.5
13
15
ZYB07
NOMESCO Finland
Outreach service at sheltered housing unit
8.7
6.5
13
15
W10
ICD-10 Finland
Fall on and from stairs and steps
1.4
6.5
252
1792
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.3
6.5
378
2872
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
2.2
6.5
54
252
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.2
6.5
52
239
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
2.2
6.5
52
239
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
1.8
6.5
92
517
RS140, ,
NOMESCO Finland
6.8
6.5
15
22
XX3XW, ,
NOMESCO Finland
2.5
6.5
38
152
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.2
6.5
49
220
-69
ICPC
Other reason for encounter NEC
1.5
6.5
178
1184
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
2.2
6.5
51
233
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.3
6.4
441
3430
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.5
6.4
180
1202
H3601, E103,
ICD-10 Finland
2.6
6.4
35
135
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
5.7
6.4
17
30
T17.9
ICD-10 Finland
Foreign body in respiratory tract, part unspecified
5.7
6.4
17
30
TJD20, ,
SPAT
69.9
6.4
7
*
NAU20
NOMESCO Finland
Removal of internal fixation device from spine or neck
3.5
6.4
21
60
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
1.6
6.4
127
783
NC1BA
NOMESCO Finland
Elbow extensive X-ray examination
2.5
6.4
39
159
F21
ICD-10 Finland
Schizotypal disorder
3.2
6.4
24
75
E87.5
ICD-10 Finland
Hyperkalaemia
1.6
6.4
122
745
RL210, ,
NOMESCO Finland
3.4
6.4
22
65
OAA65, ,
SPAT
0.7
6.4
248
3433
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
3.3
6.4
23
70
A69.2
ICD-10 Finland
Lyme disease
0.6
6.4
118
1894
F60.5
ICD-10 Finland
Anankastic personality disorder
2.6
6.4
34
130
J01FA01
ATC
erythromycin; systemic
1.3
6.4
498
3942
NC2AA
NOMESCO Finland
Forearm X-ray examination
2.0
6.4
62
308
C01AA05
ATC
digoxin; systemic
1.2
6.4
647
5285
L03AA13
ATC
pegfilgrastim; parenteral
1.5
6.3
167
1101
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.6
6.3
123
755
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
1.9
6.3
78
420
F20.19
ICD-10 Finland
Hebefren schizophrenia UNS
6.5
6.3
15
23
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.1
6.3
57
275
ZX100, ,
SPAT
8.1
6.3
13
16
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
2.3
6.3
44
191
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
6.3
142
904
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
3.6
6.3
20
56
GDA10
NOMESCO Finland
Biopsy of lung
3.6
6.3
20
56
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
3.6
6.3
20
56
F32
ICD-10 Finland
Depressive episode
1.5
6.3
166
1095
NGJ60
NOMESCO Finland
Internal fixation of fracture of knee or lower leg using intramedullary nail, other or unspecified
2.3
6.3
43
185
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
1.7
6.3
100
582
N05AL05
ATC
amisulpride; oral
9.2
6.3
12
13
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
1.9
6.3
75
400
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.0
6.3
67
344
K92.1
ICD-10 Finland
Melaena
1.3
6.3
343
2584
SPAT1325
SPAT
Vaccination
1.2
6.3
1833
16467
S02.11
ICD-10 Finland
Fracture of base of skull, open
3.2
6.3
23
71
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
18.0
6.3
9
5
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
2.9
6.3
27
92
NA2AD
NOMESCO Finland
Thoracic spine CT examination
2.4
6.3
39
161
C79.41
ICD-10 Finland
Secondary malignant tumor of optic nerve and eye
+∞
6.2
6
*
J68.8
ICD-10 Finland
Other respiratory conditions due to chemicals, gases, fumes and vapours
+∞
6.2
6
*
T36N0, ,
ICD-10 Finland
+∞
6.2
6
*
5030A
ICD-9 Finland
Pneumoconiosis due to other inorganic dust[PNEUMOCONIOSIS ALIA DEFINITA]
+∞
6.2
6
*
J63.5
ICD-10 Finland
Stannosis
+∞
6.2
6
*
J65
ICD-10 Finland
Pneumoconiosis associated with tuberculosis
+∞
6.2
6
*
5078X
ICD-9 Finland
Pneumonitis due to solids and liquids, Due to other solids and liquids
+∞
6.2
6
*
7862A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Cough
2.5
6.2
37
149
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
2.5
6.2
37
149
XX2XW
NOMESCO Finland
Other teleradiological consultation
2.8
6.2
29
103
SPAT1235
SPAT
Mental health, emotional support
2.8
6.2
29
103
C01DA14
ATC
isosorbide mononitrate; oral
1.2
6.2
1258
10978
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.3
6.2
411
3181
T43.3
ICD-10 Finland
Poisoning: Phenothiazine antipsychotics and neuroleptics
26.7
6.2
8
*
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.3
6.2
43
186
NF3AA
NOMESCO Finland
Femur X-ray examination
1.6
6.2
122
751
R35
ICD-10 Finland
Polyuria
1.3
6.2
395
3042
E51.2
ICD-10 Finland
Wernicke encephalopathy
7.0
6.2
14
20
G40.30
ICD-10 Finland
Benign myoclonic eplilepsy in infancy
7.0
6.2
14
20
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.5
6.2
191
1302
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
1.5
6.2
155
1011
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
3.7
6.2
19
52
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
2.4
6.2
38
156
F60.8
ICD-10 Finland
Other specific personality disorders
3.1
6.1
24
77
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
3.5
6.1
20
57
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
2.1
6.1
52
245
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
5.3
6.1
17
32
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
2.7
6.1
32
121
AA9CW, ,
NOMESCO Finland
5.7
6.1
16
28
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
5.7
6.1
16
28
3459X
ICD-9 Finland
Epilepsy, unspecified
3.4
6.1
21
62
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
2.0
6.1
59
292
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
3.3
6.1
22
67
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
2.6
6.1
33
127
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
2.2
6.1
47
213
M41.9
ICD-10 Finland
Scoliosis, unspecified
2.1
6.1
54
259
IHZ04, ,
SPAT
2.1
6.1
52
246
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
2.3
6.1
43
188
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
1.7
6.1
111
671
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
4.1
6.1
16
39
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
3.8
6.1
18
48
E960X
ICD-9 Finland
Fight, brawl, rape[TAPPELU TAI VAST VÄKIV PAHP ASEITTA,TEK/UHRIN SUHD?]
3.8
6.1
18
48
B44.8
ICD-10 Finland
Other forms of aspergillosis
12.5
6.1
10
8
C08CA05
ATC
nifedipine; systemic
1.3
6.1
376
2886
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
3.0
6.1
25
83
T17.4
ICD-10 Finland
Foreign body in trachea
8.6
6.0
12
14
D72
ICPC
Viral hepatitis
8.6
6.0
12
14
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
1.7
6.0
92
529
XKD00
NOMESCO Finland
Uroflowmetry
1.2
6.0
1131
9807
R32
ICD-10 Finland
Unspecified urinary incontinence
1.6
6.0
135
859
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
1.6
6.0
117
719
A10AA02, ,
ATC
1.5
6.0
171
1147
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
1.8
6.0
76
413
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
1.7
6.0
104
620
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
2.5
6.0
35
140
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
3.2
6.0
23
73

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Pleural plaque with presence of asbestos
J92.0 [45567277]
2.3e+00
2.9e+00
3.7e+00
—
4.1e+00
3.6e+00
3.4e+00
cases:2.81%
controls:0.30%
cases:2.62%
controls:0.14%
cases:1.09%
controls:0.03%
—
—
cases:1.64%
controls:0.03%
cases:5.30%
controls:0.15%
cases:8.69%
controls:0.33%
181
194
6264
64118
169
93
6278
64235
70
17
6376
64311
—
88
17
5265
64169
240
95
4285
61948
306
167
3215
50168
Pneumonia, unspecified
J18.9 [45601123]
1.2e+00
1.8e+00
3.7e+00
6.1e+00
3.1e+00
1.6e+00
8.9e-01
cases:12.13%
controls:4.16%
cases:10.63%
controls:1.84%
cases:8.70%
controls:0.23%
cases:6.69%
controls:0.02%
cases:5.77%
controls:0.27%
cases:9.92%
controls:2.18%
cases:15.48%
controls:6.98%
782
2678
5663
61634
685
1183
5762
63145
561
146
5885
64182
431
10
6015
64318
309
174
5044
64012
449
1354
4076
60689
545
3513
2976
46822
Pulmonary Disease
29 [38004472]
8.8e-01
1.6e+00
2.4e+00
6.5e+00
3.0e+00
2.3e+00
1.6e+00
cases:20.98%
controls:9.92%
cases:21.70%
controls:5.12%
cases:9.65%
controls:0.97%
cases:27.20%
controls:0.06%
cases:15.84%
controls:0.95%
cases:34.76%
controls:5.14%
cases:37.83%
controls:10.92%
1352
6379
5093
57933
1399
3295
5048
61033
622
623
5824
63705
1753
36
4693
64292
848
609
4505
63577
1573
3191
2952
58852
1332
5496
2189
44839
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.5e+00
1.9e+00
2.7e+00
5.0e+00
3.3e+00
2.1e+00
1.7e+00
cases:3.12%
controls:0.72%
cases:1.71%
controls:0.26%
cases:0.68%
controls:0.05%
cases:1.09%
controls:0.01%
cases:1.23%
controls:0.05%
cases:2.17%
controls:0.27%
cases:4.46%
controls:0.82%
201
461
6244
63851
110
168
6337
64160
44
30
6402
64298
70
5
6376
64323
66
31
5287
64155
98
168
4427
61875
157
414
3364
49921
Bacteria identified in Blood by Culture
600-7 [3023368]
8.2e-01
1.5e+00
3.2e+00
6.3e+00
3.5e+00
1.3e+00
7.0e-01
cases:11.19%
controls:5.24%
cases:10.69%
controls:2.52%
cases:8.13%
controls:0.37%
cases:10.13%
controls:0.02%
cases:11.04%
controls:0.38%
cases:10.10%
controls:2.99%
cases:15.59%
controls:8.39%
721
3369
5724
60943
689
1624
5758
62704
524
237
5922
64091
653
13
5793
64315
591
241
4762
63945
457
1855
4068
60188
549
4224
2972
46111
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
1.2e+00
3.1e+00
3.7e+00
1.0e+50
5.0e+00
2.5e+00
1.6e+00
cases:0.34%
controls:0.10%
cases:0.70%
controls:0.03%
cases:0.33%
controls:0.01%
cases:0.12%
controls:0.00%
cases:1.12%
controls:0.01%
cases:0.62%
controls:0.05%
cases:0.80%
controls:0.16%
22
67
6423
64245
45
21
6402
64307
21
5
6425
64323
8
0
6438
64328
60
5
5293
64181
28
32
4497
62011
28
82
3493
50253
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
1.0e+00
1.4e+00
2.8e+00
5.3e+00
3.9e+00
1.3e+00
1.1e+00
cases:2.79%
controls:1.02%
cases:2.51%
controls:0.61%
cases:1.38%
controls:0.08%
cases:1.47%
controls:0.01%
cases:4.20%
controls:0.09%
cases:2.52%
controls:0.67%
cases:4.97%
controls:1.77%
180
653
6265
63659
162
395
6285
63933
89
54
6357
64274
95
5
6351
64323
225
57
5128
64129
114
415
4411
61628
175
891
3346
49444
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 [3020565]
1.7e+00
2.4e+00
4.2e+00
—
4.7e+00
1.9e+00
1.4e+00
cases:0.81%
controls:0.16%
cases:0.90%
controls:0.09%
cases:0.53%
controls:0.01%
—
—
cases:1.16%
controls:0.01%
cases:0.80%
controls:0.12%
cases:1.36%
controls:0.33%
52
100
6393
64212
58
55
6389
64273
34
5
6412
64323
—
62
7
5291
64179
36
73
4489
61970
48
168
3473
50167
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
7.5e-01
1.6e+00
2.7e+00
5.1e+00
3.6e+00
1.6e+00
9.1e-01
cases:5.65%
controls:2.76%
cases:5.66%
controls:1.24%
cases:2.90%
controls:0.21%
cases:1.23%
controls:0.01%
cases:7.19%
controls:0.21%
cases:5.79%
controls:1.26%
cases:8.49%
controls:3.58%
364
1777
6081
62535
365
797
6082
63531
187
134
6259
64194
79
5
6367
64323
385
135
4968
64051
262
781
4263
61262
299
1804
3222
48531
High resolution CT examination of lungs
GD1DD [2001303632]
1.2e+00
2.4e+00
3.8e+00
1.0e+50
3.3e+00
3.0e+00
2.3e+00
cases:1.52%
controls:0.44%
cases:1.89%
controls:0.17%
cases:0.81%
controls:0.02%
cases:2.39%
controls:0.00%
cases:0.37%
controls:0.01%
cases:2.92%
controls:0.15%
cases:4.40%
controls:0.47%
98
286
6347
64026
122
109
6325
64219
52
12
6394
64316
154
0
6292
64328
20
9
5333
64177
132
95
4393
61948
155
237
3366
50098
Flexible bronchoscopy
UGC12 [2001303610]
1.4e+00
2.5e+00
4.2e+00
—
4.4e+00
1.9e+00
1.3e+00
cases:3.07%
controls:0.77%
cases:3.57%
controls:0.30%
cases:1.24%
controls:0.02%
—
—
cases:1.53%
controls:0.02%
cases:1.92%
controls:0.28%
cases:2.93%
controls:0.84%
198
494
6247
63818
230
190
6217
64138
80
12
6366
64316
—
82
12
5271
64174
87
175
4438
61868
103
425
3418
49910
Inpatient Hospital
21 [8717]
7.5e-01
1.3e+00
2.5e+00
6.6e+00
2.7e+00
1.2e+00
7.7e-01
cases:53.53%
controls:35.28%
cases:34.67%
controls:12.82%
cases:19.89%
controls:2.02%
cases:38.44%
controls:0.09%
cases:23.71%
controls:2.08%
cases:31.71%
controls:12.57%
cases:47.29%
controls:29.25%
3450
22690
2995
41622
2235
8246
4212
56082
1282
1298
5164
63030
2478
56
3968
64272
1269
1338
4084
62848
1435
7796
3090
54247
1665
14721
1856
35614
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 [3031478]
1.5e+00
2.4e+00
4.2e+00
—
4.3e+00
1.9e+00
1.4e+00
cases:0.82%
controls:0.18%
cases:1.05%
controls:0.10%
cases:0.61%
controls:0.01%
—
—
cases:1.25%
controls:0.02%
cases:0.82%
controls:0.12%
cases:1.62%
controls:0.41%
53
115
6392
64197
68
63
6379
64265
39
6
6407
64322
—
67
11
5286
64175
37
77
4488
61966
57
204
3464
50131
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
1.4e+00
2.4e+00
3.4e+00
—
4.7e+00
1.9e+00
1.6e+00
cases:0.67%
controls:0.16%
cases:0.70%
controls:0.06%
cases:0.39%
controls:0.01%
—
—
cases:1.03%
controls:0.01%
cases:0.57%
controls:0.08%
cases:1.19%
controls:0.23%
43
104
6402
64208
45
41
6402
64287
25
8
6421
64320
—
55
6
5298
64180
26
52
4499
61991
42
117
3479
50218
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1.4e+00
1.8e+00
3.9e+00
1.0e+50
4.7e+00
2.3e+00
1.4e+00
cases:1.06%
controls:0.26%
cases:0.70%
controls:0.11%
cases:0.70%
controls:0.01%
cases:0.71%
controls:0.00%
cases:1.74%
controls:0.02%
cases:0.95%
controls:0.10%
cases:1.65%
controls:0.43%
68
168
6377
64144
45
73
6402
64255
45
9
6401
64319
46
0
6400
64328
93
10
5260
64176
43
61
4482
61982
58
215
3463
50120
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 [3012477]
1.5e+00
2.2e+00
4.1e+00
—
4.3e+00
2.0e+00
1.3e+00
cases:0.87%
controls:0.19%
cases:0.93%
controls:0.11%
cases:0.57%
controls:0.01%
—
—
cases:1.20%
controls:0.02%
cases:0.93%
controls:0.13%
cases:1.48%
controls:0.43%
56
120
6389
64192
60
70
6387
64258
37
6
6409
64322
—
64
11
5289
64175
42
82
4483
61961
52
215
3469
50120
Mycobacterium sp identified in Specimen
40699-1 [3042631]
1.2e+00
2.6e+00
3.3e+00
1.0e+50
4.5e+00
2.2e+00
1.5e+00
cases:0.78%
controls:0.23%
cases:1.18%
controls:0.09%
cases:0.37%
controls:0.01%
cases:0.12%
controls:0.00%
cases:0.86%
controls:0.01%
cases:0.62%
controls:0.07%
cases:1.08%
controls:0.24%
50
146
6395
64166
76
59
6371
64269
24
9
6422
64319
8
0
6438
64328
46
6
5307
64180
28
44
4497
61999
38
123
3483
50212
Thorax X-ray examination
GD1AA [2001303617]
6.5e-01
1.3e+00
2.5e+00
6.0e+00
2.3e+00
1.5e+00
1.0e+00
cases:17.18%
controls:9.74%
cases:13.01%
controls:3.94%
cases:5.41%
controls:0.46%
cases:9.77%
controls:0.03%
cases:4.39%
controls:0.46%
cases:15.27%
controls:3.90%
cases:25.56%
controls:10.93%
1107
6264
5338
58048
839
2537
5608
61791
349
299
6097
64029
630
18
5816
64310
235
296
5118
63890
691
2419
3834
59624
900
5500
2621
44835
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]
1.5e+00
2.2e+00
3.3e+00
—
4.5e+00
1.9e+00
1.7e+00
cases:0.95%
controls:0.21%
cases:0.74%
controls:0.08%
cases:0.33%
controls:0.01%
—
—
cases:1.10%
controls:0.01%
cases:0.64%
controls:0.10%
cases:1.14%
controls:0.21%
61
134
6384
64178
48
52
6399
64276
21
8
6425
64320
—
59
8
5294
64178
29
59
4496
61984
40
107
3481
50228
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
1.5e+00
2.3e+00
3.9e+00
—
4.3e+00
1.9e+00
1.3e+00
cases:0.95%
controls:0.21%
cases:1.18%
controls:0.12%
cases:0.68%
controls:0.01%
—
—
cases:1.42%
controls:0.02%
cases:1.02%
controls:0.15%
cases:1.68%
controls:0.48%
61
136
6384
64176
76
80
6371
64248
44
9
6402
64319
—
76
13
5277
64173
46
93
4479
61950
59
244
3462
50091
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
1.5e+00
2.2e+00
3.5e+00
—
4.5e+00
1.9e+00
1.5e+00
cases:1.06%
controls:0.24%
cases:0.96%
controls:0.11%
cases:0.45%
controls:0.01%
—
—
cases:1.25%
controls:0.01%
cases:0.80%
controls:0.13%
cases:1.53%
controls:0.33%
68
154
6377
64158
62
72
6385
64256
29
9
6417
64319
—
67
9
5286
64177
36
78
4489
61965
54
168
3467
50167
Schizophrenia, unspecified
F20.9 [45576533]
1.9e+00
2.0e+00
3.1e+00
1.0e+50
3.4e+00
2.5e+00
2.2e+00
cases:0.88%
controls:0.14%
cases:0.47%
controls:0.07%
cases:0.25%
controls:0.01%
cases:0.34%
controls:0.00%
cases:0.37%
controls:0.01%
cases:0.57%
controls:0.05%
cases:1.08%
controls:0.13%
57
89
6388
64223
30
42
6417
64286
16
7
6430
64321
22
0
6424
64328
20
8
5333
64178
26
30
4499
62013
38
63
3483
50272
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
7.5e-01
1.3e+00
2.3e+00
5.2e+00
3.2e+00
1.2e+00
9.0e-01
cases:4.56%
controls:2.22%
cases:3.88%
controls:1.06%
cases:1.50%
controls:0.15%
cases:1.72%
controls:0.01%
cases:2.35%
controls:0.10%
cases:3.27%
controls:1.00%
cases:6.13%
controls:2.58%
294
1425
6151
62887
250
682
6197
63646
97
97
6349
64231
111
6
6335
64322
126
65
5227
64121
148
618
4377
61425
216
1298
3305
49037
Emergency Room and Inpatient Visit
ERIP [262]
6.3e-01
1.3e+00
2.8e+00
6.4e+00
2.6e+00
7.6e-01
3.6e-01
cases:9.59%
controls:5.36%
cases:11.09%
controls:3.44%
cases:7.24%
controls:0.46%
cases:14.23%
controls:0.03%
cases:6.43%
controls:0.49%
cases:8.35%
controls:4.09%
cases:15.39%
controls:11.28%
618
3445
5827
60867
715
2215
5732
62113
467
293
5979
64035
917
17
5529
64311
344
317
5009
63869
378
2537
4147
59506
542
5678
2979
44657
Physiotherapist
Z3226 [2001311560]
7.4e-01
1.4e+00
2.3e+00
5.6e+00
2.5e+00
1.3e+00
1.1e+00
cases:4.70%
controls:2.30%
cases:2.50%
controls:0.65%
cases:0.88%
controls:0.09%
cases:2.02%
controls:0.01%
cases:1.05%
controls:0.09%
cases:2.34%
controls:0.64%
cases:5.06%
controls:1.80%
303
1476
6142
62836
161
417
6286
63911
57
57
6389
64271
130
5
6316
64323
56
55
5297
64131
106
395
4419
61648
178
905
3343
49430
Emergency Room Visit
ER [9203]
6.9e-01
1.3e+00
2.7e+00
6.6e+00
1.9e+00
1.0e+00
7.1e-01
cases:51.02%
controls:34.40%
cases:34.31%
controls:12.66%
cases:20.85%
controls:1.71%
cases:32.42%
controls:0.07%
cases:10.29%
controls:1.74%
cases:29.22%
controls:12.86%
cases:50.38%
controls:33.25%
3288
22124
3157
42188
2212
8145
4235
56183
1344
1102
5102
63226
2090
42
4356
64286
551
1114
4802
63072
1322
7978
3203
54065
1774
16738
1747
33597
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
2.2e+00
2.9e+00
3.1e+00
—
—
3.3e+00
3.2e+00
cases:0.40%
controls:0.05%
cases:0.42%
controls:0.02%
cases:0.17%
controls:0.01%
—
—
—
—
cases:0.60%
controls:0.02%
cases:1.19%
controls:0.05%
26
29
6419
64283
27
15
6420
64313
11
5
6435
64323
—
—
27
14
4498
62029
42
25
3479
50310
Office Visit
OMOP4822458 [581477]
7.6e-01
1.4e+00
2.4e+00
4.7e+00
3.1e+00
1.5e+00
8.8e-01
cases:17.05%
controls:8.78%
cases:9.17%
controls:2.43%
cases:3.21%
controls:0.31%
cases:2.08%
controls:0.02%
cases:6.78%
controls:0.33%
cases:9.61%
controls:2.41%
cases:16.25%
controls:7.42%
1099
5645
5346
58667
591
1561
5856
62767
207
200
6239
64128
134
13
6312
64315
363
214
4990
63972
435
1493
4090
60550
572
3737
2949
46598
Other and unspecified convulsions
R56.8 [45602033]
1.5e+00
2.1e+00
3.8e+00
1.0e+50
3.3e+00
2.3e+00
1.5e+00
cases:1.97%
controls:0.44%
cases:1.13%
controls:0.14%
cases:0.79%
controls:0.02%
cases:1.30%
controls:0.00%
cases:0.47%
controls:0.02%
cases:1.52%
controls:0.16%
cases:1.93%
controls:0.45%
127
284
6318
64028
73
87
6374
64241
51
11
6395
64317
84
0
6362
64328
25
11
5328
64175
69
98
4456
61945
68
229
3453
50106
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
5.9e-01
9.7e-01
2.8e+00
5.5e+00
3.2e+00
9.3e-01
4.0e-01
cases:3.91%
controls:2.20%
cases:3.23%
controls:1.24%
cases:2.53%
controls:0.16%
cases:3.80%
controls:0.02%
cases:4.05%
controls:0.17%
cases:3.38%
controls:1.37%
cases:5.74%
controls:3.93%
252
1418
6193
62894
208
799
6239
63529
163
100
6283
64228
245
10
6201
64318
217
108
5136
64078
153
847
4372
61196
202
1977
3319
48358
Bacteria identified in Sputum by Culture
6460-0 [3023419]
1.3e+00
2.1e+00
3.2e+00
—
4.3e+00
2.0e+00
1.6e+00
cases:0.81%
controls:0.21%
cases:0.85%
controls:0.11%
cases:0.33%
controls:0.01%
—
—
cases:1.36%
controls:0.02%
cases:0.80%
controls:0.10%
cases:1.33%
controls:0.28%
52
138
6393
64174
55
71
6392
64257
21
9
6425
64319
—
73
12
5280
64174
36
64
4489
61979
47
141
3474
50194
Chronic viral hepatitis C
B18.2 [45590846]
2.3e+00
2.4e+00
2.9e+00
1.0e+50
—
3.1e+00
3.7e+00
cases:0.53%
controls:0.05%
cases:0.37%
controls:0.03%
cases:0.14%
controls:0.01%
cases:0.14%
controls:0.00%
—
—
cases:0.55%
controls:0.02%
cases:1.53%
controls:0.04%
34
34
6411
64278
24
21
6423
64307
9
5
6437
64323
9
0
6437
64328
—
25
15
4500
62028
54
20
3467
50315
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
1.4e+00
2.1e+00
3.5e+00
—
4.1e+00
1.9e+00
1.3e+00
cases:1.37%
controls:0.33%
cases:1.27%
controls:0.15%
cases:0.64%
controls:0.02%
—
—
cases:1.53%
controls:0.03%
cases:1.17%
controls:0.18%
cases:1.96%
controls:0.52%
88
210
6357
64102
82
97
6365
64231
41
12
6405
64316
—
82
17
5271
64169
53
111
4472
61932
69
260
3452
50075
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.6e+00
2.1e+00
2.9e+00
1.0e+50
3.6e+00
2.3e+00
1.8e+00
cases:0.92%
controls:0.18%
cases:0.62%
controls:0.07%
cases:0.25%
controls:0.01%
cases:0.33%
controls:0.00%
cases:0.45%
controls:0.01%
cases:0.88%
controls:0.09%
cases:1.36%
controls:0.22%
59
114
6386
64198
40
48
6407
64280
16
9
6430
64319
21
0
6425
64328
24
8
5329
64178
40
53
4485
61990
48
110
3473
50225
Inpatient Visit
IP [9201]
4.6e-01
1.0e+00
2.3e+00
6.3e+00
2.9e+00
1.1e+00
4.6e-01
cases:12.82%
controls:8.47%
cases:9.52%
controls:3.57%
cases:3.61%
controls:0.39%
cases:8.18%
controls:0.02%
cases:6.71%
controls:0.41%
cases:9.81%
controls:3.55%
cases:15.22%
controls:10.15%
826
5445
5619
58867
614
2298
5833
62030
233
253
6213
64075
527
11
5919
64317
359
264
4994
63922
444
2203
4081
59840
536
5109
2985
45226
Change of gastrostomy tube
TJD20 [2001304799]
2.6e+00
3.6e+00
—
—
—
4.3e+00
3.9e+00
cases:0.43%
controls:0.03%
cases:0.29%
controls:0.01%
—
—
—
—
—
—
cases:0.80%
controls:0.01%
cases:0.60%
controls:0.01%
28
21
6417
64291
19
5
6428
64323
—
—
—
36
7
4489
62036
21
6
3500
50329
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
1.4e+00
2.1e+00
3.5e+00
—
4.1e+00
1.9e+00
1.3e+00
cases:1.27%
controls:0.32%
cases:1.30%
controls:0.15%
cases:0.61%
controls:0.02%
—
—
cases:1.55%
controls:0.02%
cases:1.26%
controls:0.19%
cases:1.90%
controls:0.52%
82
204
6363
64108
84
99
6363
64229
39
12
6407
64316
—
83
16
5270
64170
57
115
4468
61928
67
264
3454
50071
Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 [45581456]
1.8e+00
2.2e+00
2.1e+00
—
3.3e+00
2.5e+00
2.4e+00
cases:0.37%
controls:0.06%
cases:0.20%
controls:0.02%
cases:0.11%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:0.44%
controls:0.04%
cases:0.74%
controls:0.07%
24
39
6421
64273
13
14
6434
64314
7
9
6439
64319
—
14
6
5339
64180
20
22
4505
62021
26
33
3495
50302
Alcohol dependence currently independent
F10.20 [2000501677]
1.5e+00
2.2e+00
2.6e+00
1.0e+50
3.2e+00
2.3e+00
2.5e+00
cases:0.67%
controls:0.14%
cases:0.36%
controls:0.04%
cases:0.11%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.19%
controls:0.01%
cases:0.51%
controls:0.05%
cases:1.33%
controls:0.11%
43
92
6402
64220
23
25
6424
64303
7
5
6439
64323
6
0
6440
64328
10
5
5343
64181
23
31
4502
62012
47
57
3474
50278
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
1.3e+00
2.1e+00
2.9e+00
—
3.2e+00
3.0e+00
1.8e+00
cases:0.39%
controls:0.11%
cases:0.26%
controls:0.03%
cases:0.17%
controls:0.01%
—
—
cases:0.28%
controls:0.01%
cases:0.62%
controls:0.03%
cases:0.82%
controls:0.13%
25
70
6420
64242
17
21
6430
64307
11
6
6435
64322
—
15
7
5338
64179
28
19
4497
62024
29
67
3492
50268
Motor neuron disease
G12.2 [45591160]
2.8e+00
3.0e+00
3.3e+00
1.0e+50
3.3e+00
2.1e+00
—
cases:0.34%
controls:0.02%
cases:0.54%
controls:0.03%
cases:0.37%
controls:0.01%
cases:0.34%
controls:0.00%
cases:0.37%
controls:0.01%
cases:0.27%
controls:0.03%
—
—
22
14
6423
64298
35
18
6412
64310
24
9
6422
64319
22
0
6424
64328
20
9
5333
64177
12
21
4513
62022
—
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
6.4e-01
1.1e+00
2.7e+00
5.6e+00
3.0e+00
8.5e-01
4.3e-01
cases:10.83%
controls:5.99%
cases:7.26%
controls:2.50%
cases:3.96%
controls:0.28%
cases:4.93%
controls:0.02%
cases:5.03%
controls:0.27%
cases:5.86%
controls:2.59%
cases:11.87%
controls:8.07%
698
3855
5747
60457
468
1610
5979
62718
255
181
6191
64147
318
12
6128
64316
269
175
5084
64011
265
1605
4260
60438
418
4061
3103
46274
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
2.0e+00
2.4e+00
2.4e+00
1.0e+50
3.0e+00
2.4e+00
2.1e+00
cases:0.51%
controls:0.07%
cases:0.39%
controls:0.03%
cases:0.16%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.32%
controls:0.02%
cases:0.49%
controls:0.04%
cases:0.68%
controls:0.09%
33
47
6412
64265
25
22
6422
64306
10
9
6436
64319
6
0
6440
64328
17
10
5336
64176
22
27
4503
62016
24
43
3497
50292
Neurology
13 [38004458]
8.6e-01
1.2e+00
2.3e+00
5.5e+00
2.2e+00
1.3e+00
7.6e-01
cases:23.09%
controls:11.25%
cases:14.07%
controls:4.50%
cases:6.22%
controls:0.66%
cases:7.73%
controls:0.03%
cases:5.68%
controls:0.69%
cases:15.14%
controls:4.54%
cases:21.78%
controls:11.57%
1488
7233
4957
57079
907
2895
5540
61433
401
425
6045
63903
498
21
5948
64307
304
445
5049
63741
685
2817
3840
59226
767
5826
2754
44509
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
1.6e+00
2.1e+00
3.6e+00
—
2.6e+00
2.3e+00
1.9e+00
cases:1.02%
controls:0.21%
cases:0.84%
controls:0.10%
cases:0.34%
controls:0.01%
—
—
cases:0.32%
controls:0.02%
cases:1.10%
controls:0.11%
cases:1.45%
controls:0.23%
66
136
6379
64176
54
64
6393
64264
22
6
6424
64322
—
17
15
5336
64171
50
68
4475
61975
51
115
3470
50220
Internal Medicine
11 [38004456]
6.6e-01
1.1e+00
2.3e+00
6.2e+00
2.0e+00
1.1e+00
7.2e-01
cases:40.73%
controls:26.23%
cases:27.41%
controls:10.88%
cases:15.33%
controls:1.75%
cases:26.47%
controls:0.07%
cases:12.54%
controls:1.87%
cases:26.23%
controls:11.04%
cases:41.49%
controls:25.61%
2625
16870
3820
47442
1767
7001
4680
57327
988
1128
5458
63200
1706
46
4740
64282
671
1203
4682
62983
1187
6848
3338
55195
1461
12889
2060
37446
Base excess in Venous blood by calculation
1927-3 [3002032]
7.7e-01
1.1e+00
2.6e+00
5.6e+00
2.8e+00
8.8e-01
3.2e-01
cases:3.54%
controls:1.66%
cases:3.15%
controls:1.03%
cases:2.03%
controls:0.16%
cases:2.14%
controls:0.01%
cases:2.93%
controls:0.19%
cases:2.90%
controls:1.22%
cases:4.71%
controls:3.45%
228
1070
6217
63242
203
665
6244
63663
131
100
6315
64228
138
5
6308
64323
157
122
5196
64064
131
757
4394
61286
166
1738
3355
48597
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
7.8e-01
1.2e+00
2.6e+00
5.7e+00
2.7e+00
8.8e-01
3.2e-01
cases:3.55%
controls:1.67%
cases:3.21%
controls:1.03%
cases:1.99%
controls:0.16%
cases:2.22%
controls:0.01%
cases:2.91%
controls:0.19%
cases:2.96%
controls:1.25%
cases:4.77%
controls:3.52%
229
1071
6216
63241
207
663
6240
63665
128
101
6318
64227
143
5
6303
64323
156
125
5197
64061
134
776
4391
61267
168
1770
3353
48565
Addiction-induced dependence is currently independent but uses substitute intermittent medication
F11.22 [2000501716]
2.6e+00
2.6e+00
2.5e+00
—
—
2.9e+00
3.6e+00
cases:0.19%
controls:0.01%
cases:0.20%
controls:0.02%
cases:0.11%
controls:0.01%
—
—
—
—
cases:0.31%
controls:0.02%
cases:0.80%
controls:0.02%
12
9
6433
64303
13
10
6434
64318
7
6
6439
64322
—
—
14
11
4511
62032
28
11
3493
50324
Psychiatry
26 [38004469]
1.3e+00
1.7e+00
2.0e+00
2.7e+00
2.6e+00
2.1e+00
1.6e+00
cases:10.32%
controls:3.10%
cases:7.37%
controls:1.38%
cases:3.48%
controls:0.50%
cases:0.56%
controls:0.04%
cases:6.28%
controls:0.48%
cases:10.41%
controls:1.40%
cases:14.46%
controls:3.19%
665
1994
5780
62318
475
888
5972
63440
224
321
6222
64007
36
24
6410
64304
336
309
5017
63877
471
871
4054
61172
509
1607
3012
48728
Outpatient Hospital
22 [8756]
5.8e-01
1.1e+00
2.3e+00
6.0e+00
2.3e+00
1.1e+00
7.1e-01
cases:39.81%
controls:27.04%
cases:21.17%
controls:8.28%
cases:9.91%
controls:1.08%
cases:16.82%
controls:0.05%
cases:9.77%
controls:1.11%
cases:19.71%
controls:7.68%
cases:35.13%
controls:21.04%
2566
17392
3879
46920
1365
5325
5082
59003
639
694
5807
63634
1084
32
5362
64296
523
712
4830
63474
892
4762
3633
57281
1237
10588
2284
39747
lacosamide; oral, parenteral
N03AX18 [21604440]
1.8e+00
2.2e+00
2.1e+00
—
2.7e+00
2.8e+00
2.4e+00
cases:0.28%
controls:0.05%
cases:0.40%
controls:0.05%
cases:0.23%
controls:0.03%
—
—
cases:0.37%
controls:0.02%
cases:0.95%
controls:0.06%
cases:0.82%
controls:0.07%
18
29
6427
64283
26
30
6421
64298
15
19
6431
64309
—
20
16
5333
64170
43
35
4482
62008
29
37
3492
50298
pH of Venous blood
2746-6 [3012544]
7.7e-01
1.1e+00
2.5e+00
5.7e+00
2.7e+00
8.6e-01
3.1e-01
cases:3.66%
controls:1.72%
cases:3.23%
controls:1.04%
cases:1.99%
controls:0.16%
cases:2.16%
controls:0.01%
cases:2.90%
controls:0.19%
cases:2.87%
controls:1.24%
cases:4.74%
controls:3.53%
236
1107
6209
63205
208
672
6239
63656
128
104
6318
64224
139
5
6307
64323
155
124
5198
64062
130
767
4395
61276
167
1779
3354
48556
Interstitial pulmonary disease, unspecified
J84.9 [45543277]
1.3e+00
2.3e+00
3.0e+00
—
2.7e+00
2.4e+00
2.1e+00
cases:0.76%
controls:0.20%
cases:1.38%
controls:0.14%
cases:0.64%
controls:0.03%
—
—
cases:0.47%
controls:0.03%
cases:1.70%
controls:0.15%
cases:2.30%
controls:0.28%
49
130
6396
64182
89
87
6358
64241
41
21
6405
64307
—
25
20
5328
64166
77
95
4448
61948
81
140
3440
50195
Chronic obstructive pulmonary disease with acute lower respiratory infection
J44.0 [45601131]
1.0e+00
1.3e+00
2.2e+00
5.0e+00
2.4e+00
1.0e+00
9.0e-01
cases:1.99%
controls:0.71%
cases:1.38%
controls:0.40%
cases:0.59%
controls:0.07%
cases:1.16%
controls:0.01%
cases:0.84%
controls:0.07%
cases:1.33%
controls:0.47%
cases:3.01%
controls:1.25%
128
459
6317
63853
89
256
6358
64072
38
43
6408
64285
75
5
6371
64323
45
48
5308
64138
60
293
4465
61750
106
628
3415
49707
Extensive high resolution CT examination of lungs
GD1ED [2001303637]
1.1e+00
2.4e+00
—
1.0e+50
4.0e+00
3.6e+00
2.8e+00
cases:0.76%
controls:0.26%
cases:0.84%
controls:0.07%
—
—
cases:0.79%
controls:0.00%
cases:0.41%
controls:0.01%
cases:1.61%
controls:0.05%
cases:1.99%
controls:0.13%
49
169
6396
64143
54
47
6393
64281
—
51
0
6395
64328
22
5
5331
64181
73
28
4452
62015
70
65
3451
50270
Physiotherapy
R4110 [2001310233]
4.6e-01
9.9e-01
2.2e+00
6.1e+00
2.3e+00
9.9e-01
6.9e-01
cases:7.65%
controls:4.95%
cases:4.92%
controls:1.89%
cases:2.20%
controls:0.25%
cases:4.62%
controls:0.01%
cases:2.32%
controls:0.23%
cases:4.33%
controls:1.65%
cases:8.95%
controls:4.68%
493
3184
5952
61128
317
1215
6130
63113
142
159
6304
64169
298
7
6148
64321
124
145
5229
64041
196
1022
4329
61021
315
2354
3206
47981
Fractional oxyhemoglobin in Capillary blood
2715-1 [3022806]
1.0e+00
2.0e+00
3.6e+00
1.0e+50
3.6e+00
1.9e+00
1.6e+00
cases:0.62%
controls:0.23%
cases:0.60%
controls:0.08%
cases:0.28%
controls:0.01%
cases:0.31%
controls:0.00%
cases:0.47%
controls:0.01%
cases:0.51%
controls:0.07%
cases:0.88%
controls:0.18%
40
145
6405
64167
39
52
6408
64276
18
5
6428
64323
20
0
6426
64328
25
8
5328
64178
23
46
4502
61997
31
89
3490
50246
Gas panel - Central venous blood
97535-9 [1616796]
1.3e+00
1.7e+00
3.4e+00
—
4.1e+00
1.9e+00
1.4e+00
cases:1.23%
controls:0.34%
cases:1.12%
controls:0.20%
cases:0.85%
controls:0.03%
—
—
cases:2.07%
controls:0.04%
cases:1.41%
controls:0.21%
cases:2.22%
controls:0.58%
79
217
6366
64095
72
129
6375
64199
55
19
6391
64309
—
111
23
5242
64163
64
128
4461
61915
78
291
3443
50044
Occupatioal Medicine
901 [44777713]
1.9e+00
2.7e+00
4.0e+00
—
—
3.1e+00
2.0e+00
cases:1.33%
controls:0.20%
cases:1.29%
controls:0.09%
cases:0.53%
controls:0.01%
—
—
—
—
cases:1.94%
controls:0.09%
cases:2.36%
controls:0.32%
86
126
6359
64186
83
59
6364
64269
34
6
6412
64322
—
—
88
54
4437
61989
83
161
3438
50174
Sequelae of intracerebral haemorrhage
I69.1 [45538404]
1.6e+00
1.9e+00
3.3e+00
1.0e+50
3.1e+00
2.2e+00
1.6e+00
cases:0.67%
controls:0.14%
cases:0.51%
controls:0.08%
cases:0.22%
controls:0.01%
cases:0.29%
controls:0.00%
cases:0.21%
controls:0.01%
cases:0.77%
controls:0.09%
cases:1.25%
controls:0.25%
43
90
6402
64222
33
51
6414
64277
14
5
6432
64323
19
0
6427
64328
11
6
5342
64180
35
53
4490
61990
44
128
3477
50207
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
1.1e+00
1.8e+00
3.2e+00
—
4.1e+00
1.9e+00
1.5e+00
cases:1.40%
controls:0.47%
cases:1.07%
controls:0.18%
cases:0.67%
controls:0.03%
—
—
cases:1.64%
controls:0.03%
cases:1.13%
controls:0.17%
cases:1.65%
controls:0.37%
90
300
6355
64012
69
116
6378
64212
43
18
6403
64310
—
88
17
5265
64169
51
107
4474
61936
58
186
3463
50149
General Practice
1 [38004446]
7.8e-01
1.3e+00
2.3e+00
5.2e+00
2.7e+00
9.7e-01
4.7e-01
cases:30.41%
controls:16.74%
cases:22.32%
controls:7.59%
cases:10.87%
controls:1.24%
cases:10.58%
controls:0.07%
cases:16.98%
controls:1.34%
cases:19.82%
controls:8.60%
cases:30.76%
controls:21.65%
1960
10769
4485
53543
1439
4885
5008
59443
701
799
5745
63529
682
44
5764
64284
909
858
4444
63328
897
5336
3628
56707
1083
10897
2438
39438
Epilepsy, unspecified
G40.9 [45562083]
1.6e+00
2.1e+00
2.7e+00
—
3.1e+00
2.3e+00
1.9e+00
cases:2.06%
controls:0.42%
cases:1.64%
controls:0.20%
cases:0.51%
controls:0.04%
—
—
cases:0.77%
controls:0.04%
cases:2.01%
controls:0.21%
cases:3.24%
controls:0.52%
133
272
6312
64040
106
128
6341
64200
33
23
6413
64305
—
41
23
5312
64163
91
129
4434
61914
114
262
3407
50073
Mixed personality disorders
F61.0 [2000502024]
1.8e+00
1.8e+00
2.3e+00
—
2.7e+00
2.5e+00
2.5e+00
cases:0.37%
controls:0.06%
cases:0.19%
controls:0.03%
cases:0.09%
controls:0.01%
—
—
cases:0.19%
controls:0.01%
cases:0.40%
controls:0.03%
cases:0.88%
controls:0.07%
24
39
6421
64273
12
20
6435
64308
6
6
6440
64322
—
10
8
5343
64178
18
21
4507
62022
31
36
3490
50299
Base excess in Blood by calculation
11555-0 [3012501]
1.1e+00
1.8e+00
3.2e+00
—
4.1e+00
1.9e+00
1.5e+00
cases:1.40%
controls:0.47%
cases:1.07%
controls:0.18%
cases:0.67%
controls:0.03%
—
—
cases:1.64%
controls:0.03%
cases:1.13%
controls:0.17%
cases:1.65%
controls:0.37%
90
300
6355
64012
69
117
6378
64211
43
18
6403
64310
—
88
17
5265
64169
51
107
4474
61936
58
186
3463
50149
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
1.1e+00
1.8e+00
3.2e+00
—
4.1e+00
1.9e+00
1.5e+00
cases:1.40%
controls:0.47%
cases:1.07%
controls:0.18%
cases:0.67%
controls:0.03%
—
—
cases:1.64%
controls:0.03%
cases:1.13%
controls:0.17%
cases:1.65%
controls:0.37%
90
300
6355
64012
69
117
6378
64211
43
18
6403
64310
—
88
17
5265
64169
51
107
4474
61936
58
186
3463
50149
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
5.5e-01
1.0e+00
2.6e+00
5.9e+00
2.5e+00
7.4e-01
3.2e-01
cases:14.06%
controls:8.63%
cases:11.14%
controls:4.37%
cases:7.31%
controls:0.57%
cases:8.53%
controls:0.03%
cases:6.91%
controls:0.63%
cases:9.28%
controls:4.64%
cases:16.30%
controls:12.40%
906
5547
5539
58765
718
2811
5729
61517
471
368
5975
63960
550
17
5896
64311
370
404
4983
63782
420
2881
4105
59162
574
6241
2947
44094
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
5.7e-01
1.1e+00
2.7e+00
5.2e+00
2.7e+00
7.7e-01
5.1e-01
cases:5.01%
controls:2.89%
cases:3.57%
controls:1.23%
cases:1.77%
controls:0.13%
cases:1.72%
controls:0.01%
cases:1.83%
controls:0.12%
cases:2.30%
controls:1.08%
cases:5.65%
controls:3.49%
323
1860
6122
62452
230
793
6217
63535
114
81
6332
64247
111
6
6335
64322
98
79
5255
64107
104
669
4421
61374
199
1756
3322
48579
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
9.1e-01
1.9e+00
3.6e+00
1.0e+50
3.8e+00
1.8e+00
1.5e+00
cases:0.65%
controls:0.26%
cases:0.74%
controls:0.11%
cases:0.45%
controls:0.01%
cases:0.50%
controls:0.00%
cases:0.75%
controls:0.02%
cases:0.64%
controls:0.11%
cases:1.36%
controls:0.30%
42
169
6403
64143
48
69
6399
64259
29
8
6417
64320
32
0
6414
64328
40
11
5313
64175
29
69
4496
61974
48
149
3473
50186
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
1.4e+00
2.0e+00
2.8e+00
—
3.0e+00
2.4e+00
1.9e+00
cases:1.01%
controls:0.25%
cases:0.88%
controls:0.13%
cases:0.39%
controls:0.02%
—
—
cases:0.58%
controls:0.03%
cases:1.48%
controls:0.14%
cases:2.02%
controls:0.29%
65
160
6380
64152
57
81
6390
64247
25
15
6421
64313
—
31
19
5322
64167
67
84
4458
61959
71
147
3450
50188
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
5.5e-01
1.0e+00
2.5e+00
5.4e+00
2.7e+00
9.2e-01
4.7e-01
cases:9.71%
controls:5.85%
cases:6.69%
controls:2.51%
cases:3.99%
controls:0.35%
cases:2.87%
controls:0.01%
cases:4.33%
controls:0.31%
cases:6.25%
controls:2.58%
cases:12.33%
controls:8.11%
626
3763
5819
60549
431
1614
6016
62714
257
226
6189
64102
185
9
6261
64319
232
197
5121
63989
283
1601
4242
60442
434
4084
3087
46251
Speech therapy
R4130 [2001310235]
1.6e+00
2.2e+00
2.7e+00
1.0e+50
4.0e+00
1.7e+00
1.2e+00
cases:0.84%
controls:0.16%
cases:0.68%
controls:0.07%
cases:0.25%
controls:0.02%
cases:0.78%
controls:0.00%
cases:0.60%
controls:0.01%
cases:0.57%
controls:0.11%
cases:0.85%
controls:0.26%
54
106
6391
64206
44
47
6403
64281
16
11
6430
64317
50
0
6396
64328
32
7
5321
64179
26
67
4499
61976
30
132
3491
50203
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
9.5e-01
1.8e+00
3.5e+00
—
3.9e+00
1.8e+00
1.4e+00
cases:0.81%
controls:0.31%
cases:0.99%
controls:0.17%
cases:0.68%
controls:0.02%
—
—
cases:1.20%
controls:0.02%
cases:1.04%
controls:0.18%
cases:1.87%
controls:0.49%
52
202
6393
64110
64
111
6383
64217
44
13
6402
64315
—
64
15
5289
64171
47
110
4478
61933
66
246
3455
50089
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
1.1e+00
2.3e+00
2.8e+00
—
4.3e+00
1.7e+00
1.2e+00
cases:1.12%
controls:0.39%
cases:1.52%
controls:0.16%
cases:0.42%
controls:0.02%
—
—
cases:1.23%
controls:0.02%
cases:0.73%
controls:0.14%
cases:1.33%
controls:0.42%
72
251
6373
64061
98
104
6349
64224
27
16
6419
64312
—
66
11
5287
64175
33
84
4492
61959
47
210
3474
50125
clobazam; oral
N05BA09 [21604574]
1.8e+00
2.0e+00
2.1e+00
—
2.7e+00
2.6e+00
2.2e+00
cases:0.28%
controls:0.05%
cases:0.22%
controls:0.03%
cases:0.09%
controls:0.01%
—
—
cases:0.11%
controls:0.01%
cases:0.33%
controls:0.03%
cases:0.34%
controls:0.04%
18
31
6427
64281
14
19
6433
64309
6
7
6440
64321
—
6
5
5347
64181
15
16
4510
62027
12
20
3509
50315
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.9e-01
1.0e+00
2.5e+00
5.7e+00
2.4e+00
7.9e-01
3.1e-01
cases:19.63%
controls:13.03%
cases:16.81%
controls:6.80%
cases:10.35%
controls:0.95%
cases:11.71%
controls:0.05%
cases:10.01%
controls:0.95%
cases:14.19%
controls:6.99%
cases:22.98%
controls:18.00%
1265
8379
5180
55933
1084
4375
5363
59953
667
609
5779
63719
755
29
5691
64299
536
611
4817
63575
642
4339
3883
57704
809
9058
2712
41277
Bronchial lavation
TGC00 [2001303585]
1.5e+00
3.1e+00
—
—
4.4e+00
2.4e+00
1.9e+00
cases:0.78%
controls:0.18%
cases:1.32%
controls:0.06%
—
—
—
—
cases:0.73%
controls:0.01%
cases:0.77%
controls:0.07%
cases:1.25%
controls:0.19%
50
116
6395
64196
85
40
6362
64288
—
—
39
6
5314
64180
35
42
4490
62001
44
98
3477
50237
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
1.2e+00
1.9e+00
3.1e+00
—
4.5e+00
1.6e+00
8.8e-01
cases:1.66%
controls:0.52%
cases:1.72%
controls:0.26%
cases:0.92%
controls:0.04%
—
—
cases:3.18%
controls:0.04%
cases:1.64%
controls:0.33%
cases:2.78%
controls:1.18%
107
332
6338
63980
111
167
6336
64161
59
26
6387
64302
—
170
24
5183
64162
74
206
4451
61837
98
593
3423
49742
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
4.4e-01
8.5e-01
2.5e+00
5.6e+00
2.7e+00
6.4e-01
3.8e-01
cases:6.53%
controls:4.29%
cases:4.61%
controls:2.02%
cases:2.92%
controls:0.24%
cases:2.06%
controls:0.01%
cases:3.12%
controls:0.22%
cases:3.29%
controls:1.76%
cases:7.19%
controls:5.05%
421
2757
6024
61555
297
1298
6150
63030
188
152
6258
64176
133
5
6313
64323
167
138
5186
64048
149
1094
4376
60949
253
2540
3268
47795
Dysphagia
R13 [45573013]
1.3e+00
2.1e+00
2.9e+00
1.0e+50
3.9e+00
2.1e+00
9.6e-01
cases:2.64%
controls:0.76%
cases:2.09%
controls:0.27%
cases:0.99%
controls:0.06%
cases:0.71%
controls:0.00%
cases:1.70%
controls:0.04%
cases:2.45%
controls:0.30%
cases:2.39%
controls:0.93%
170
488
6275
63824
135
172
6312
64156
64
37
6382
64291
46
0
6400
64328
91
23
5262
64163
111
189
4414
61854
84
466
3437
49869
Neurosurgery
14 [38004459]
7.5e-01
1.1e+00
2.4e+00
4.6e+00
2.0e+00
1.4e+00
8.9e-01
cases:4.84%
controls:2.36%
cases:2.73%
controls:0.90%
cases:1.57%
controls:0.14%
cases:0.93%
controls:0.01%
cases:1.03%
controls:0.15%
cases:3.23%
controls:0.84%
cases:5.48%
controls:2.33%
312
1515
6133
62797
176
582
6271
63746
101
89
6345
64239
60
6
6386
64322
55
94
5298
64092
146
519
4379
61524
193
1174
3328
49161
High dependency care
WX882 [2001310847]
1.2e+00
2.1e+00
3.5e+00
1.0e+50
3.2e+00
2.1e+00
1.0e+00
cases:0.71%
controls:0.22%
cases:0.57%
controls:0.07%
cases:0.37%
controls:0.01%
cases:0.84%
controls:0.00%
cases:0.30%
controls:0.01%
cases:0.51%
controls:0.06%
cases:0.71%
controls:0.25%
46
143
6399
64169
37
45
6410
64283
24
7
6422
64321
54
0
6392
64328
16
8
5337
64178
23
39
4502
62004
25
126
3496
50209
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.1e-01
9.0e-01
2.5e+00
5.6e+00
2.6e+00
6.9e-01
4.0e-01
cases:9.01%
controls:6.17%
cases:6.30%
controls:2.65%
cases:3.77%
controls:0.32%
cases:3.13%
controls:0.01%
cases:3.98%
controls:0.31%
cases:4.69%
controls:2.41%
cases:10.00%
controls:6.94%
581
3966
5864
60346
406
1703
6041
62625
243
204
6203
64124
202
8
6244
64320
213
196
5140
63990
212
1496
4313
60547
352
3492
3169
46843
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
6.3e-01
9.6e-01
2.1e+00
5.0e+00
2.9e+00
8.7e-01
5.7e-01
cases:3.30%
controls:1.79%
cases:2.85%
controls:1.11%
cases:1.95%
controls:0.25%
cases:1.37%
controls:0.01%
cases:4.43%
controls:0.25%
cases:2.85%
controls:1.22%
cases:4.54%
controls:2.61%
213
1150
6232
63162
184
713
6263
63615
126
160
6320
64168
88
6
6358
64322
237
159
5116
64027
129
755
4396
61288
160
1316
3361
49019
Dyspnoea
R06.0 [45558449]
5.5e-01
1.3e+00
2.5e+00
4.9e+00
1.9e+00
1.0e+00
7.0e-01
cases:6.84%
controls:4.08%
cases:5.72%
controls:1.55%
cases:2.25%
controls:0.18%
cases:1.83%
controls:0.01%
cases:1.48%
controls:0.22%
cases:4.66%
controls:1.70%
cases:10.00%
controls:5.22%
441
2624
6004
61688
369
997
6078
63331
145
116
6301
64212
118
9
6328
64319
79
139
5274
64047
211
1054
4314
60989
352
2628
3169
47707
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
8.3e-01
1.4e+00
2.8e+00
2.5e+00
3.2e+00
1.5e+00
8.2e-01
cases:1.51%
controls:0.66%
cases:1.10%
controls:0.27%
cases:0.51%
controls:0.03%
cases:0.09%
controls:0.01%
cases:0.82%
controls:0.03%
cases:1.08%
controls:0.24%
cases:1.90%
controls:0.85%
97
427
6348
63885
71
175
6376
64153
33
21
6413
64307
6
5
6440
64323
44
22
5309
64164
49
149
4476
61894
67
426
3454
49909
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.6e-01
9.9e-01
2.1e+00
5.5e+00
2.5e+00
8.7e-01
5.0e-01
cases:15.92%
controls:9.76%
cases:13.29%
controls:5.38%
cases:6.44%
controls:0.87%
cases:6.28%
controls:0.03%
cases:9.99%
controls:0.88%
cases:12.55%
controls:5.66%
cases:20.05%
controls:13.23%
1026
6279
5419
58033
857
3460
5590
60868
415
559
6031
63769
405
18
6041
64310
535
563
4818
63623
568
3510
3957
58533
706
6659
2815
43676
Sequelae of cerebral infarction
I69.3 [45533476]
1.0e+00
1.2e+00
1.9e+00
4.5e+00
2.2e+00
1.4e+00
7.6e-01
cases:4.24%
controls:1.55%
cases:2.99%
controls:0.92%
cases:1.26%
controls:0.20%
cases:2.44%
controls:0.03%
cases:1.87%
controls:0.22%
cases:4.22%
controls:1.08%
cases:5.40%
controls:2.59%
273
997
6172
63315
193
589
6254
63739
81
127
6365
64201
157
18
6289
64310
100
139
5253
64047
191
670
4334
61373
190
1303
3331
49032
Supplier / Service Provider
OMOP5117446 [33004]
-4.0e-01
2.3e-01
8.2e-01
3.1e+00
3.0e+00
3.0e+00
3.2e+00
cases:17.41%
controls:23.88%
cases:9.17%
controls:7.40%
cases:1.82%
controls:0.81%
cases:0.87%
controls:0.04%
cases:1.33%
controls:0.07%
cases:8.91%
controls:0.49%
cases:20.02%
controls:1.06%
1122
15357
5323
48955
591
4759
5856
59569
117
518
6329
63810
56
25
6390
64303
71
43
5282
64143
403
304
4122
61739
705
534
2816
49801
Parainfluenza type 2 nucleic acid detection
222351000000102 [44790048]
1.2e+00
1.8e+00
3.5e+00
—
3.5e+00
1.9e+00
9.9e-01
cases:0.50%
controls:0.15%
cases:0.53%
controls:0.09%
cases:0.31%
controls:0.01%
—
—
cases:0.62%
controls:0.02%
cases:0.57%
controls:0.09%
cases:0.71%
controls:0.26%
32
94
6413
64218
34
56
6413
64272
20
6
6426
64322
—
33
12
5320
64174
26
55
4499
61988
25
133
3496
50202
Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]
1.2e+00
1.8e+00
3.5e+00
—
3.5e+00
1.9e+00
9.9e-01
cases:0.50%
controls:0.15%
cases:0.53%
controls:0.09%
cases:0.31%
controls:0.01%
—
—
cases:0.62%
controls:0.02%
cases:0.57%
controls:0.09%
cases:0.71%
controls:0.26%
32
94
6413
64218
34
56
6413
64272
20
6
6426
64322
—
33
12
5320
64174
26
55
4499
61988
25
133
3496
50202
Parainfluenza type 4 nucleic acid detection
810871000000102 [44806118]
1.2e+00
1.8e+00
3.5e+00
—
3.5e+00
1.9e+00
9.9e-01
cases:0.50%
controls:0.15%
cases:0.53%
controls:0.09%
cases:0.31%
controls:0.01%
—
—
cases:0.62%
controls:0.02%
cases:0.57%
controls:0.09%
cases:0.71%
controls:0.26%
32
94
6413
64218
34
56
6413
64272
20
6
6426
64322
—
33
12
5320
64174
26
55
4499
61988
25
133
3496
50202
Parainfluenza type 1 nucleic acid detection
222341000000100 [44790047]
1.2e+00
1.8e+00
3.5e+00
—
3.5e+00
1.9e+00
9.9e-01
cases:0.50%
controls:0.15%
cases:0.53%
controls:0.09%
cases:0.31%
controls:0.01%
—
—
cases:0.62%
controls:0.02%
cases:0.57%
controls:0.09%
cases:0.71%
controls:0.26%
32
94
6413
64218
34
56
6413
64272
20
6
6426
64322
—
33
12
5320
64174
26
55
4499
61988
25
133
3496
50202
Abdominal X-ray examination without contrast
JN3AA [2001305553]
1.1e+00
1.5e+00
3.9e+00
—
3.4e+00
1.7e+00
1.2e+00
cases:1.35%
controls:0.45%
cases:0.65%
controls:0.14%
cases:0.51%
controls:0.01%
—
—
cases:0.28%
controls:0.01%
cases:0.75%
controls:0.13%
cases:1.45%
controls:0.42%
87
291
6358
64021
42
90
6405
64238
33
7
6413
64321
—
15
6
5338
64180
34
82
4491
61961
51
212
3470
50123
Cerebral aneurysm, nonruptured
I67.1 [45538401]
9.5e-01
1.8e+00
2.5e+00
—
3.5e+00
2.6e+00
1.6e+00
cases:0.43%
controls:0.17%
cases:0.40%
controls:0.07%
cases:0.20%
controls:0.02%
—
—
cases:0.35%
controls:0.01%
cases:0.71%
controls:0.05%
cases:0.91%
controls:0.18%
28
108
6417
64204
26
45
6421
64283
13
11
6433
64317
—
19
7
5334
64179
32
33
4493
62010
32
90
3489
50245
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
9.6e-01
1.8e+00
4.0e+00
—
3.4e+00
1.7e+00
1.1e+00
cases:5.62%
controls:2.23%
cases:4.50%
controls:0.79%
cases:4.41%
controls:0.09%
—
—
cases:2.56%
controls:0.09%
cases:4.13%
controls:0.81%
cases:7.84%
controls:2.63%
362
1434
6083
62878
290
511
6157
63817
284
57
6162
64271
—
137
58
5216
64128
187
505
4338
61538
276
1322
3245
49013
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
8.2e-01
1.3e+00
1.8e+00
4.9e+00
2.0e+00
1.2e+00
8.6e-01
cases:6.30%
controls:2.86%
cases:6.11%
controls:1.71%
cases:2.16%
controls:0.38%
cases:3.96%
controls:0.03%
cases:2.75%
controls:0.38%
cases:5.88%
controls:1.88%
cases:8.69%
controls:3.86%
406
1841
6039
62471
394
1099
6053
63229
139
245
6307
64083
255
20
6191
64308
147
243
5206
63943
266
1165
4259
60878
306
1942
3215
48393
Thorax CT examination
GD1AD [2001303618]
1.1e+00
2.1e+00
3.1e+00
1.0e+50
3.1e+00
2.0e+00
1.5e+00
cases:1.24%
controls:0.42%
cases:1.81%
controls:0.24%
cases:0.62%
controls:0.03%
cases:1.30%
controls:0.00%
cases:0.54%
controls:0.02%
cases:1.99%
controls:0.27%
cases:3.44%
controls:0.82%
80
270
6365
64042
117
152
6330
64176
40
19
6406
64309
84
0
6362
64328
29
15
5324
64171
90
167
4435
61876
121
411
3400
49924
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
1.6e+00
2.0e+00
1.9e+00
1.0e+50
3.6e+00
2.2e+00
1.6e+00
cases:1.24%
controls:0.26%
cases:1.10%
controls:0.15%
cases:0.25%
controls:0.04%
cases:0.11%
controls:0.00%
cases:0.77%
controls:0.02%
cases:1.30%
controls:0.15%
cases:1.76%
controls:0.38%
80
166
6365
64146
71
97
6376
64231
16
25
6430
64303
7
0
6439
64328
41
13
5312
64173
59
95
4466
61948
62
190
3459
50145
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
1.4e+00
2.1e+00
2.9e+00
1.0e+50
2.4e+00
1.9e+00
2.1e+00
cases:0.42%
controls:0.10%
cases:0.39%
controls:0.05%
cases:0.17%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.15%
controls:0.01%
cases:0.31%
controls:0.05%
cases:0.85%
controls:0.11%
27
65
6418
64247
25
31
6422
64297
11
6
6435
64322
6
0
6440
64328
8
9
5345
64177
14
29
4511
62014
30
54
3491
50281
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]
1.9e+00
2.0e+00
2.2e+00
—
3.1e+00
1.7e+00
1.9e+00
cases:0.84%
controls:0.13%
cases:0.73%
controls:0.10%
cases:0.22%
controls:0.02%
—
—
cases:0.43%
controls:0.02%
cases:0.60%
controls:0.11%
cases:1.11%
controls:0.17%
54
83
6391
64229
47
63
6400
64265
14
16
6432
64312
—
23
12
5330
64174
27
70
4498
61973
39
85
3482
50250
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
1.1e+00
2.4e+00
3.2e+00
—
3.0e+00
2.1e+00
1.0e+00
cases:3.77%
controls:1.23%
cases:4.99%
controls:0.50%
cases:2.08%
controls:0.09%
—
—
cases:1.48%
controls:0.08%
cases:3.51%
controls:0.46%
cases:3.98%
controls:1.45%
243
791
6202
63521
322
320
6125
64008
134
56
6312
64272
—
79
50
5274
64136
159
283
4366
61760
140
728
3381
49607
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
1.3e+00
2.1e+00
2.7e+00
—
3.8e+00
1.6e+00
1.1e+00
cases:1.96%
controls:0.53%
cases:2.05%
controls:0.27%
cases:0.62%
controls:0.04%
—
—
cases:1.77%
controls:0.04%
cases:1.22%
controls:0.24%
cases:2.61%
controls:0.85%
126
338
6319
63974
132
171
6315
64157
40
27
6406
64301
—
95
25
5258
64161
55
148
4470
61895
92
426
3429
49909
Asthma, unspecified
J45.9 [45562456]
6.5e-01
1.1e+00
1.7e+00
4.9e+00
2.0e+00
1.3e+00
1.0e+00
cases:6.08%
controls:3.26%
cases:4.37%
controls:1.56%
cases:1.61%
controls:0.29%
cases:2.59%
controls:0.02%
cases:1.89%
controls:0.25%
cases:5.90%
controls:1.61%
cases:10.00%
controls:3.92%
392
2099
6053
62213
282
1006
6165
63322
104
188
6342
64140
167
13
6279
64315
101
163
5252
64023
267
998
4258
61045
352
1973
3169
48362
Medical doctor
Z2221 [2001311556]
4.4e-01
8.5e-01
2.0e+00
5.7e+00
1.7e+00
1.1e+00
9.1e-01
cases:7.39%
controls:4.89%
cases:3.65%
controls:1.59%
cases:1.64%
controls:0.23%
cases:2.19%
controls:0.01%
cases:1.12%
controls:0.20%
cases:4.29%
controls:1.45%
cases:7.84%
controls:3.30%
476
3146
5969
61166
235
1023
6212
63305
106
151
6340
64177
141
5
6305
64323
60
130
5293
64056
194
902
4331
61141
276
1663
3245
48672
pH of Blood
11558-4 [3010421]
1.1e+00
1.7e+00
3.0e+00
—
4.0e+00
1.7e+00
1.3e+00
cases:1.49%
controls:0.51%
cases:1.23%
controls:0.23%
cases:0.79%
controls:0.04%
—
—
cases:1.92%
controls:0.04%
cases:1.41%
controls:0.27%
cases:2.33%
controls:0.68%
96
330
6349
63982
79
151
6368
64177
51
26
6395
64302
—
103
23
5250
64163
64
167
4461
61876
82
341
3439
49994
Cardiac arrest with successful resuscitation
I46.0 [45533454]
6.8e-01
1.1e+00
3.7e+00
1.0e+50
4.3e+00
2.9e+00
1.7e+00
cases:0.26%
controls:0.13%
cases:0.14%
controls:0.05%
cases:0.45%
controls:0.01%
cases:2.13%
controls:0.00%
cases:1.18%
controls:0.02%
cases:1.10%
controls:0.06%
cases:0.77%
controls:0.15%
17
86
6428
64226
9
29
6438
64299
29
7
6417
64321
137
0
6309
64328
63
10
5290
64176
50
38
4475
62005
27
74
3494
50261
Malignant neoplasm: Lower third of oesophagus
C15.5 [45547480]
2.1e+00
2.5e+00
3.2e+00
—
2.7e+00
2.2e+00
1.1e+00
cases:0.36%
controls:0.04%
cases:0.53%
controls:0.05%
cases:0.42%
controls:0.02%
—
—
cases:0.35%
controls:0.02%
cases:0.44%
controls:0.05%
cases:0.26%
controls:0.09%
23
27
6422
64285
34
29
6413
64299
27
11
6419
64317
—
19
16
5334
64170
20
32
4505
62011
9
44
3512
50291
Unspecified nonorganic psychosis
F29 [45533099]
1.3e+00
1.7e+00
1.5e+00
2.5e+00
2.1e+00
1.7e+00
1.8e+00
cases:0.79%
controls:0.22%
cases:0.48%
controls:0.09%
cases:0.16%
controls:0.03%
cases:0.09%
controls:0.01%
cases:0.34%
controls:0.04%
cases:0.53%
controls:0.10%
cases:1.22%
controls:0.20%
51
140
6394
64172
31
56
6416
64272
10
22
6436
64306
6
5
6440
64323
18
27
5335
64159
24
60
4501
61983
43
103
3478
50232
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]
8.3e-01
1.5e+00
3.1e+00
—
4.3e+00
1.7e+00
1.2e+00
cases:0.51%
controls:0.22%
cases:0.37%
controls:0.08%
cases:0.20%
controls:0.01%
—
—
cases:0.65%
controls:0.01%
cases:0.49%
controls:0.09%
cases:0.85%
controls:0.25%
33
144
6412
64168
24
52
6423
64276
13
6
6433
64322
—
35
6
5318
64180
22
58
4503
61985
30
124
3491
50211
Predominantly allergic asthma
J45.0 [45557624]
7.6e-01
1.2e+00
1.6e+00
4.5e+00
1.7e+00
1.5e+00
1.4e+00
cases:1.82%
controls:0.85%
cases:1.18%
controls:0.36%
cases:0.31%
controls:0.06%
cases:0.70%
controls:0.01%
cases:0.43%
controls:0.08%
cases:1.68%
controls:0.38%
cases:3.49%
controls:0.90%
117
549
6328
63763
76
234
6371
64094
20
41
6426
64287
45
5
6401
64323
23
53
5330
64133
76
235
4449
61808
123
451
3398
49884
Thorax extensive CT-examination
GD1BD [2001303621]
9.6e-01
2.1e+00
2.8e+00
1.0e+50
2.8e+00
2.2e+00
1.7e+00
cases:1.68%
controls:0.65%
cases:1.10%
controls:0.14%
cases:0.25%
controls:0.02%
cases:0.70%
controls:0.00%
cases:0.26%
controls:0.02%
cases:1.17%
controls:0.13%
cases:2.04%
controls:0.37%
108
416
6337
63896
71
89
6376
64239
16
10
6430
64318
45
0
6401
64328
14
10
5339
64176
53
82
4472
61961
72
188
3449
50147
levetiracetam; oral, parenteral
N03AX14 [21604436]
1.5e+00
1.9e+00
2.2e+00
—
2.6e+00
2.3e+00
2.0e+00
cases:1.29%
controls:0.29%
cases:1.58%
controls:0.25%
cases:0.76%
controls:0.09%
—
—
cases:1.35%
controls:0.10%
cases:2.85%
controls:0.28%
cases:3.12%
controls:0.42%
83
186
6362
64126
102
160
6345
64168
49
55
6397
64273
—
72
64
5281
64122
129
176
4396
61867
110
212
3411
50123
Bacterial pneumonia, unspecified
J15.9 [45557621]
1.2e+00
1.9e+00
3.3e+00
—
3.2e+00
1.6e+00
1.2e+00
cases:3.52%
controls:1.07%
cases:2.70%
controls:0.40%
cases:1.49%
controls:0.05%
—
—
cases:1.55%
controls:0.06%
cases:2.56%
controls:0.51%
cases:4.77%
controls:1.51%
227
688
6218
63624
174
259
6273
64069
96
35
6350
64293
—
83
41
5270
64145
116
315
4409
61728
168
762
3353
49573
Recurrent depressive disorder, unspecified
F33.9 [45581458]
1.6e+00
1.9e+00
2.0e+00
—
2.6e+00
2.4e+00
1.9e+00
cases:0.96%
controls:0.20%
cases:0.54%
controls:0.08%
cases:0.23%
controls:0.03%
—
—
cases:0.32%
controls:0.02%
cases:0.73%
controls:0.07%
cases:1.48%
controls:0.22%
62
127
6383
64185
35
50
6412
64278
15
20
6431
64308
—
17
15
5336
64171
33
41
4492
62002
52
112
3469
50223
Norclozapine [Moles/volume] in Serum or Plasma
14851-0 [3008832]
1.9e+00
2.0e+00
2.0e+00
—
3.0e+00
1.6e+00
1.9e+00
cases:0.78%
controls:0.11%
cases:0.65%
controls:0.09%
cases:0.19%
controls:0.02%
—
—
cases:0.32%
controls:0.02%
cases:0.51%
controls:0.10%
cases:1.05%
controls:0.16%
50
72
6395
64240
42
57
6405
64271
12
16
6434
64312
—
17
10
5336
64176
23
62
4502
61981
37
82
3484
50253
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
5.3e-01
1.1e+00
2.1e+00
4.7e+00
2.5e+00
1.0e+00
5.2e-01
cases:16.74%
controls:10.55%
cases:15.54%
controls:5.82%
cases:9.29%
controls:1.26%
cases:5.21%
controls:0.05%
cases:13.13%
controls:1.17%
cases:15.31%
controls:6.05%
cases:22.66%
controls:14.84%
1079
6784
5366
57528
1002
3745
5445
60583
599
812
5847
63516
336
33
6110
64295
703
752
4650
63434
693
3751
3832
58292
798
7468
2723
42867
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
4.6e-01
9.5e-01
2.2e+00
5.0e+00
2.6e+00
8.8e-01
4.6e-01
cases:5.23%
controls:3.37%
cases:3.24%
controls:1.28%
cases:1.38%
controls:0.16%
cases:1.10%
controls:0.01%
cases:1.66%
controls:0.13%
cases:3.07%
controls:1.30%
cases:6.76%
controls:4.39%
337
2169
6108
62143
209
824
6238
63504
89
103
6357
64225
71
5
6375
64323
89
81
5264
64105
139
805
4386
61238
238
2210
3283
48125
Social worker
Z2446 [2001311559]
1.2e+00
1.7e+00
2.5e+00
—
3.4e+00
2.1e+00
1.5e+00
cases:1.86%
controls:0.56%
cases:0.90%
controls:0.16%
cases:0.20%
controls:0.02%
—
—
cases:0.69%
controls:0.02%
cases:1.19%
controls:0.15%
cases:2.19%
controls:0.49%
120
359
6325
63953
58
102
6389
64226
13
11
6433
64317
—
37
15
5316
64171
54
91
4471
61952
77
246
3444
50089
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
C50.41 [2000501002]
3.9e-01
1.4e+00
1.9e+00
4.4e+00
2.0e+00
1.5e+00
1.2e+00
cases:0.76%
controls:0.52%
cases:1.43%
controls:0.36%
cases:0.65%
controls:0.09%
cases:0.73%
controls:0.01%
cases:0.77%
controls:0.10%
cases:1.68%
controls:0.37%
cases:1.82%
controls:0.55%
49
332
6396
63980
92
229
6355
64099
42
61
6404
64267
47
6
6399
64322
41
67
5312
64119
76
228
4449
61815
64
276
3457
50059
Other and unspecified intestinal obstruction
K56.6 [45562499]
1.0e+00
1.8e+00
3.2e+00
1.0e+50
3.8e+00
1.6e+00
1.0e+00
cases:0.84%
controls:0.30%
cases:0.54%
controls:0.09%
cases:0.61%
controls:0.02%
cases:1.12%
controls:0.00%
cases:0.54%
controls:0.01%
cases:0.64%
controls:0.13%
cases:1.11%
controls:0.41%
54
194
6391
64118
35
58
6412
64270
39
16
6407
64312
72
0
6374
64328
29
8
5324
64178
29
81
4496
61962
39
204
3482
50131
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
6.6e-01
1.0e+00
2.0e+00
4.0e+00
3.0e+00
9.9e-01
7.4e-01
cases:5.03%
controls:2.65%
cases:4.34%
controls:1.57%
cases:2.48%
controls:0.33%
cases:0.82%
controls:0.02%
cases:6.09%
controls:0.33%
cases:4.38%
controls:1.68%
cases:7.27%
controls:3.61%
324
1707
6121
62605
280
1013
6167
63315
160
213
6286
64115
53
10
6393
64318
326
214
5027
63972
198
1042
4327
61001
256
1819
3265
48516
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
1.0e+00
1.4e+00
3.7e+00
—
4.0e+00
1.4e+00
8.4e-01
cases:1.60%
controls:0.59%
cases:1.07%
controls:0.27%
cases:0.92%
controls:0.02%
—
—
cases:1.72%
controls:0.03%
cases:1.02%
controls:0.25%
cases:2.07%
controls:0.91%
103
380
6342
63932
69
171
6378
64157
59
15
6387
64313
—
92
20
5261
64166
46
157
4479
61886
73
458
3448
49877
Neurological sympt/complt other
N29 [2002000734]
1.2e+00
1.9e+00
2.6e+00
—
2.9e+00
2.4e+00
1.2e+00
cases:0.53%
controls:0.16%
cases:0.36%
controls:0.05%
cases:0.11%
controls:0.01%
—
—
cases:0.21%
controls:0.01%
cases:0.55%
controls:0.05%
cases:0.60%
controls:0.18%
34
101
6411
64211
23
34
6424
64294
7
5
6439
64323
—
11
7
5342
64179
25
30
4500
62013
21
91
3500
50244
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.3e+00
1.8e+00
2.3e+00
—
3.0e+00
2.2e+00
1.8e+00
cases:1.32%
controls:0.37%
cases:0.76%
controls:0.12%
cases:0.39%
controls:0.04%
—
—
cases:0.69%
controls:0.04%
cases:1.13%
controls:0.12%
cases:2.10%
controls:0.36%
85
238
6360
64074
49
80
6398
64248
25
26
6421
64302
—
37
23
5316
64163
51
76
4474
61967
74
183
3447
50152
moxifloxacin; oral, parenteral
J01MA14 [21603021]
8.6e-01
1.8e+00
3.0e+00
1.0e+50
3.7e+00
1.6e+00
1.2e+00
cases:2.28%
controls:0.97%
cases:1.71%
controls:0.28%
cases:0.68%
controls:0.03%
cases:0.08%
controls:0.00%
cases:1.21%
controls:0.03%
cases:1.30%
controls:0.26%
cases:3.58%
controls:1.06%
147
627
6298
63685
110
178
6337
64150
44
21
6402
64307
5
0
6441
64328
65
19
5288
64167
59
163
4466
61880
126
535
3395
49800
Granulocytes [#/volume] in Blood
30394-1 [3035715]
1.0e+00
1.9e+00
2.5e+00
—
3.1e+00
1.9e+00
1.9e+00
cases:1.09%
controls:0.40%
cases:0.70%
controls:0.10%
cases:0.29%
controls:0.02%
—
—
cases:0.34%
controls:0.02%
cases:0.60%
controls:0.09%
cases:1.28%
controls:0.19%
70
260
6375
64052
45
67
6402
64261
19
16
6427
64312
—
18
10
5335
64176
27
53
4498
61990
45
96
3476
50239
Intracerebral haemorrhage in hemisphere, subcortical
I61.0 [45605803]
1.3e+00
1.5e+00
3.4e+00
1.0e+50
3.1e+00
1.9e+00
1.1e+00
cases:0.45%
controls:0.13%
cases:0.23%
controls:0.05%
cases:0.43%
controls:0.01%
cases:0.70%
controls:0.00%
cases:0.45%
controls:0.02%
cases:0.55%
controls:0.08%
cases:0.65%
controls:0.22%
29
82
6416
64230
15
32
6432
64296
28
9
6418
64319
45
0
6401
64328
24
13
5329
64173
25
52
4500
61991
23
113
3498
50222
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
2.3e+00
3.3e+00
—
1.0e+50
—
3.7e+00
3.0e+00
cases:1.40%
controls:0.14%
cases:1.04%
controls:0.04%
—
—
cases:3.15%
controls:0.00%
—
—
cases:1.35%
controls:0.03%
cases:2.56%
controls:0.13%
90
87
6355
64225
67
26
6380
64302
—
203
0
6243
64328
—
61
21
4464
62022
90
67
3431
50268
disulfiram; oral
N07BB01 [21604821]
1.6e+00
1.9e+00
2.4e+00
—
2.2e+00
2.2e+00
2.0e+00
cases:1.80%
controls:0.35%
cases:0.79%
controls:0.12%
cases:0.16%
controls:0.01%
—
—
cases:0.15%
controls:0.02%
cases:0.95%
controls:0.11%
cases:1.93%
controls:0.27%
116
228
6329
64084
51
76
6396
64252
10
9
6436
64319
—
8
11
5345
64175
43
69
4482
61974
68
136
3453
50199
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
5.3e-01
9.6e-01
2.0e+00
5.2e+00
2.4e+00
7.9e-01
3.7e-01
cases:17.22%
controls:10.87%
cases:14.89%
controls:6.26%
cases:6.97%
controls:1.01%
cases:5.96%
controls:0.04%
cases:10.22%
controls:1.01%
cases:13.61%
controls:6.66%
cases:21.30%
controls:15.73%
1110
6990
5335
57322
960
4027
5487
60301
449
650
5997
63678
384
23
6062
64305
547
651
4806
63535
616
4129
3909
57914
750
7919
2771
42416
Paranoid schizophrenia continuous
F20.00 [2000501920]
1.6e+00
1.8e+00
2.1e+00
—
2.4e+00
2.2e+00
2.1e+00
cases:0.84%
controls:0.17%
cases:0.64%
controls:0.10%
cases:0.36%
controls:0.05%
—
—
cases:0.47%
controls:0.04%
cases:0.91%
controls:0.10%
cases:1.33%
controls:0.17%
54
107
6391
64205
41
65
6406
64263
23
29
6423
64299
—
25
28
5328
64158
41
62
4484
61981
47
84
3474
50251
Emergency Medicine
93 [38004510]
5.2e-01
9.8e-01
2.5e+00
5.8e+00
1.5e+00
6.5e-01
2.9e-01
cases:20.88%
controls:13.58%
cases:18.49%
controls:7.84%
cases:12.21%
controls:1.14%
cases:15.00%
controls:0.06%
cases:5.21%
controls:1.19%
cases:15.69%
controls:8.85%
cases:26.61%
controls:21.39%
1346
8736
5099
55576
1192
5044
5255
59284
787
734
5659
63594
967
36
5479
64292
279
766
5074
63420
710
5490
3815
56553
937
10766
2584
39569
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
C34.32 [2000500619]
1.8e+00
2.4e+00
2.8e+00
1.0e+50
2.9e+00
2.2e+00
1.1e+00
cases:0.28%
controls:0.05%
cases:0.50%
controls:0.05%
cases:0.37%
controls:0.02%
cases:0.37%
controls:0.00%
cases:0.32%
controls:0.02%
cases:0.55%
controls:0.06%
cases:0.34%
controls:0.11%
18
30
6427
64282
32
29
6415
64299
24
14
6422
64314
24
0
6422
64328
17
11
5336
64175
25
38
4500
62005
12
55
3509
50280
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
1.3e+00
1.8e+00
2.9e+00
1.0e+50
2.2e+00
2.2e+00
1.7e+00
cases:0.70%
controls:0.19%
cases:0.43%
controls:0.07%
cases:0.14%
controls:0.01%
cases:0.42%
controls:0.00%
cases:0.13%
controls:0.01%
cases:0.57%
controls:0.06%
cases:1.48%
controls:0.27%
45
121
6400
64191
28
48
6419
64280
9
5
6437
64323
27
0
6419
64328
7
9
5346
64177
26
39
4499
62004
52
135
3469
50200
Spirometry
127783003 [4133840]
8.4e-01
1.5e+00
3.0e+00
1.0e+50
1.8e+00
2.7e+00
2.3e+00
cases:1.13%
controls:0.49%
cases:0.73%
controls:0.17%
cases:0.22%
controls:0.01%
cases:0.42%
controls:0.00%
cases:0.15%
controls:0.02%
cases:1.83%
controls:0.12%
cases:3.64%
controls:0.38%
73
316
6372
63996
47
109
6400
64219
14
7
6432
64321
27
0
6419
64328
8
16
5345
64170
83
75
4442
61968
128
192
3393
50143
Parkinson disease
G20 [45538098]
1.4e+00
1.4e+00
2.0e+00
4.6e+00
1.9e+00
8.4e-01
9.1e-02
cases:3.15%
controls:0.82%
cases:2.59%
controls:0.68%
cases:1.38%
controls:0.19%
cases:1.75%
controls:0.02%
cases:1.25%
controls:0.18%
cases:1.75%
controls:0.76%
cases:1.25%
controls:1.14%
203
527
6242
63785
167
438
6280
63890
89
120
6357
64208
113
12
6333
64316
67
117
5286
64069
79
473
4446
61570
44
575
3477
49760
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
3.1e-01
8.6e-01
2.5e+00
4.6e+00
2.8e+00
6.4e-01
4.1e-01
cases:7.08%
controls:5.30%
cases:5.93%
controls:2.60%
cases:3.88%
controls:0.35%
cases:2.92%
controls:0.03%
cases:5.32%
controls:0.33%
cases:4.73%
controls:2.56%
cases:9.15%
controls:6.28%
456
3411
5989
60901
382
1674
6065
62654
250
223
6196
64105
188
20
6258
64308
285
212
5068
63974
214
1588
4311
60455
322
3160
3199
47175
Intensive care
WX872 [2001310844]
6.0e-01
1.4e+00
4.1e+00
—
3.2e+00
1.6e+00
1.1e+00
cases:1.09%
controls:0.60%
cases:0.64%
controls:0.16%
cases:0.78%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:0.57%
controls:0.11%
cases:1.22%
controls:0.41%
70
386
6375
63926
41
102
6406
64226
50
8
6396
64320
—
14
7
5339
64179
26
71
4499
61972
43
206
3478
50129
Oxygen saturation in Capillary blood
2709-4 [3021901]
1.0e+00
1.6e+00
3.2e+00
—
3.9e+00
1.4e+00
9.3e-01
cases:0.70%
controls:0.25%
cases:0.82%
controls:0.17%
cases:0.61%
controls:0.02%
—
—
cases:1.46%
controls:0.03%
cases:0.86%
controls:0.22%
cases:1.76%
controls:0.71%
45
163
6400
64149
53
109
6394
64219
39
16
6407
64312
—
78
19
5275
64167
39
135
4486
61908
62
355
3459
49980
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
9.1e-01
1.8e+00
2.7e+00
—
2.0e+00
2.3e+00
2.2e+00
cases:4.47%
controls:1.85%
cases:3.41%
controls:0.59%
cases:1.04%
controls:0.07%
—
—
cases:0.47%
controls:0.06%
cases:4.82%
controls:0.49%
cases:9.03%
controls:1.06%
288
1187
6157
63125
220
382
6227
63946
67
45
6379
64283
—
25
39
5328
64147
218
304
4307
61739
318
534
3203
49801
FEV1/FVC
19926-5 [3011505]
9.1e-01
1.8e+00
2.7e+00
—
2.0e+00
2.3e+00
2.2e+00
cases:4.47%
controls:1.85%
cases:3.41%
controls:0.59%
cases:1.04%
controls:0.07%
—
—
cases:0.47%
controls:0.06%
cases:4.82%
controls:0.49%
cases:9.03%
controls:1.06%
288
1187
6157
63125
220
382
6227
63946
67
45
6379
64283
—
25
39
5328
64147
218
304
4307
61739
318
534
3203
49801
FEV1
20150-9 [3024653]
9.1e-01
1.8e+00
2.7e+00
—
2.0e+00
2.3e+00
2.2e+00
cases:4.47%
controls:1.85%
cases:3.41%
controls:0.59%
cases:1.04%
controls:0.07%
—
—
cases:0.47%
controls:0.06%
cases:4.82%
controls:0.49%
cases:9.03%
controls:1.06%
288
1187
6157
63125
220
382
6227
63946
67
45
6379
64283
—
25
39
5328
64147
218
304
4307
61739
318
534
3203
49801
Chronic respiratory failure
J96.1 [45557632]
1.5e+00
1.8e+00
2.4e+00
—
2.8e+00
1.9e+00
1.6e+00
cases:0.81%
controls:0.18%
cases:0.98%
controls:0.16%
cases:0.42%
controls:0.04%
—
—
cases:0.60%
controls:0.04%
cases:1.24%
controls:0.19%
cases:1.96%
controls:0.40%
52
117
6393
64195
63
105
6384
64223
27
24
6419
64304
—
32
24
5321
64162
56
118
4469
61925
69
201
3452
50134
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
1.0e+00
1.6e+00
3.1e+00
—
3.9e+00
1.4e+00
9.7e-01
cases:0.84%
controls:0.31%
cases:0.99%
controls:0.21%
cases:0.67%
controls:0.03%
—
—
cases:1.70%
controls:0.04%
cases:1.06%
controls:0.25%
cases:2.07%
controls:0.80%
54
197
6391
64115
64
136
6383
64192
43
19
6403
64309
—
91
23
5262
64163
48
158
4477
61885
73
401
3448
49934
Haematemesis
K92.0 [45605964]
1.3e+00
1.6e+00
3.2e+00
1.0e+50
3.4e+00
1.6e+00
8.2e-01
cases:0.82%
controls:0.23%
cases:0.40%
controls:0.08%
cases:0.26%
controls:0.01%
cases:0.34%
controls:0.00%
cases:0.24%
controls:0.01%
cases:0.38%
controls:0.08%
cases:0.57%
controls:0.25%
53
151
6392
64161
26
50
6421
64278
17
7
6429
64321
22
0
6424
64328
13
5
5340
64181
17
47
4508
61996
20
126
3501
50209
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
9.1e-01
1.9e+00
2.5e+00
—
3.0e+00
1.8e+00
1.7e+00
cases:1.13%
controls:0.46%
cases:0.81%
controls:0.12%
cases:0.36%
controls:0.03%
—
—
cases:0.41%
controls:0.02%
cases:0.62%
controls:0.10%
cases:1.39%
controls:0.25%
73
295
6372
64017
52
76
6395
64252
23
18
6423
64310
—
22
13
5331
64173
28
65
4497
61978
49
124
3472
50211
Sepsis, unspecified
A41.9 [45585911]
1.1e+00
1.9e+00
3.3e+00
1.0e+50
3.0e+00
1.5e+00
1.1e+00
cases:0.82%
controls:0.27%
cases:0.71%
controls:0.10%
cases:0.29%
controls:0.01%
cases:0.56%
controls:0.00%
cases:0.30%
controls:0.02%
cases:0.57%
controls:0.13%
cases:1.48%
controls:0.51%
53
173
6392
64139
46
66
6401
64262
19
7
6427
64321
36
0
6410
64328
16
10
5337
64176
26
78
4499
61965
52
259
3469
50076
Other interstitial pulmonary diseases with fibrosis
J84.1 [45557630]
1.3e+00
2.1e+00
2.4e+00
—
2.1e+00
2.0e+00
2.0e+00
cases:0.87%
controls:0.24%
cases:1.41%
controls:0.18%
cases:0.62%
controls:0.05%
—
—
cases:0.45%
controls:0.05%
cases:1.46%
controls:0.20%
cases:2.70%
controls:0.38%
56
155
6389
64157
91
117
6356
64211
40
35
6406
64293
—
24
34
5329
64152
66
127
4459
61916
95
190
3426
50145
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
3.1e-01
8.3e-01
2.3e+00
5.2e+00
2.4e+00
6.1e-01
2.2e-01
cases:11.47%
controls:8.65%
cases:8.25%
controls:3.78%
cases:4.55%
controls:0.46%
cases:3.41%
controls:0.02%
cases:4.52%
controls:0.43%
cases:6.17%
controls:3.46%
cases:12.55%
controls:10.31%
739
5565
5706
58747
532
2432
5915
61896
293
294
6153
64034
220
13
6226
64315
242
274
5111
63912
279
2147
4246
59896
442
5190
3079
45145
Alcohol dependence continuous use
F10.25 [2000501682]
1.6e+00
2.1e+00
2.3e+00
1.0e+50
3.1e+00
2.6e+00
2.4e+00
cases:0.67%
controls:0.13%
cases:0.36%
controls:0.04%
cases:0.08%
controls:0.01%
cases:0.11%
controls:0.00%
cases:0.24%
controls:0.01%
cases:0.69%
controls:0.05%
cases:1.28%
controls:0.12%
43
83
6402
64229
23
27
6424
64301
5
5
6441
64323
7
0
6439
64328
13
7
5340
64179
31
32
4494
62011
45
60
3476
50275
Alcohol dependence currently abstinent, but staying in restrictive environment
F10.21 [2000501678]
2.0e+00
3.3e+00
—
—
—
3.8e+00
2.8e+00
cases:0.28%
controls:0.04%
cases:0.29%
controls:0.01%
—
—
—
—
—
—
cases:0.49%
controls:0.01%
cases:0.57%
controls:0.03%
18
25
6427
64287
19
7
6428
64321
—
—
—
22
7
4503
62036
20
17
3501
50318
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
2.0e+00
3.1e+00
—
1.0e+50
—
3.4e+00
3.4e+00
cases:0.31%
controls:0.04%
cases:0.29%
controls:0.01%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.49%
controls:0.02%
cases:1.02%
controls:0.04%
20
26
6425
64286
19
9
6428
64319
—
7
0
6439
64328
—
22
10
4503
62033
36
18
3485
50317
Sodium [Moles/volume] in Urine
2955-3 [3003181]
9.4e-01
1.7e+00
3.5e+00
1.0e+50
3.2e+00
1.7e+00
7.8e-01
cases:0.70%
controls:0.28%
cases:0.64%
controls:0.12%
cases:0.29%
controls:0.01%
cases:0.17%
controls:0.00%
cases:0.43%
controls:0.02%
cases:0.75%
controls:0.13%
cases:0.91%
controls:0.42%
45
177
6400
64135
41
74
6406
64254
19
6
6427
64322
11
0
6435
64328
23
11
5330
64175
34
82
4491
61961
32
211
3489
50124
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
1.4e+00
1.8e+00
1.6e+00
—
2.8e+00
2.2e+00
2.0e+00
cases:0.92%
controls:0.24%
cases:0.62%
controls:0.11%
cases:0.22%
controls:0.04%
—
—
cases:0.56%
controls:0.03%
cases:0.93%
controls:0.10%
cases:1.85%
controls:0.24%
59
153
6386
64159
40
69
6407
64259
14
28
6432
64300
—
30
21
5323
64165
42
62
4483
61981
65
122
3456
50213
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
2.9e-01
7.3e-01
2.2e+00
5.6e+00
2.5e+00
5.5e-01
1.5e-01
cases:5.63%
controls:4.29%
cases:4.47%
controls:2.20%
cases:2.58%
controls:0.29%
cases:3.21%
controls:0.01%
cases:3.79%
controls:0.33%
cases:3.87%
controls:2.26%
cases:6.82%
controls:5.95%
363
2759
6082
61553
288
1417
6159
62911
166
188
6280
64140
207
8
6239
64320
203
214
5150
63972
175
1401
4350
60642
240
2994
3281
47341
Paralysis of vocal cords and larynx
J38.0 [45543265]
1.1e+00
1.6e+00
2.0e+00
1.0e+50
3.2e+00
2.4e+00
1.5e+00
cases:0.45%
controls:0.15%
cases:0.34%
controls:0.07%
cases:0.12%
controls:0.02%
cases:0.09%
controls:0.00%
cases:0.32%
controls:0.01%
cases:0.55%
controls:0.05%
cases:0.57%
controls:0.13%
29
97
6416
64215
22
43
6425
64285
8
11
6438
64317
6
0
6440
64328
17
8
5336
64178
25
31
4500
62012
20
67
3501
50268
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
1.1e+00
1.4e+00
2.9e+00
—
3.9e+00
1.4e+00
1.1e+00
cases:2.75%
controls:0.98%
cases:2.05%
controls:0.54%
cases:1.26%
controls:0.07%
—
—
cases:3.53%
controls:0.07%
cases:2.17%
controls:0.55%
cases:4.43%
controls:1.46%
177
629
6268
63683
132
345
6315
63983
81
44
6365
64284
—
189
46
5164
64140
98
342
4427
61701
156
734
3365
49601
Osmolality of Urine
2695-5 [3026782]
4.4e-01
9.7e-01
2.1e+00
4.7e+00
2.1e+00
8.9e-01
5.0e-01
cases:7.62%
controls:5.06%
cases:5.52%
controls:2.18%
cases:2.65%
controls:0.32%
cases:1.80%
controls:0.02%
cases:2.75%
controls:0.33%
cases:4.95%
controls:2.10%
cases:8.44%
controls:5.28%
491
3257
5954
61055
356
1401
6091
62927
171
206
6275
64122
116
11
6330
64317
147
211
5206
63975
224
1305
4301
60738
297
2659
3224
47676
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
7.3e-01
1.8e+00
3.5e+00
—
3.1e+00
1.6e+00
1.1e+00
cases:1.51%
controls:0.73%
cases:1.43%
controls:0.25%
cases:0.79%
controls:0.02%
—
—
cases:0.56%
controls:0.02%
cases:1.13%
controls:0.23%
cases:2.30%
controls:0.80%
97
470
6348
63842
92
161
6355
64167
51
16
6395
64312
—
30
16
5323
64170
51
143
4474
61900
81
404
3440
49931
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
1.0e+00
1.3e+00
2.8e+00
—
3.9e+00
1.3e+00
1.3e+00
cases:1.88%
controls:0.67%
cases:1.26%
controls:0.34%
cases:0.67%
controls:0.04%
—
—
cases:2.20%
controls:0.04%
cases:1.26%
controls:0.35%
cases:2.67%
controls:0.75%
121
433
6324
63879
81
219
6366
64109
43
26
6403
64302
—
118
28
5235
64158
57
216
4468
61827
94
375
3427
49960
Alcohol depence active use
F10.24 [2000501681]
1.5e+00
2.4e+00
—
—
3.4e+00
2.3e+00
2.2e+00
cases:0.45%
controls:0.10%
cases:0.29%
controls:0.03%
—
—
—
—
cases:0.22%
controls:0.01%
cases:0.35%
controls:0.04%
cases:0.85%
controls:0.10%
29
64
6416
64248
19
18
6428
64310
—
—
12
5
5341
64181
16
23
4509
62020
30
48
3491
50287
clozapine; oral, parenteral
N05AH02 [21604542]
2.0e+00
2.1e+00
1.9e+00
2.0e+00
1.5e+00
2.1e+00
2.1e+00
cases:1.44%
controls:0.20%
cases:1.44%
controls:0.18%
cases:0.93%
controls:0.14%
cases:0.08%
controls:0.01%
cases:0.64%
controls:0.14%
cases:1.52%
controls:0.19%
cases:1.79%
controls:0.23%
93
126
6352
64186
93
116
6354
64212
60
89
6386
64239
5
7
6441
64321
34
93
5319
64093
69
116
4456
61927
63
115
3458
50220
Simple antibody therapy of primary tumour
WB401 [2001310646]
—
2.0e+00
2.3e+00
—
2.4e+00
2.6e+00
2.4e+00
—
—
cases:0.23%
controls:0.03%
cases:0.12%
controls:0.01%
—
—
cases:0.13%
controls:0.01%
cases:0.27%
controls:0.02%
cases:0.17%
controls:0.02%
—
15
20
6432
64308
8
8
6438
64320
—
7
8
5346
64178
12
12
4513
62031
6
8
3515
50327
prednisolone; oral, parenteral
H02AB06 [21602734]
6.0e-01
1.0e+00
1.6e+00
3.9e+00
2.4e+00
1.3e+00
8.4e-01
cases:17.98%
controls:10.70%
cases:13.91%
controls:5.41%
cases:4.67%
controls:1.00%
cases:1.94%
controls:0.04%
cases:10.24%
controls:1.07%
cases:17.61%
controls:5.38%
cases:24.17%
controls:12.13%
1159
6882
5286
57430
897
3480
5550
60848
301
646
6145
63682
125
25
6321
64303
548
689
4805
63497
797
3335
3728
58708
851
6108
2670
44227
prednisolone
A07EA01 [21600653]
6.0e-01
1.0e+00
1.6e+00
3.9e+00
2.3e+00
1.3e+00
8.3e-01
cases:18.03%
controls:10.77%
cases:13.93%
controls:5.43%
cases:4.67%
controls:1.00%
cases:1.94%
controls:0.04%
cases:10.24%
controls:1.08%
cases:17.61%
controls:5.41%
cases:24.25%
controls:12.21%
1162
6925
5283
57387
898
3492
5549
60836
301
646
6145
63682
125
25
6321
64303
548
691
4805
63495
797
3357
3728
58686
854
6146
2667
44189
pH of Capillary blood
2745-8 [3009343]
1.0e+00
1.4e+00
2.9e+00
—
3.9e+00
1.3e+00
1.1e+00
cases:2.78%
controls:1.01%
cases:2.37%
controls:0.59%
cases:1.37%
controls:0.08%
—
—
cases:4.11%
controls:0.09%
cases:2.43%
controls:0.64%
cases:4.77%
controls:1.70%
179
648
6266
63664
153
382
6294
63946
88
50
6358
64278
—
220
56
5133
64130
110
399
4415
61644
168
854
3353
49481
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
2.9e-01
7.5e-01
2.3e+00
5.4e+00
2.1e+00
6.1e-01
1.7e-01
cases:8.50%
controls:6.53%
cases:7.65%
controls:3.75%
cases:4.92%
controls:0.50%
cases:4.41%
controls:0.02%
cases:4.37%
controls:0.56%
cases:7.27%
controls:4.07%
cases:14.23%
controls:12.23%
548
4200
5897
60112
493
2410
5954
61918
317
320
6129
64008
284
14
6162
64314
234
358
5119
63828
329
2524
4196
59519
501
6156
3020
44179
Monitored bed care
WX892 [2001310850]
8.7e-01
1.5e+00
3.9e+00
—
2.8e+00
1.5e+00
1.1e+00
cases:2.16%
controls:0.91%
cases:1.44%
controls:0.33%
cases:1.38%
controls:0.03%
—
—
cases:0.50%
controls:0.03%
cases:1.22%
controls:0.28%
cases:2.67%
controls:0.93%
139
586
6306
63726
93
213
6354
64115
89
19
6357
64309
—
27
19
5326
64167
55
174
4470
61869
94
470
3427
49865
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
9.6e-01
1.5e+00
3.2e+00
—
3.9e+00
1.3e+00
7.4e-01
cases:2.13%
controls:0.82%
cases:2.11%
controls:0.47%
cases:1.43%
controls:0.06%
—
—
cases:2.69%
controls:0.06%
cases:1.81%
controls:0.50%
cases:3.10%
controls:1.51%
137
528
6308
63784
136
305
6311
64023
92
39
6354
64289
—
144
36
5209
64150
82
309
4443
61734
109
758
3412
49577
Diffusion capacity of lung
54715006 [4182985]
7.0e-01
1.5e+00
2.8e+00
1.0e+50
2.4e+00
2.4e+00
1.8e+00
cases:0.61%
controls:0.30%
cases:0.56%
controls:0.12%
cases:0.20%
controls:0.01%
cases:0.23%
controls:0.00%
cases:0.13%
controls:0.01%
cases:1.13%
controls:0.10%
cases:1.68%
controls:0.29%
39
193
6406
64119
36
80
6411
64248
13
8
6433
64320
15
0
6431
64328
7
8
5346
64178
51
61
4474
61982
59
144
3462
50191
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1.0e+00
1.5e+00
2.9e+00
—
3.9e+00
1.4e+00
8.5e-01
cases:0.95%
controls:0.35%
cases:1.19%
controls:0.26%
cases:0.70%
controls:0.04%
—
—
cases:1.76%
controls:0.04%
cases:1.24%
controls:0.30%
cases:2.47%
controls:1.07%
61
223
6384
64089
77
170
6370
64158
45
26
6401
64302
—
94
23
5259
64163
56
184
4469
61859
87
539
3434
49796
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
9.7e-01
1.6e+00
2.9e+00
1.0e+50
4.1e+00
1.4e+00
6.8e-01
cases:2.89%
controls:1.12%
cases:2.33%
controls:0.49%
cases:0.96%
controls:0.05%
cases:0.16%
controls:0.00%
cases:3.42%
controls:0.06%
cases:2.32%
controls:0.59%
cases:3.44%
controls:1.77%
186
719
6259
63593
150
315
6297
64013
62
35
6384
64293
10
0
6436
64328
183
39
5170
64147
105
368
4420
61675
121
893
3400
49442
FEV1 percent change
69983-5 [42868472]
8.4e-01
1.7e+00
2.7e+00
—
2.2e+00
2.1e+00
2.0e+00
cases:3.69%
controls:1.63%
cases:2.64%
controls:0.51%
cases:0.78%
controls:0.05%
—
—
cases:0.35%
controls:0.04%
cases:3.23%
controls:0.39%
cases:6.76%
controls:0.96%
238
1051
6207
63261
170
330
6277
63998
50
34
6396
64294
—
19
26
5334
64160
146
243
4379
61800
238
481
3283
49854
FVC percent change Respiratory system
69982-7 [42868471]
8.4e-01
1.7e+00
2.7e+00
—
2.2e+00
2.1e+00
2.0e+00
cases:3.69%
controls:1.63%
cases:2.64%
controls:0.51%
cases:0.78%
controls:0.05%
—
—
cases:0.35%
controls:0.04%
cases:3.23%
controls:0.39%
cases:6.76%
controls:0.96%
238
1051
6207
63261
170
330
6277
63998
50
34
6396
64294
—
19
26
5334
64160
146
243
4379
61800
238
481
3283
49854
FEV1/FVC --post bronchodilation
69970-2 [42868459]
8.4e-01
1.7e+00
2.7e+00
—
2.2e+00
2.1e+00
2.0e+00
cases:3.69%
controls:1.63%
cases:2.64%
controls:0.51%
cases:0.78%
controls:0.05%
—
—
cases:0.35%
controls:0.04%
cases:3.23%
controls:0.39%
cases:6.76%
controls:0.96%
238
1051
6207
63261
170
330
6277
63998
50
34
6396
64294
—
19
26
5334
64160
146
243
4379
61800
238
481
3283
49854
FEV1 --post bronchodilation
20155-8 [3023550]
8.4e-01
1.7e+00
2.7e+00
—
2.2e+00
2.1e+00
2.0e+00
cases:3.69%
controls:1.63%
cases:2.64%
controls:0.51%
cases:0.78%
controls:0.05%
—
—
cases:0.35%
controls:0.04%
cases:3.23%
controls:0.39%
cases:6.76%
controls:0.96%
238
1051
6207
63261
170
330
6277
63998
50
34
6396
64294
—
19
26
5334
64160
146
243
4379
61800
238
481
3283
49854
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
8.4e-01
1.7e+00
2.7e+00
—
2.2e+00
2.1e+00
2.0e+00
cases:3.69%
controls:1.63%
cases:2.64%
controls:0.51%
cases:0.78%
controls:0.05%
—
—
cases:0.35%
controls:0.04%
cases:3.23%
controls:0.39%
cases:6.76%
controls:0.96%
238
1051
6207
63261
170
330
6277
63998
50
34
6396
64294
—
19
26
5334
64160
146
243
4379
61800
238
481
3283
49854
Differential panel, method unspecified - Blood
69738-3 [42870588]
5.5e-01
1.0e+00
1.9e+00
3.7e+00
2.5e+00
1.1e+00
6.4e-01
cases:11.00%
controls:6.67%
cases:10.39%
controls:3.97%
cases:4.96%
controls:0.77%
cases:1.58%
controls:0.04%
cases:8.97%
controls:0.77%
cases:11.05%
controls:4.05%
cases:15.45%
controls:8.76%
709
4287
5736
60025
670
2557
5777
61771
320
493
6126
63835
102
25
6344
64303
480
494
4873
63692
500
2512
4025
59531
544
4410
2977
45925
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
5.0e-01
9.5e-01
2.0e+00
4.0e+00
2.6e+00
9.7e-01
4.7e-01
cases:3.27%
controls:2.00%
cases:2.13%
controls:0.84%
cases:0.87%
controls:0.12%
cases:0.43%
controls:0.01%
cases:1.57%
controls:0.12%
cases:2.19%
controls:0.84%
cases:3.86%
controls:2.46%
211
1289
6234
63023
137
538
6310
63790
56
80
6390
64248
28
5
6418
64323
84
78
5269
64108
99
522
4426
61521
136
1238
3385
49097
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
C34.11 [2000500600]
1.8e+00
2.5e+00
2.8e+00
—
2.3e+00
2.0e+00
1.1e+00
cases:0.23%
controls:0.04%
cases:0.64%
controls:0.05%
cases:0.42%
controls:0.02%
—
—
cases:0.34%
controls:0.03%
cases:0.53%
controls:0.08%
cases:0.34%
controls:0.11%
15
25
6430
64287
41
34
6406
64294
27
16
6419
64312
—
18
21
5335
64165
24
47
4501
61996
12
55
3509
50280
Nutritional therapy
R4190 [2001310243]
1.1e+00
1.8e+00
2.2e+00
—
3.0e+00
1.8e+00
1.5e+00
cases:0.64%
controls:0.21%
cases:0.60%
controls:0.10%
cases:0.22%
controls:0.02%
—
—
cases:0.37%
controls:0.02%
cases:0.62%
controls:0.10%
cases:1.02%
controls:0.23%
41
132
6404
64180
39
67
6408
64261
14
16
6432
64312
—
20
12
5333
64174
28
63
4497
61980
36
116
3485
50219
Gas panel - Capillary blood
24337-8 [3022313]
1.1e+00
1.3e+00
2.7e+00
—
3.9e+00
1.3e+00
1.1e+00
cases:2.25%
controls:0.79%
cases:1.61%
controls:0.43%
cases:0.79%
controls:0.05%
—
—
cases:2.80%
controls:0.06%
cases:1.57%
controls:0.45%
cases:3.27%
controls:1.08%
145
509
6300
63803
104
279
6343
64049
51
35
6395
64293
—
150
37
5203
64149
71
279
4454
61764
115
546
3406
49789
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
1.0e+00
1.4e+00
3.1e+00
—
3.5e+00
1.5e+00
7.7e-01
cases:0.93%
controls:0.33%
cases:0.54%
controls:0.13%
cases:0.17%
controls:0.01%
—
—
cases:0.41%
controls:0.01%
cases:0.46%
controls:0.10%
cases:0.82%
controls:0.38%
60
213
6385
64099
35
86
6412
64242
11
5
6435
64323
—
22
8
5331
64178
21
62
4504
61981
29
192
3492
50143
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
1.0e+00
1.4e+00
3.1e+00
—
3.5e+00
1.5e+00
7.7e-01
cases:0.90%
controls:0.33%
cases:0.54%
controls:0.13%
cases:0.17%
controls:0.01%
—
—
cases:0.41%
controls:0.01%
cases:0.46%
controls:0.10%
cases:0.82%
controls:0.38%
58
213
6387
64099
35
84
6412
64244
11
5
6435
64323
—
22
8
5331
64178
21
62
4504
61981
29
192
3492
50143
Gas panel - Arterial blood
24336-0 [3019060]
8.0e-01
1.4e+00
2.8e+00
1.0e+50
4.0e+00
1.5e+00
9.2e-01
cases:2.75%
controls:1.26%
cases:2.03%
controls:0.53%
cases:1.07%
controls:0.07%
cases:2.23%
controls:0.00%
cases:2.88%
controls:0.05%
cases:2.17%
controls:0.49%
cases:3.83%
controls:1.57%
177
808
6268
63504
131
340
6316
63988
69
44
6377
64284
144
0
6302
64328
154
35
5199
64151
98
306
4427
61737
135
791
3386
49544
Decubitus ulcer and pressure area
L89 [45601235]
1.4e+00
2.0e+00
2.6e+00
1.0e+50
2.6e+00
1.7e+00
1.0e+00
cases:0.71%
controls:0.17%
cases:0.50%
controls:0.07%
cases:0.31%
controls:0.02%
cases:0.23%
controls:0.00%
cases:0.35%
controls:0.03%
cases:0.62%
controls:0.12%
cases:0.99%
controls:0.37%
46
111
6399
64201
32
42
6415
64286
20
15
6426
64313
15
0
6431
64328
19
17
5334
64169
28
72
4497
61971
35
186
3486
50149
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61365-3 [40764126]
1.7e+00
2.6e+00
3.4e+00
—
—
2.0e+00
1.7e+00
cases:0.62%
controls:0.12%
cases:0.50%
controls:0.04%
cases:0.23%
controls:0.01%
—
—
—
—
cases:0.42%
controls:0.06%
cases:0.80%
controls:0.15%
40
75
6405
64237
32
25
6415
64303
15
5
6431
64323
—
—
19
37
4506
62006
28
73
3493
50262
Chronic alcohol abuse
P15 [2002000811]
1.4e+00
1.5e+00
2.0e+00
—
2.5e+00
2.1e+00
1.7e+00
cases:0.92%
controls:0.22%
cases:0.50%
controls:0.11%
cases:0.19%
controls:0.02%
—
—
cases:0.22%
controls:0.02%
cases:0.82%
controls:0.10%
cases:1.76%
controls:0.31%
59
143
6386
64169
32
71
6415
64257
12
16
6434
64312
—
12
12
5341
64174
37
64
4488
61979
62
157
3459
50178
Medical Oncology
90 [38004507]
4.8e-01
1.4e+00
1.8e+00
3.6e+00
1.7e+00
1.3e+00
8.0e-01
cases:6.45%
controls:4.09%
cases:10.70%
controls:2.79%
cases:5.97%
controls:1.02%
cases:3.18%
controls:0.09%
cases:5.32%
controls:0.98%
cases:10.03%
controls:2.83%
cases:10.11%
controls:4.80%
416
2630
6029
61682
690
1793
5757
62535
385
657
6061
63671
205
56
6241
64272
285
631
5068
63555
454
1753
4071
60290
356
2418
3165
47917
Urine methamphetamine measurement
313579004 [4198724]
2.1e+00
2.9e+00
—
1.0e+50
—
3.4e+00
2.8e+00
cases:0.36%
controls:0.05%
cases:0.20%
controls:0.01%
—
—
cases:0.22%
controls:0.00%
—
—
cases:0.24%
controls:0.01%
cases:0.54%
controls:0.03%
23
29
6422
64283
13
7
6434
64321
—
14
0
6432
64328
—
11
5
4514
62038
19
16
3502
50319
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
8.5e-01
1.4e+00
3.2e+00
—
3.4e+00
1.6e+00
7.4e-01
cases:1.44%
controls:0.62%
cases:0.90%
controls:0.23%
cases:0.42%
controls:0.02%
—
—
cases:0.73%
controls:0.02%
cases:0.86%
controls:0.17%
cases:1.36%
controls:0.66%
93
399
6352
63913
58
146
6389
64182
27
11
6419
64317
—
39
15
5314
64171
39
107
4486
61936
48
331
3473
50004
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
9.3e-01
1.2e+00
3.3e+00
—
3.3e+00
1.6e+00
9.9e-01
cases:0.79%
controls:0.31%
cases:0.60%
controls:0.18%
cases:0.57%
controls:0.02%
—
—
cases:0.82%
controls:0.03%
cases:0.95%
controls:0.20%
cases:1.87%
controls:0.71%
51
202
6394
64110
39
118
6408
64210
37
14
6409
64314
—
44
20
5309
64166
43
126
4482
61917
66
355
3455
49980
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.8e-01
7.5e-01
2.1e+00
4.8e+00
2.5e+00
6.6e-01
1.5e-01
cases:33.62%
controls:27.71%
cases:32.74%
controls:18.75%
cases:24.74%
controls:4.00%
cases:26.23%
controls:0.30%
cases:33.14%
controls:3.85%
cases:31.89%
controls:19.48%
cases:41.01%
controls:37.32%
2167
17821
4278
46491
2111
12059
4336
52269
1595
2576
4851
61752
1691
190
4755
64138
1774
2469
3579
61717
1443
12086
3082
49957
1444
18786
2077
31549
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
4.8e-01
8.9e-01
2.0e+00
4.3e+00
2.3e+00
8.2e-01
4.1e-01
cases:9.22%
controls:5.93%
cases:6.36%
controls:2.72%
cases:2.79%
controls:0.41%
cases:1.05%
controls:0.01%
cases:3.68%
controls:0.38%
cases:6.12%
controls:2.78%
cases:11.76%
controls:8.10%
594
3816
5851
60496
410
1752
6037
62576
180
261
6266
64067
68
9
6378
64319
197
246
5156
63940
277
1726
4248
60317
414
4076
3107
46259
Conditions requiring daily forced enteral nutrition
504 [2001600363]
2.1e+00
3.4e+00
—
—
—
3.4e+00
2.2e+00
cases:0.73%
controls:0.09%
cases:0.81%
controls:0.03%
—
—
—
—
—
—
cases:0.93%
controls:0.03%
cases:0.45%
controls:0.05%
47
55
6398
64257
52
17
6395
64311
—
—
—
42
19
4483
62024
16
26
3505
50309
combinations of penicillins
J01CR50 [21602867]
1.3e+00
2.5e+00
—
—
3.8e+00
2.2e+00
1.3e+00
cases:0.29%
controls:0.08%
cases:0.29%
controls:0.02%
—
—
—
—
cases:0.35%
controls:0.01%
cases:0.40%
controls:0.04%
cases:0.43%
controls:0.12%
19
51
6426
64261
19
15
6428
64313
—
—
19
5
5334
64181
18
27
4507
62016
15
60
3506
50275
Myeloperoxidase Ab [Units/volume] in Serum
6969-0 [3023150]
8.7e-01
1.8e+00
2.8e+00
—
3.1e+00
1.7e+00
9.3e-01
cases:0.59%
controls:0.25%
cases:0.48%
controls:0.08%
cases:0.19%
controls:0.01%
—
—
cases:0.34%
controls:0.02%
cases:0.46%
controls:0.09%
cases:0.80%
controls:0.32%
38
160
6407
64152
31
53
6416
64275
12
7
6434
64321
—
18
10
5335
64176
21
54
4504
61989
28
159
3493
50176
Bacteria identified in Urine by Culture
630-4 [3026008]
5.4e-01
9.5e-01
2.0e+00
4.5e+00
2.0e+00
8.3e-01
3.0e-01
cases:9.82%
controls:5.97%
cases:8.31%
controls:3.40%
cases:3.88%
controls:0.52%
cases:2.00%
controls:0.02%
cases:3.77%
controls:0.55%
cases:7.91%
controls:3.63%
cases:12.58%
controls:9.59%
633
3840
5812
60472
536
2187
5911
62141
250
333
6196
63995
129
14
6317
64314
202
356
5151
63830
358
2251
4167
59792
443
4829
3078
45506
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
5.6e-01
1.0e+00
1.7e+00
3.7e+00
2.4e+00
1.1e+00
5.5e-01
cases:6.13%
controls:3.58%
cases:5.46%
controls:2.08%
cases:2.28%
controls:0.41%
cases:0.65%
controls:0.02%
cases:3.77%
controls:0.35%
cases:6.12%
controls:2.16%
cases:9.09%
controls:5.44%
395
2302
6050
62010
352
1340
6095
62988
147
261
6299
64067
42
10
6404
64318
202
222
5151
63964
277
1338
4248
60705
320
2739
3201
47596
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.0e+00
1.7e+00
2.1e+00
1.0e+50
2.9e+00
2.0e+00
1.5e+00
cases:1.38%
controls:0.50%
cases:0.95%
controls:0.18%
cases:0.25%
controls:0.03%
cases:0.08%
controls:0.00%
cases:0.49%
controls:0.03%
cases:1.17%
controls:0.16%
cases:2.22%
controls:0.53%
89
323
6356
63989
61
113
6386
64215
16
20
6430
64308
5
0
6441
64328
26
18
5327
64168
53
99
4472
61944
78
265
3443
50070
Supine thorax X-ray examination
GD1QA [2001303648]
1.2e+00
1.7e+00
3.5e+00
—
2.5e+00
1.3e+00
7.9e-01
cases:8.44%
controls:2.61%
cases:6.92%
controls:1.29%
cases:5.69%
controls:0.18%
—
—
cases:2.39%
controls:0.20%
cases:5.64%
controls:1.57%
cases:9.88%
controls:4.75%
544
1680
5901
62632
446
827
6001
63501
367
115
6079
64213
—
128
130
5225
64056
255
975
4270
61068
348
2391
3173
47944
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.8e-01
9.9e-01
1.8e+00
3.7e+00
2.5e+00
1.1e+00
5.7e-01
cases:14.51%
controls:9.52%
cases:13.90%
controls:5.67%
cases:6.45%
controls:1.10%
cases:2.03%
controls:0.05%
cases:11.71%
controls:1.07%
cases:14.85%
controls:5.74%
cases:21.02%
controls:13.03%
935
6122
5510
58190
896
3647
5551
60681
416
708
6030
63620
131
34
6315
64294
627
688
4726
63498
672
3564
3853
58479
740
6558
2781
43777
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.9e-01
9.9e-01
1.8e+00
3.7e+00
2.5e+00
1.1e+00
5.7e-01
cases:14.54%
controls:9.48%
cases:13.93%
controls:5.66%
cases:6.44%
controls:1.10%
cases:2.02%
controls:0.05%
cases:11.60%
controls:1.07%
cases:14.83%
controls:5.74%
cases:21.02%
controls:13.03%
937
6094
5508
58218
898
3641
5549
60687
415
705
6031
63623
130
34
6316
64294
621
687
4732
63499
671
3562
3854
58481
740
6559
2781
43776
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.9e-01
1.0e+00
1.8e+00
3.6e+00
2.5e+00
1.0e+00
5.7e-01
cases:14.51%
controls:9.44%
cases:13.96%
controls:5.64%
cases:6.45%
controls:1.09%
cases:1.99%
controls:0.05%
cases:11.62%
controls:1.07%
cases:14.78%
controls:5.74%
cases:21.05%
controls:13.07%
935
6069
5510
58243
900
3626
5547
60702
416
703
6030
63625
128
34
6318
64294
622
686
4731
63500
669
3559
3856
58484
741
6577
2780
43758
Status epilepticus, unspecified
G41.9 [45557235]
2.4e+00
2.2e+00
—
1.0e+50
—
3.8e+00
2.7e+00
cases:0.22%
controls:0.02%
cases:0.14%
controls:0.02%
—
—
cases:0.62%
controls:0.00%
—
—
cases:0.62%
controls:0.01%
cases:0.74%
controls:0.05%
14
13
6431
64299
9
10
6438
64318
—
40
0
6406
64328
—
28
9
4497
62034
26
24
3495
50311
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
1.0e+00
1.2e+00
3.0e+00
—
4.1e+00
1.0e+00
7.1e-01
cases:2.03%
controls:0.74%
cases:1.38%
controls:0.44%
cases:1.10%
controls:0.05%
—
—
cases:2.05%
controls:0.04%
cases:1.28%
controls:0.45%
cases:3.04%
controls:1.51%
131
474
6314
63838
89
280
6358
64048
71
34
6375
64294
—
110
23
5243
64163
58
282
4467
61761
107
761
3414
49574
Base excess in Arterial blood by calculation
1925-7 [3003396]
8.6e-01
1.3e+00
3.1e+00
—
3.9e+00
1.2e+00
6.8e-01
cases:4.38%
controls:1.90%
cases:3.27%
controls:0.95%
cases:2.50%
controls:0.12%
—
—
cases:4.65%
controls:0.10%
cases:3.31%
controls:0.98%
cases:6.08%
controls:3.18%
282
1223
6163
63089
211
613
6236
63715
161
75
6285
64253
—
249
62
5104
64124
150
605
4375
61438
214
1603
3307
48732
pH of Arterial blood
2744-1 [3019977]
8.6e-01
1.2e+00
3.1e+00
—
3.9e+00
1.2e+00
6.9e-01
cases:4.38%
controls:1.91%
cases:3.26%
controls:0.97%
cases:2.48%
controls:0.12%
—
—
cases:4.65%
controls:0.10%
cases:3.29%
controls:0.97%
cases:6.13%
controls:3.17%
282
1227
6163
63085
210
621
6237
63707
160
74
6286
64254
—
249
62
5104
64124
149
604
4376
61439
216
1595
3305
48740
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
4.3e-01
7.6e-01
1.9e+00
4.6e+00
2.3e+00
6.8e-01
3.5e-01
cases:17.86%
controls:12.38%
cases:11.31%
controls:5.64%
cases:4.51%
controls:0.69%
cases:2.45%
controls:0.03%
cases:6.59%
controls:0.67%
cases:10.78%
controls:5.78%
cases:21.36%
controls:16.07%
1151
7961
5294
56351
729
3629
5718
60699
291
441
6155
63887
158
17
6288
64311
353
431
5000
63755
488
3587
4037
58456
752
8089
2769
42246
Upper gastrointestinal surgery
106 [44777669]
4.3e-01
8.0e-01
1.9e+00
4.6e+00
1.8e+00
9.7e-01
5.4e-01
cases:14.49%
controls:9.93%
cases:8.36%
controls:3.94%
cases:4.02%
controls:0.64%
cases:3.51%
controls:0.04%
cases:3.61%
controls:0.62%
cases:9.70%
controls:3.90%
cases:16.96%
controls:10.59%
934
6383
5511
57929
539
2535
5908
61793
259
412
6187
63916
226
23
6220
64305
193
396
5160
63790
439
2421
4086
59622
597
5331
2924
45004
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
3.9e-01
8.4e-01
2.0e+00
4.5e+00
1.9e+00
8.5e-01
4.8e-01
cases:6.86%
controls:4.75%
cases:4.93%
controls:2.19%
cases:2.47%
controls:0.34%
cases:1.83%
controls:0.02%
cases:2.47%
controls:0.36%
cases:5.04%
controls:2.22%
cases:9.09%
controls:5.85%
442
3056
6003
61256
318
1406
6129
62922
159
220
6287
64108
118
13
6328
64315
132
231
5221
63955
228
1375
4297
60668
320
2944
3201
47391
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
8.7e-01
1.3e+00
3.1e+00
—
3.9e+00
1.2e+00
6.5e-01
cases:4.42%
controls:1.90%
cases:3.35%
controls:0.96%
cases:2.45%
controls:0.12%
—
—
cases:4.60%
controls:0.10%
cases:3.25%
controls:0.98%
cases:5.91%
controls:3.17%
285
1221
6160
63091
216
619
6231
63709
158
74
6288
64254
—
246
61
5107
64125
147
611
4378
61432
208
1597
3313
48738
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
4.6e-01
9.8e-01
1.8e+00
3.7e+00
2.5e+00
1.0e+00
5.6e-01
cases:14.48%
controls:9.69%
cases:14.07%
controls:5.80%
cases:6.61%
controls:1.12%
cases:2.03%
controls:0.05%
cases:11.79%
controls:1.09%
cases:14.83%
controls:5.92%
cases:21.36%
controls:13.44%
933
6230
5512
58082
907
3730
5540
60598
426
719
6020
63609
131
34
6315
64294
631
702
4722
63484
671
3673
3854
58370
752
6763
2769
43572
Intracerebral haemorrhage, unspecified
I61.9 [45576882]
1.2e+00
2.0e+00
3.9e+00
—
2.6e+00
1.4e+00
8.0e-01
cases:0.40%
controls:0.12%
cases:0.29%
controls:0.04%
cases:0.37%
controls:0.01%
—
—
cases:0.21%
controls:0.02%
cases:0.22%
controls:0.05%
cases:0.48%
controls:0.22%
26
78
6419
64234
19
27
6428
64301
24
5
6422
64323
—
11
10
5342
64176
10
34
4515
62009
17
109
3504
50226
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.0e+00
1.5e+00
2.3e+00
—
3.3e+00
1.7e+00
1.2e+00
cases:0.61%
controls:0.22%
cases:0.64%
controls:0.14%
cases:0.28%
controls:0.03%
—
—
cases:0.75%
controls:0.03%
cases:0.73%
controls:0.14%
cases:1.28%
controls:0.39%
39
144
6406
64168
41
88
6406
64240
18
18
6428
64310
—
40
18
5313
64168
33
87
4492
61956
45
195
3476
50140
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
8.7e-01
1.3e+00
3.1e+00
—
3.9e+00
1.2e+00
6.6e-01
cases:4.42%
controls:1.90%
cases:3.35%
controls:0.96%
cases:2.45%
controls:0.12%
—
—
cases:4.60%
controls:0.10%
cases:3.25%
controls:0.99%
cases:5.96%
controls:3.17%
285
1222
6160
63090
216
620
6231
63708
158
76
6288
64252
—
246
62
5107
64124
147
612
4378
61431
210
1597
3311
48738
Malaise and fatigue
R53 [45553741]
8.6e-01
1.1e+00
2.4e+00
4.4e+00
1.3e+00
5.7e-01
4.1e-01
cases:6.73%
controls:2.97%
cases:4.20%
controls:1.41%
cases:1.82%
controls:0.18%
cases:0.62%
controls:0.01%
cases:0.65%
controls:0.19%
cases:2.81%
controls:1.61%
cases:7.61%
controls:5.18%
434
1913
6011
62399
271
907
6176
63421
117
113
6329
64215
40
5
6406
64323
35
119
5318
64067
127
996
4398
61047
268
2607
3253
47728
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
9.4e-01
1.6e+00
3.0e+00
1.0e+50
2.5e+00
1.9e+00
9.4e-01
cases:1.54%
controls:0.61%
cases:1.10%
controls:0.22%
cases:0.45%
controls:0.02%
cases:1.44%
controls:0.00%
cases:0.30%
controls:0.02%
cases:1.17%
controls:0.17%
cases:1.31%
controls:0.52%
99
391
6346
63921
71
142
6376
64186
29
14
6417
64314
93
0
6353
64328
16
16
5337
64170
53
105
4472
61938
46
260
3475
50075
Poisoning by systemic antibiotics
T36 [45756588]
2.2e+00
2.7e+00
—
1.0e+50
—
3.3e+00
2.8e+00
cases:1.80%
controls:0.21%
cases:1.21%
controls:0.08%
—
—
cases:4.06%
controls:0.00%
—
—
cases:1.90%
controls:0.07%
cases:3.24%
controls:0.21%
116
137
6329
64175
78
51
6369
64277
—
262
0
6184
64328
—
86
44
4439
61999
114
107
3407
50228
Oesophageal obstruction
K22.2 [45552917]
1.3e+00
2.1e+00
2.7e+00
1.0e+50
2.7e+00
2.1e+00
1.1e+00
cases:0.43%
controls:0.12%
cases:0.34%
controls:0.04%
cases:0.20%
controls:0.01%
cases:0.17%
controls:0.00%
cases:0.19%
controls:0.01%
cases:0.42%
controls:0.05%
cases:0.34%
controls:0.11%
28
75
6417
64237
22
26
6425
64302
13
9
6433
64319
11
0
6435
64328
10
8
5343
64178
19
32
4506
62011
12
55
3509
50280
Basophils [#/volume] in Blood
26444-0 [3006315]
4.8e-01
9.8e-01
1.8e+00
3.6e+00
2.4e+00
1.1e+00
5.6e-01
cases:15.13%
controls:9.93%
cases:14.32%
controls:5.92%
cases:6.59%
controls:1.13%
cases:1.95%
controls:0.05%
cases:11.60%
controls:1.12%
cases:15.80%
controls:6.13%
cases:22.24%
controls:14.10%
975
6386
5470
57926
923
3809
5524
60519
425
728
6021
63600
126
35
6320
64293
621
721
4732
63465
715
3803
3810
58240
783
7097
2738
43238
Insertion of central venous catheter through periferal vein
TPH30 [2001309602]
9.0e-01
2.0e+00
2.5e+00
1.0e+50
3.0e+00
1.5e+00
1.9e+00
cases:0.25%
controls:0.10%
cases:0.26%
controls:0.03%
cases:0.09%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.15%
controls:0.01%
cases:0.20%
controls:0.04%
cases:0.62%
controls:0.09%
16
65
6429
64247
17
22
6430
64306
6
5
6440
64323
6
0
6440
64328
8
5
5345
64181
9
27
4516
62016
22
46
3499
50289
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.7e-01
9.8e-01
1.8e+00
3.6e+00
2.4e+00
1.0e+00
5.6e-01
cases:14.97%
controls:9.87%
cases:14.24%
controls:5.89%
cases:6.59%
controls:1.13%
cases:1.95%
controls:0.05%
cases:11.56%
controls:1.12%
cases:15.60%
controls:6.09%
cases:22.10%
controls:14.00%
965
6349
5480
57963
918
3787
5529
60541
425
727
6021
63601
126
35
6320
64293
619
719
4734
63467
706
3778
3819
58265
778
7047
2743
43288
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.5e-01
9.8e-01
1.8e+00
4.0e+00
2.2e+00
9.9e-01
5.4e-01
cases:17.39%
controls:11.84%
cases:17.62%
controls:7.40%
cases:9.79%
controls:1.76%
cases:4.59%
controls:0.09%
cases:13.41%
controls:1.76%
cases:17.88%
controls:7.48%
cases:24.57%
controls:16.00%
1121
7616
5324
56696
1136
4759
5311
59569
631
1134
5815
63194
296
57
6150
64271
718
1130
4635
63056
809
4638
3716
57405
865
8055
2656
42280
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.6e-01
9.6e-01
1.8e+00
3.6e+00
2.4e+00
1.0e+00
5.4e-01
cases:15.36%
controls:10.29%
cases:14.56%
controls:6.13%
cases:6.76%
controls:1.17%
cases:1.99%
controls:0.05%
cases:11.83%
controls:1.15%
cases:15.78%
controls:6.36%
cases:22.47%
controls:14.50%
990
6617
5455
57695
939
3946
5508
60382
436
752
6010
63576
128
34
6318
64294
633
741
4720
63445
714
3947
3811
58096
791
7299
2730
43036
Oxygen saturation in Arterial blood
2708-6 [3016502]
8.4e-01
1.2e+00
3.0e+00
—
3.9e+00
1.2e+00
6.1e-01
cases:3.74%
controls:1.65%
cases:2.84%
controls:0.86%
cases:2.14%
controls:0.10%
—
—
cases:4.17%
controls:0.09%
cases:2.98%
controls:0.89%
cases:5.20%
controls:2.89%
241
1063
6204
63249
183
552
6264
63776
138
67
6308
64261
—
223
56
5130
64130
135
550
4390
61493
183
1457
3338
48878
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.9e-01
9.6e-01
1.8e+00
3.6e+00
2.4e+00
1.1e+00
5.5e-01
cases:15.92%
controls:10.35%
cases:14.67%
controls:6.16%
cases:6.97%
controls:1.20%
cases:2.05%
controls:0.06%
cases:11.81%
controls:1.19%
cases:16.18%
controls:6.32%
cases:22.75%
controls:14.54%
1026
6657
5419
57655
946
3965
5501
60363
449
771
5997
63557
132
38
6314
64290
632
766
4721
63420
732
3924
3793
58119
801
7319
2720
43016
Treatment plan or consultation
WZC00 [2001310885]
4.0e-01
1.3e+00
1.5e+00
4.5e+00
1.6e+00
9.5e-01
5.8e-01
cases:7.18%
controls:4.94%
cases:6.89%
controls:1.99%
cases:1.18%
controls:0.27%
cases:0.87%
controls:0.01%
cases:1.18%
controls:0.25%
cases:4.73%
controls:1.88%
cases:9.86%
controls:5.78%
463
3175
5982
61137
444
1280
6003
63048
76
172
6370
64156
56
6
6390
64322
63
158
5290
64028
214
1165
4311
60878
347
2907
3174
47428
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
7.8e-01
1.3e+00
3.1e+00
1.0e+50
3.8e+00
1.4e+00
5.1e-01
cases:2.48%
controls:1.16%
cases:1.97%
controls:0.55%
cases:1.40%
controls:0.07%
cases:2.89%
controls:0.00%
cases:2.73%
controls:0.06%
cases:2.21%
controls:0.57%
cases:3.12%
controls:1.89%
160
744
6285
63568
127
353
6320
63975
90
43
6356
64285
186
0
6260
64328
146
40
5207
64146
100
354
4425
61689
110
953
3411
49382
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
1.3e+00
1.4e+00
2.3e+00
—
3.1e+00
1.9e+00
8.4e-01
cases:0.43%
controls:0.12%
cases:0.22%
controls:0.05%
cases:0.14%
controls:0.01%
—
—
cases:0.17%
controls:0.01%
cases:0.35%
controls:0.05%
cases:0.54%
controls:0.23%
28
78
6417
64234
14
33
6433
64295
9
9
6437
64319
—
9
5
5344
64181
16
34
4509
62009
19
118
3502
50217
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
6.5e-01
1.3e+00
2.8e+00
1.0e+50
2.9e+00
1.7e+00
1.5e+00
cases:0.88%
controls:0.46%
cases:0.54%
controls:0.16%
cases:0.17%
controls:0.01%
cases:0.29%
controls:0.00%
cases:0.24%
controls:0.01%
cases:0.51%
controls:0.09%
cases:0.88%
controls:0.19%
57
297
6388
64015
35
100
6412
64228
11
7
6435
64321
19
0
6427
64328
13
9
5340
64177
23
56
4502
61987
31
95
3490
50240
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
6.7e-01
1.2e+00
3.0e+00
—
3.8e+00
1.3e+00
7.8e-01
cases:1.26%
controls:0.65%
cases:0.93%
controls:0.28%
cases:0.67%
controls:0.03%
—
—
cases:1.74%
controls:0.04%
cases:0.93%
controls:0.25%
cases:1.79%
controls:0.82%
81
418
6364
63894
60
178
6387
64150
43
21
6403
64307
—
93
26
5260
64160
42
155
4483
61888
63
415
3458
49920
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
4.5e-01
7.8e-01
1.8e+00
4.5e+00
2.3e+00
6.3e-01
2.8e-01
cases:10.01%
controls:6.61%
cases:8.11%
controls:3.90%
cases:3.24%
controls:0.54%
cases:1.71%
controls:0.02%
cases:5.27%
controls:0.57%
cases:7.69%
controls:4.26%
cases:14.29%
controls:11.23%
645
4252
5800
60060
523
2506
5924
61822
209
349
6237
63979
110
12
6336
64316
282
363
5071
63823
348
2644
4177
59399
503
5653
3018
44682
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
4.5e-01
9.4e-01
1.8e+00
3.6e+00
2.5e+00
9.7e-01
5.3e-01
cases:13.95%
controls:9.39%
cases:13.26%
controls:5.64%
cases:6.07%
controls:1.06%
cases:1.89%
controls:0.05%
cases:11.06%
controls:1.05%
cases:13.97%
controls:5.78%
cases:20.45%
controls:13.11%
899
6037
5546
58275
855
3628
5592
60700
391
684
6055
63644
122
34
6324
64294
592
676
4761
63510
632
3586
3893
58457
720
6601
2801
43734
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
7.5e-01
1.2e+00
3.2e+00
—
4.0e+00
1.0e+00
4.2e-01
cases:1.75%
controls:0.84%
cases:1.44%
controls:0.43%
cases:1.23%
controls:0.05%
—
—
cases:2.45%
controls:0.05%
cases:1.17%
controls:0.41%
cases:2.30%
controls:1.53%
113
538
6332
63774
93
277
6354
64051
79
31
6367
64297
—
131
29
5222
64157
53
257
4472
61786
81
769
3440
49566
Multidisciplinary treatment meeting
WZC20 [2001310890]
7.5e-01
2.0e+00
2.4e+00
—
3.0e+00
1.6e+00
1.0e+00
cases:1.12%
controls:0.53%
cases:1.57%
controls:0.23%
cases:0.25%
controls:0.02%
—
—
cases:0.30%
controls:0.02%
cases:0.69%
controls:0.14%
cases:1.25%
controls:0.45%
72
343
6373
63969
101
145
6346
64183
16
14
6430
64314
—
16
10
5337
64176
31
89
4494
61954
44
225
3477
50110
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
7.6e-01
1.2e+00
3.2e+00
—
3.9e+00
1.2e+00
4.9e-01
cases:3.17%
controls:1.50%
cases:2.53%
controls:0.79%
cases:2.08%
controls:0.09%
—
—
cases:3.70%
controls:0.08%
cases:2.61%
controls:0.81%
cases:4.26%
controls:2.66%
204
966
6241
63346
163
511
6284
63817
134
58
6312
64270
—
198
49
5155
64137
118
500
4407
61543
150
1338
3371
48997
Percutaneous gastrostomy
JDB10 [2001304713]
2.3e+00
3.2e+00
—
1.0e+50
—
3.5e+00
1.6e+00
cases:0.64%
controls:0.06%
cases:0.62%
controls:0.02%
—
—
cases:0.39%
controls:0.00%
—
—
cases:0.69%
controls:0.02%
cases:0.37%
controls:0.07%
41
40
6404
64272
40
16
6407
64312
—
25
0
6421
64328
—
31
13
4494
62030
13
37
3508
50298
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
1.0e+00
1.2e+00
3.6e+00
1.0e+50
3.7e+00
1.1e+00
5.7e-01
cases:1.01%
controls:0.37%
cases:0.39%
controls:0.12%
cases:0.36%
controls:0.01%
cases:0.43%
controls:0.00%
cases:0.75%
controls:0.02%
cases:0.33%
controls:0.11%
cases:0.65%
controls:0.37%
65
236
6380
64076
25
75
6422
64253
23
6
6423
64322
28
0
6418
64328
40
12
5313
64174
15
69
4510
61974
23
186
3498
50149
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
7.5e-01
1.2e+00
3.2e+00
—
3.3e+00
1.4e+00
6.5e-01
cases:0.95%
controls:0.45%
cases:0.67%
controls:0.20%
cases:0.36%
controls:0.01%
—
—
cases:0.52%
controls:0.02%
cases:0.66%
controls:0.16%
cases:1.11%
controls:0.58%
61
288
6384
64024
43
126
6404
64202
23
9
6423
64319
—
28
12
5325
64174
30
98
4495
61945
39
294
3482
50041
pH of Serum or Plasma
2753-2 [3018418]
5.0e-01
9.6e-01
1.7e+00
4.1e+00
2.2e+00
7.5e-01
4.4e-01
cases:9.78%
controls:6.17%
cases:8.44%
controls:3.40%
cases:2.93%
controls:0.57%
cases:1.12%
controls:0.02%
cases:4.97%
controls:0.57%
cases:7.47%
controls:3.67%
cases:12.95%
controls:8.77%
630
3965
5815
60347
544
2186
5903
62142
189
365
6257
63963
72
12
6374
64316
266
366
5087
63820
338
2275
4187
59768
456
4413
3065
45922
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.8e-01
8.3e-01
2.0e+00
4.5e+00
1.9e+00
6.8e-01
2.7e-01
cases:8.47%
controls:5.93%
cases:7.26%
controls:3.30%
cases:3.72%
controls:0.53%
cases:2.42%
controls:0.03%
cases:3.53%
controls:0.55%
cases:6.59%
controls:3.44%
cases:11.39%
controls:8.90%
546
3812
5899
60500
468
2124
5979
62204
240
343
6206
63985
156
17
6290
64311
189
355
5164
63831
298
2136
4227
59907
401
4479
3120
45856
EKG study
11524-6 [3013512]
3.8e-01
6.6e-01
1.8e+00
5.4e+00
1.9e+00
4.2e-01
1.5e-01
cases:10.94%
controls:7.71%
cases:8.31%
controls:4.47%
cases:3.44%
controls:0.57%
cases:3.01%
controls:0.01%
cases:3.68%
controls:0.58%
cases:6.98%
controls:4.70%
cases:13.01%
controls:11.41%
705
4961
5740
59351
536
2876
5911
61452
222
369
6224
63959
194
9
6252
64319
197
374
5156
63812
316
2914
4209
59129
458
5745
3063
44590
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
9.5e-01
1.6e+00
3.1e+00
—
3.0e+00
1.3e+00
6.8e-01
cases:5.79%
controls:2.33%
cases:6.13%
controls:1.35%
cases:4.00%
controls:0.18%
—
—
cases:4.05%
controls:0.22%
cases:5.33%
controls:1.57%
cases:9.46%
controls:5.04%
373
1497
6072
62815
395
866
6052
63462
258
116
6188
64212
—
217
139
5136
64047
241
972
4284
61071
333
2539
3188
47796
Bipolar affective disorder, currently in remission
F31.7 [45581457]
1.0e+00
1.3e+00
2.6e+00
—
2.4e+00
1.5e+00
1.7e+00
cases:0.43%
controls:0.16%
cases:0.25%
controls:0.07%
cases:0.17%
controls:0.01%
—
—
cases:0.13%
controls:0.01%
cases:0.31%
controls:0.07%
cases:0.88%
controls:0.16%
28
100
6417
64212
16
42
6431
64286
11
8
6435
64320
—
7
8
5346
64178
14
44
4511
61999
31
79
3490
50256
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
7.0e-01
1.4e+00
2.9e+00
—
3.2e+00
1.5e+00
8.5e-01
cases:3.01%
controls:1.52%
cases:2.75%
controls:0.71%
cases:1.27%
controls:0.07%
—
—
cases:2.15%
controls:0.09%
cases:2.76%
controls:0.62%
cases:4.17%
controls:1.83%
194
977
6251
63335
177
455
6270
63873
82
47
6364
64281
—
115
56
5238
64130
125
386
4400
61657
147
922
3374
49413
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.9e-01
7.9e-01
2.0e+00
4.5e+00
1.9e+00
6.7e-01
2.6e-01
cases:21.89%
controls:15.95%
cases:17.20%
controls:8.63%
cases:9.14%
controls:1.40%
cases:5.76%
controls:0.07%
cases:8.78%
controls:1.39%
cases:16.00%
controls:8.88%
cases:25.45%
controls:20.81%
1411
10258
5034
54054
1109
5554
5338
58774
589
898
5857
63430
371
42
6075
64286
470
892
4883
63294
724
5509
3801
56534
896
10475
2625
39860
Glomerular basement membrane Ab [Units/volume] in Serum
49774-3 [3032700]
1.0e+00
1.4e+00
3.1e+00
—
3.4e+00
1.6e+00
3.8e-01
cases:0.37%
controls:0.14%
cases:0.25%
controls:0.06%
cases:0.17%
controls:0.01%
—
—
cases:0.22%
controls:0.01%
cases:0.31%
controls:0.06%
cases:0.43%
controls:0.29%
24
87
6421
64225
16
39
6431
64289
11
5
6435
64323
—
12
5
5341
64181
14
37
4511
62006
15
147
3506
50188
Delirium, unspecified
F05.9 [45591078]
1.1e+00
1.7e+00
3.6e+00
—
2.8e+00
1.2e+00
6.1e-01
cases:0.67%
controls:0.22%
cases:0.47%
controls:0.08%
cases:0.34%
controls:0.01%
—
—
cases:0.28%
controls:0.02%
cases:0.40%
controls:0.11%
cases:0.71%
controls:0.39%
43
139
6402
64173
30
54
6417
64274
22
6
6424
64322
—
15
11
5338
64175
18
71
4507
61972
25
194
3496
50141
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
3.9e-01
7.8e-01
1.8e+00
4.8e+00
1.9e+00
6.4e-01
2.0e-01
cases:7.88%
controls:5.48%
cases:6.17%
controls:2.93%
cases:2.47%
controls:0.43%
cases:1.63%
controls:0.01%
cases:2.84%
controls:0.42%
cases:5.79%
controls:3.15%
cases:10.14%
controls:8.44%
508
3522
5937
60790
398
1886
6049
62442
159
278
6287
64050
105
9
6341
64319
152
268
5201
63918
262
1953
4263
60090
357
4249
3164
46086
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 [3016881]
1.4e+00
2.0e+00
—
1.0e+50
4.2e+00
1.6e+00
1.3e+00
cases:0.57%
controls:0.14%
cases:0.53%
controls:0.07%
—
—
cases:0.23%
controls:0.00%
cases:0.50%
controls:0.01%
cases:0.35%
controls:0.07%
cases:0.65%
controls:0.18%
37
91
6408
64221
34
44
6413
64284
—
15
0
6431
64328
27
5
5326
64181
16
46
4509
61997
23
92
3498
50243
Speech disorder
N19 [2002000730]
1.8e+00
1.7e+00
—
—
3.5e+00
2.3e+00
1.3e+00
cases:0.54%
controls:0.09%
cases:0.19%
controls:0.04%
—
—
—
—
cases:0.35%
controls:0.01%
cases:0.35%
controls:0.04%
cases:0.45%
controls:0.12%
35
60
6410
64252
12
23
6435
64305
—
—
19
7
5334
64179
16
23
4509
62020
16
62
3505
50273
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
7.8e-01
1.0e+00
3.0e+00
1.0e+50
3.8e+00
1.3e+00
6.2e-01
cases:1.37%
controls:0.63%
cases:0.81%
controls:0.30%
cases:0.70%
controls:0.04%
cases:1.44%
controls:0.00%
cases:1.20%
controls:0.03%
cases:1.08%
controls:0.29%
cases:1.62%
controls:0.88%
88
404
6357
63908
52
191
6395
64137
45
23
6401
64305
93
0
6353
64328
64
18
5289
64168
49
182
4476
61861
57
443
3464
49892
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
5.0e-01
9.3e-01
1.8e+00
3.6e+00
2.4e+00
8.2e-01
3.7e-01
cases:14.66%
controls:9.44%
cases:12.66%
controls:5.39%
cases:5.01%
controls:0.85%
cases:1.69%
controls:0.05%
cases:9.25%
controls:0.87%
cases:11.80%
controls:5.55%
cases:18.43%
controls:13.47%
945
6072
5500
58240
816
3468
5631
60860
323
550
6123
63778
109
31
6337
64297
495
561
4858
63625
534
3444
3991
58599
649
6781
2872
43554
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.9e-01
7.9e-01
2.0e+00
4.5e+00
1.9e+00
6.7e-01
2.5e-01
cases:11.61%
controls:8.16%
cases:8.89%
controls:4.25%
cases:4.62%
controls:0.68%
cases:3.07%
controls:0.04%
cases:4.54%
controls:0.70%
cases:8.20%
controls:4.37%
cases:14.12%
controls:11.31%
748
5250
5697
59062
573
2734
5874
61594
298
436
6148
63892
198
23
6248
64305
243
448
5110
63738
371
2709
4154
59334
497
5695
3024
44640
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
9.6e-01
1.5e+00
3.2e+00
—
3.0e+00
1.3e+00
5.5e-01
cases:3.99%
controls:1.57%
cases:4.06%
controls:0.98%
cases:2.90%
controls:0.13%
—
—
cases:3.19%
controls:0.17%
cases:4.22%
controls:1.16%
cases:6.53%
controls:3.89%
257
1011
6188
63301
262
628
6185
63700
187
81
6259
64247
—
171
106
5182
64080
191
720
4334
61323
230
1959
3291
48376
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 [3025023]
1.5e+00
2.0e+00
—
1.0e+50
4.2e+00
1.5e+00
1.3e+00
cases:0.54%
controls:0.13%
cases:0.48%
controls:0.07%
—
—
cases:0.23%
controls:0.00%
cases:0.50%
controls:0.01%
cases:0.33%
controls:0.07%
cases:0.65%
controls:0.17%
35
82
6410
64230
31
44
6416
64284
—
15
0
6431
64328
27
5
5326
64181
15
46
4510
61997
23
87
3498
50248
Congestive heart failure
I50.0 [45567179]
6.6e-01
9.6e-01
1.8e+00
4.5e+00
1.8e+00
6.6e-01
3.2e-01
cases:2.19%
controls:1.14%
cases:1.92%
controls:0.74%
cases:0.95%
controls:0.15%
cases:0.96%
controls:0.01%
cases:0.92%
controls:0.15%
cases:1.61%
controls:0.84%
cases:2.98%
controls:2.17%
141
733
6304
63579
124
478
6323
63850
61
98
6385
64230
62
7
6384
64321
49
98
5304
64088
73
519
4452
61524
105
1094
3416
49241
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
5.7e-01
1.4e+00
3.1e+00
—
2.8e+00
1.7e+00
8.5e-01
cases:1.24%
controls:0.71%
cases:1.10%
controls:0.26%
cases:0.53%
controls:0.02%
—
—
cases:0.49%
controls:0.03%
cases:1.15%
controls:0.22%
cases:2.10%
controls:0.91%
80
454
6365
63858
71
168
6376
64160
34
15
6412
64313
—
26
20
5327
64166
52
135
4473
61908
74
458
3447
49877
Bacteria [Presence] in Urine
87829-8 [36304419]
4.0e-01
7.9e-01
2.0e+00
4.4e+00
1.8e+00
7.2e-01
3.4e-01
cases:8.25%
controls:5.71%
cases:6.61%
controls:3.10%
cases:3.48%
controls:0.51%
cases:2.28%
controls:0.03%
cases:3.16%
controls:0.52%
cases:6.39%
controls:3.22%
cases:11.05%
controls:8.09%
532
3673
5913
60639
426
1994
6021
62334
224
327
6222
64001
147
19
6299
64309
169
332
5184
63854
289
1997
4236
60046
389
4070
3132
46265
Dementia in Parkinson's disease without information on additional symptoms
F02.39*G20 [2000501631]
2.4e+00
2.6e+00
2.8e+00
1.0e+50
2.7e+00
9.1e-01
7.2e-01
cases:0.51%
controls:0.05%
cases:0.40%
controls:0.03%
cases:0.12%
controls:0.01%
cases:0.16%
controls:0.00%
cases:0.11%
controls:0.01%
cases:0.13%
controls:0.05%
cases:0.20%
controls:0.10%
33
30
6412
64282
26
20
6421
64308
8
5
6438
64323
10
0
6436
64328
6
5
5347
64181
6
33
4519
62010
7
49
3514
50286
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.8e-01
8.3e-01
1.8e+00
4.2e+00
2.1e+00
7.6e-01
3.5e-01
cases:25.65%
controls:19.09%
cases:23.53%
controls:11.83%
cases:12.36%
controls:2.35%
cases:5.86%
controls:0.09%
cases:15.95%
controls:2.22%
cases:22.94%
controls:12.21%
cases:32.58%
controls:25.37%
1653
12276
4792
52036
1517
7611
4930
56717
797
1509
5649
62819
378
61
6068
64267
854
1426
4499
62760
1038
7577
3487
54466
1147
12771
2374
37564
Bacterial infection, unspecified
A49.9 [45590816]
1.2e+00
1.6e+00
3.2e+00
—
2.4e+00
1.3e+00
7.3e-01
cases:3.97%
controls:1.25%
cases:2.84%
controls:0.56%
cases:1.46%
controls:0.06%
—
—
cases:0.86%
controls:0.08%
cases:2.45%
controls:0.70%
cases:4.57%
controls:2.26%
256
807
6189
63505
183
360
6264
63968
94
39
6352
64289
—
46
52
5307
64134
111
434
4414
61609
161
1136
3360
49199
Implementation of occupational therapy rehabilitation plan
SPAT1226 [2001700327]
1.3e+00
1.4e+00
1.8e+00
—
3.2e+00
1.7e+00
9.8e-01
cases:1.09%
controls:0.29%
cases:0.47%
controls:0.12%
cases:0.11%
controls:0.02%
—
—
cases:0.28%
controls:0.01%
cases:0.66%
controls:0.12%
cases:0.82%
controls:0.31%
70
188
6375
64124
30
75
6417
64253
7
12
6439
64316
—
15
7
5338
64179
30
77
4495
61966
29
156
3492
50179
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
9.8e-01
1.4e+00
3.1e+00
—
3.0e+00
1.3e+00
5.4e-01
cases:4.19%
controls:1.61%
cases:3.88%
controls:0.96%
cases:2.70%
controls:0.12%
—
—
cases:3.12%
controls:0.16%
cases:3.93%
controls:1.12%
cases:6.16%
controls:3.68%
270
1035
6175
63277
250
616
6197
63712
174
79
6272
64249
—
167
102
5186
64084
178
697
4347
61346
217
1851
3304
48484
Lactate [Moles/volume] in Blood
32693-4 [3047181]
5.8e-01
1.5e+00
3.1e+00
—
3.8e+00
1.4e+00
5.1e-01
cases:1.01%
controls:0.57%
cases:1.07%
controls:0.24%
cases:0.70%
controls:0.03%
—
—
cases:1.20%
controls:0.03%
cases:0.91%
controls:0.23%
cases:1.33%
controls:0.80%
65
364
6380
63948
69
152
6378
64176
45
20
6401
64308
—
64
18
5289
64168
41
143
4484
61900
47
404
3474
49931
Cerebral infarction due to thrombosis of precerebral arteries
I63.0 [45538393]
1.0e+00
1.3e+00
3.0e+00
1.0e+50
3.2e+00
1.8e+00
8.9e-01
cases:0.45%
controls:0.16%
cases:0.19%
controls:0.05%
cases:0.16%
controls:0.01%
cases:0.39%
controls:0.00%
cases:0.22%
controls:0.01%
cases:0.27%
controls:0.04%
cases:0.43%
controls:0.17%
29
105
6416
64207
12
32
6435
64296
10
5
6436
64323
25
0
6421
64328
12
6
5341
64180
12
26
4513
62017
15
88
3506
50247
Heart failure, unspecified
I50.9 [45576879]
5.9e-01
9.7e-01
1.7e+00
4.5e+00
1.6e+00
6.3e-01
3.6e-01
cases:5.14%
controls:2.91%
cases:4.58%
controls:1.79%
cases:2.16%
controls:0.39%
cases:2.76%
controls:0.03%
cases:1.89%
controls:0.40%
cases:4.13%
controls:2.23%
cases:7.30%
controls:5.22%
331
1873
6114
62439
295
1152
6152
63176
139
253
6307
64075
178
20
6268
64308
101
255
5252
63931
187
1386
4338
60657
257
2627
3264
47708
Withdrawal symptoms caused by alcohol with seizures
F10.31 [2000501686]
2.1e+00
2.0e+00
—
1.0e+50
—
3.5e+00
2.8e+00
cases:0.43%
controls:0.05%
cases:0.16%
controls:0.02%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.31%
controls:0.01%
cases:0.65%
controls:0.04%
28
34
6417
64278
10
14
6437
64314
—
12
0
6434
64328
—
14
6
4511
62037
23
20
3498
50315
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
9.7e-01
1.6e+00
2.8e+00
—
2.9e+00
1.4e+00
7.9e-01
cases:1.88%
controls:0.72%
cases:1.63%
controls:0.33%
cases:0.82%
controls:0.05%
—
—
cases:0.80%
controls:0.05%
cases:1.59%
controls:0.42%
cases:2.98%
controls:1.38%
121
462
6324
63850
105
215
6342
64113
53
33
6393
64295
—
43
30
5310
64156
72
258
4453
61785
105
694
3416
49641
Demanding antibody therapy of methastized malignancy
WD415 [2001310689]
1.5e+00
1.9e+00
2.4e+00
—
2.7e+00
1.9e+00
1.0e+00
cases:0.37%
controls:0.09%
cases:0.36%
controls:0.05%
cases:0.23%
controls:0.02%
—
—
cases:0.21%
controls:0.01%
cases:0.27%
controls:0.04%
cases:0.26%
controls:0.09%
24
56
6421
64256
23
34
6424
64294
15
14
6431
64314
—
11
9
5342
64177
12
25
4513
62018
9
46
3512
50289
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
7.3e-01
1.5e+00
2.7e+00
1.0e+50
2.8e+00
1.6e+00
9.3e-01
cases:0.92%
controls:0.44%
cases:0.82%
controls:0.18%
cases:0.29%
controls:0.02%
cases:0.61%
controls:0.00%
cases:0.45%
controls:0.03%
cases:0.99%
controls:0.20%
cases:1.53%
controls:0.61%
59
286
6386
64026
53
113
6394
64215
19
13
6427
64315
39
0
6407
64328
24
17
5329
64169
45
127
4480
61916
54
307
3467
50028
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
3.9e-01
8.1e-01
1.9e+00
4.4e+00
1.9e+00
6.7e-01
2.1e-01
cases:9.81%
controls:6.88%
cases:8.36%
controls:3.90%
cases:4.30%
controls:0.65%
cases:2.82%
controls:0.04%
cases:4.26%
controls:0.67%
cases:7.78%
controls:4.15%
cases:12.89%
controls:10.68%
632
4426
5813
59886
539
2508
5908
61820
277
421
6169
63907
182
23
6264
64305
228
428
5125
63758
352
2577
4173
59466
454
5375
3067
44960
Urinary tract infection, site not specified
N39.0 [45548665]
8.0e-01
1.0e+00
2.0e+00
3.8e+00
1.2e+00
9.6e-01
4.5e-01
cases:4.08%
controls:1.87%
cases:2.20%
controls:0.82%
cases:0.78%
controls:0.10%
cases:0.48%
controls:0.01%
cases:0.32%
controls:0.09%
cases:2.45%
controls:0.95%
cases:4.71%
controls:3.05%
263
1204
6182
63108
142
527
6305
63801
50
67
6396
64261
31
7
6415
64321
17
59
5336
64127
111
592
4414
61451
166
1536
3355
48799
Sequelae of intracranial injury
T90.5 [45537098]
9.7e-01
1.2e+00
2.6e+00
1.0e+50
2.2e+00
1.7e+00
1.7e+00
cases:0.36%
controls:0.14%
cases:0.23%
controls:0.07%
cases:0.12%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.11%
controls:0.01%
cases:0.33%
controls:0.06%
cases:0.71%
controls:0.14%
23
87
6422
64225
15
47
6432
64281
8
6
6438
64322
6
0
6440
64328
6
8
5347
64178
15
39
4510
62004
25
68
3496
50267
Thorax extensive CT-examination
GD1CD [2001303626]
1.9e+00
2.8e+00
—
1.0e+50
—
3.2e+00
2.3e+00
cases:0.31%
controls:0.05%
cases:0.23%
controls:0.01%
—
—
cases:0.14%
controls:0.00%
—
—
cases:0.29%
controls:0.01%
cases:0.45%
controls:0.05%
20
29
6425
64283
15
9
6432
64319
—
9
0
6437
64328
—
13
7
4512
62036
16
24
3505
50311
Other seropositive rheumatoid arthritis
M05.8 [45538634]
6.5e-01
8.7e-01
1.4e+00
4.0e+00
1.3e+00
9.9e-01
1.0e+00
cases:1.91%
controls:1.01%
cases:1.63%
controls:0.69%
cases:0.76%
controls:0.19%
cases:0.76%
controls:0.01%
cases:0.77%
controls:0.20%
cases:1.97%
controls:0.74%
cases:2.75%
controls:1.02%
123
649
6322
63663
105
445
6342
63883
49
122
6397
64206
49
9
6397
64319
41
131
5312
64055
89
457
4436
61586
97
515
3424
49820
Sequelae of subarachnoid haemorrhage
I69.0 [45543193]
1.3e+00
1.2e+00
3.5e+00
1.0e+50
—
2.4e+00
1.8e+00
cases:0.36%
controls:0.10%
cases:0.22%
controls:0.07%
cases:0.26%
controls:0.01%
cases:0.11%
controls:0.00%
—
—
cases:0.51%
controls:0.05%
cases:0.71%
controls:0.12%
23
64
6422
64248
14
43
6433
64285
17
5
6429
64323
7
0
6439
64328
—
23
28
4502
62015
25
60
3496
50275
Cerebral infarction due to embolism of cerebral arteries
I63.4 [45591475]
1.0e+00
9.1e-01
3.2e+00
—
3.2e+00
1.8e+00
5.5e-01
cases:0.98%
controls:0.36%
cases:0.39%
controls:0.16%
cases:0.54%
controls:0.02%
—
—
cases:0.75%
controls:0.03%
cases:0.99%
controls:0.16%
cases:0.91%
controls:0.53%
63
232
6382
64080
25
101
6422
64227
35
14
6411
64314
—
40
19
5313
64167
45
101
4480
61942
32
265
3489
50070
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
9.6e-01
1.2e+00
2.8e+00
—
3.6e+00
1.0e+00
4.9e-01
cases:3.20%
controls:1.25%
cases:2.42%
controls:0.72%
cases:1.69%
controls:0.10%
—
—
cases:2.67%
controls:0.07%
cases:2.23%
controls:0.81%
cases:3.92%
controls:2.44%
206
806
6239
63506
156
464
6291
63864
109
64
6337
64264
—
143
48
5210
64138
101
500
4424
61543
138
1230
3383
49105
Other specified interstitial pulmonary diseases
J84.8 [45548126]
3.3e-01
1.5e+00
2.0e+00
1.0e+50
2.0e+00
2.5e+00
2.2e+00
cases:0.17%
controls:0.12%
cases:0.45%
controls:0.10%
cases:0.25%
controls:0.03%
cases:0.26%
controls:0.00%
cases:0.22%
controls:0.03%
cases:1.37%
controls:0.11%
cases:1.33%
controls:0.15%
11
79
6434
64233
29
65
6418
64263
16
22
6430
64306
17
0
6429
64328
12
20
5341
64166
62
71
4463
61972
47
77
3474
50258
General Surgery
2 [38004447]
3.5e-01
8.2e-01
1.7e+00
4.8e+00
1.2e+00
7.6e-01
4.7e-01
cases:27.21%
controls:20.83%
cases:14.15%
controls:6.77%
cases:4.76%
controls:0.93%
cases:3.55%
controls:0.03%
cases:3.31%
controls:0.99%
cases:12.46%
controls:6.24%
cases:25.76%
controls:17.89%
1754
13394
4691
50918
912
4354
5535
59974
307
598
6139
63730
229
19
6217
64309
177
635
5176
63551
564
3869
3961
58174
907
9005
2614
41330
Blood transfusion
WW500 [2001310603]
9.5e-01
1.7e+00
2.7e+00
1.0e+50
2.3e+00
1.6e+00
9.1e-01
cases:0.71%
controls:0.28%
cases:0.82%
controls:0.15%
cases:0.36%
controls:0.02%
cases:0.29%
controls:0.00%
cases:0.28%
controls:0.03%
cases:0.64%
controls:0.14%
cases:0.88%
controls:0.36%
46
178
6399
64134
53
94
6394
64234
23
16
6423
64312
19
0
6427
64328
15
18
5338
64168
29
84
4496
61959
31
180
3490
50155
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.2e+00
1.6e+00
1.9e+00
—
2.4e+00
1.8e+00
1.3e+00
cases:1.33%
controls:0.42%
cases:0.70%
controls:0.14%
cases:0.20%
controls:0.03%
—
—
cases:0.39%
controls:0.04%
cases:0.93%
controls:0.16%
cases:1.68%
controls:0.47%
86
267
6359
64045
45
91
6402
64237
13
19
6433
64309
—
21
24
5332
64162
42
97
4483
61946
59
239
3462
50096
Osmolality of Serum or Plasma
2692-2 [3008295]
1.0e+00
1.6e+00
3.1e+00
—
2.9e+00
1.6e+00
7.3e-01
cases:0.37%
controls:0.14%
cases:0.33%
controls:0.07%
cases:0.17%
controls:0.01%
—
—
cases:0.22%
controls:0.01%
cases:0.35%
controls:0.07%
cases:0.45%
controls:0.22%
24
88
6421
64224
21
44
6426
64284
11
5
6435
64323
—
12
8
5341
64178
16
46
4509
61997
16
110
3505
50225
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
7.1e-01
8.8e-01
2.9e+00
1.0e+50
3.7e+00
1.3e+00
5.9e-01
cases:1.16%
controls:0.58%
cases:0.65%
controls:0.27%
cases:0.51%
controls:0.03%
cases:1.13%
controls:0.00%
cases:0.93%
controls:0.02%
cases:0.91%
controls:0.24%
cases:1.36%
controls:0.76%
75
370
6370
63942
42
174
6405
64154
33
18
6413
64310
73
0
6373
64328
50
15
5303
64171
41
152
4484
61891
48
381
3473
49954
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
8.9e-01
1.7e+00
2.9e+00
1.0e+50
2.6e+00
1.1e+00
9.0e-01
cases:1.26%
controls:0.52%
cases:1.41%
controls:0.27%
cases:0.81%
controls:0.05%
cases:0.99%
controls:0.00%
cases:0.50%
controls:0.04%
cases:0.86%
controls:0.29%
cases:2.22%
controls:0.91%
81
336
6364
63976
91
171
6356
64157
52
29
6394
64299
64
0
6382
64328
27
23
5326
64163
39
180
4486
61863
78
458
3443
49877
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
C50.21 [2000500994]
1.5e-01
1.6e+00
2.4e+00
—
2.8e+00
1.9e+00
1.5e+00
cases:0.20%
controls:0.17%
cases:0.57%
controls:0.12%
cases:0.36%
controls:0.03%
—
—
cases:0.43%
controls:0.03%
cases:0.69%
controls:0.11%
cases:0.77%
controls:0.17%
13
112
6432
64200
37
78
6410
64250
23
21
6423
64307
—
23
17
5330
64169
31
67
4494
61976
27
88
3494
50247
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.6e+00
1.7e+00
1.6e+00
1.7e+00
1.7e+00
1.7e+00
1.7e+00
cases:3.55%
controls:0.77%
cases:3.55%
controls:0.65%
cases:1.27%
controls:0.25%
cases:0.08%
controls:0.01%
cases:1.35%
controls:0.25%
cases:3.73%
controls:0.68%
cases:5.00%
controls:0.94%
229
492
6216
63820
229
417
6218
63911
82
163
6364
64165
5
9
6441
64319
72
159
5281
64027
169
423
4356
61620
176
474
3345
49861
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
7.6e-01
1.5e+00
1.9e+00
1.0e+50
3.7e+00
1.2e+00
1.1e+00
cases:0.96%
controls:0.45%
cases:0.96%
controls:0.22%
cases:0.22%
controls:0.03%
cases:0.14%
controls:0.00%
cases:0.82%
controls:0.02%
cases:0.62%
controls:0.20%
cases:1.62%
controls:0.57%
62
290
6383
64022
62
143
6385
64185
14
21
6432
64307
9
0
6437
64328
44
13
5309
64173
28
121
4497
61922
57
285
3464
50050
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
1.4e+00
1.7e+00
—
1.0e+50
3.1e+00
2.2e+00
1.6e+00
cases:0.76%
controls:0.19%
cases:0.47%
controls:0.08%
—
—
cases:0.45%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.60%
controls:0.07%
cases:1.65%
controls:0.32%
49
123
6396
64189
30
53
6417
64275
—
29
0
6417
64328
9
5
5344
64181
27
41
4498
62002
58
162
3463
50173
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
8.0e-01
8.5e-01
2.9e+00
—
3.9e+00
1.0e+00
5.1e-01
cases:2.13%
controls:0.96%
cases:1.26%
controls:0.54%
cases:1.05%
controls:0.06%
—
—
cases:2.20%
controls:0.05%
cases:1.48%
controls:0.53%
cases:2.73%
controls:1.66%
137
619
6308
63693
81
348
6366
63980
68
36
6378
64292
—
118
30
5235
64156
67
326
4458
61717
96
837
3425
49498
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
9.0e-01
1.4e+00
3.5e+00
—
2.9e+00
8.2e-01
4.6e-01
cases:1.26%
controls:0.51%
cases:1.92%
controls:0.46%
cases:1.60%
controls:0.05%
—
—
cases:1.10%
controls:0.06%
cases:1.28%
controls:0.57%
cases:3.18%
controls:2.03%
81
330
6364
63982
124
295
6323
64033
103
32
6343
64296
—
59
39
5294
64147
58
352
4467
61691
112
1024
3409
49311
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
8.0e-01
1.7e+00
2.9e+00
1.0e+50
2.7e+00
1.1e+00
8.7e-01
cases:1.33%
controls:0.60%
cases:1.63%
controls:0.29%
cases:0.85%
controls:0.05%
cases:0.95%
controls:0.00%
cases:0.56%
controls:0.04%
cases:0.99%
controls:0.33%
cases:2.36%
controls:1.00%
86
388
6359
63924
105
188
6342
64140
55
32
6391
64296
61
0
6385
64328
30
25
5323
64161
45
207
4480
61836
83
503
3438
49832
Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
83083-6 [42529200]
9.9e-01
1.6e+00
1.8e+00
—
2.5e+00
1.8e+00
1.3e+00
cases:0.26%
controls:0.10%
cases:0.29%
controls:0.06%
cases:0.11%
controls:0.02%
—
—
cases:0.09%
controls:0.01%
cases:0.27%
controls:0.04%
cases:0.51%
controls:0.14%
17
63
6428
64249
19
40
6428
64288
7
11
6439
64317
—
5
5
5348
64181
12
27
4513
62016
18
69
3503
50266
X-ray examination of the lungs in one projection
GD1PA [2001303645]
1.0e+00
1.4e+00
3.0e+00
—
2.5e+00
1.2e+00
8.9e-01
cases:3.30%
controls:1.21%
cases:2.44%
controls:0.61%
cases:1.09%
controls:0.06%
—
—
cases:0.82%
controls:0.07%
cases:1.92%
controls:0.60%
cases:4.49%
controls:1.90%
213
776
6232
63536
157
395
6290
63933
70
36
6376
64292
—
44
42
5309
64144
87
370
4438
61673
158
955
3363
49380
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
8.0e-01
8.6e-01
2.9e+00
—
3.9e+00
1.1e+00
5.0e-01
cases:2.13%
controls:0.97%
cases:1.29%
controls:0.55%
cases:1.09%
controls:0.06%
—
—
cases:2.22%
controls:0.05%
cases:1.55%
controls:0.53%
cases:2.70%
controls:1.66%
137
623
6308
63689
83
353
6364
63975
70
39
6376
64289
—
119
30
5234
64156
70
331
4455
61712
95
835
3426
49500
aripiprazole; oral, parenteral
N05AX12 [21604562]
1.4e+00
1.8e+00
1.8e+00
—
1.4e+00
1.7e+00
1.9e+00
cases:1.07%
controls:0.25%
cases:1.04%
controls:0.17%
cases:0.40%
controls:0.07%
—
—
cases:0.28%
controls:0.07%
cases:0.93%
controls:0.17%
cases:1.85%
controls:0.28%
69
163
6376
64149
67
107
6380
64221
26
45
6420
64283
—
15
46
5338
64140
42
108
4483
61935
65
139
3456
50196

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
3293
18284
2.59
307.64
6.5
4.5
—
—
—
0
0
1861
9855
2.23
170.46
4.9
3.2
0.80
0.82
mmol/l
6.28
1759
9198
1542
7683
2.31
162.51
11.2
7.1
1.63
0.92
mmol/l
8.48
1286
6192
1536
7697
2.29
159.32
11.3
7.1
7.41
7.42
ph
0.35
973
4289
792
2885
2.98
158.79
2.3
1.8
2.33
2.36
ug/l
0.03
697
2502
1044
4429
2.61
156.16
5.8
3.8
5.31
5.13
kpa
7.59
994
4193
1534
7751
2.27
155.54
11.3
7.1
5.19
5.05
kpa
4.93
1457
7408
1022
4301
2.63
155.34
5.8
3.8
7.42
7.41
ph
1.19
899
3578
1532
7749
2.27
154.87
11.3
7.1
10.71
11.94
kpa
21.08
1460
7402
476
1300
3.87
151.03
2.5
2.6
31.80
34.28
umol/l
1.04
424
1157
355
804
4.61
144.46
3.0
2.4
—
—
—
0
0
1563
8253
2.17
140.31
6.5
6.1
1.02
1.05
mmol/l
2.87
1457
7629
1378
6942
2.24
138.94
11.9
7.3
93.99
95.28
%
9.04
1319
6689
462
1480
3.28
114.29
4.8
4.0
—
—
—
0
0
235
463
5.22
112.63
5.3
2.7
—
—
—
0
0
2712
18611
1.77
105.35
8.2
6.1
—
—
—
0
0
294
745
4.08
103.05
6.5
4.8
352.42
343.65
umol/l
0.44
264
641
3619
27059
1.74
102.94
8.4
6.1
0.04
0.04
e9/l
0.66
3225
22952
3604
26947
1.74
102.21
8.4
6.0
0.65
0.62
e9/l
8.69
3211
22824
3399
25053
1.73
101.05
9.0
6.4
8.90
9.16
%
4.95
3234
23331
3768
28609
1.73
100.31
20.9
19.5
1.34
1.37
inr
1.99
3306
24277
3389
24995
1.73
100.20
8.8
6.3
2.44
2.85
%
23.80
3226
23271
3654
27516
1.73
100.15
8.6
6.1
1.71
1.86
e9/l
7.44
3291
23854
3520
26238
1.73
100.10
11.2
6.8
1.20
1.21
mmol/l
9.41
3293
24124
3387
24990
1.72
99.87
9.0
6.4
0.56
0.65
%
18.51
3233
23272
2629
18130
1.74
98.52
3.4
2.3
293.20
234.76
u/l
1.74
2516
17080
3426
25444
1.72
97.86
8.9
6.4
22.60
26.01
%
57.96
3277
23991
3829
29327
1.72
97.53
9.1
6.6
11.38
12.74
umol/l
6.16
3686
27954
1153
6136
2.06
97.47
7.8
7.0
10.09
11.35
mmol/l
6.31
1096
5824
3673
27823
1.72
97.35
9.2
6.2
0.18
0.20
e9/l
7.95
3297
23923
1178
6329
2.05
96.98
13.4
7.9
119.41
120.57
g/l
1.07
1142
6188
403
1349
3.12
92.29
3.6
2.7
15.65
16.05
%
1.69
394
1327
855
4142
2.22
91.79
10.7
6.4
25.21
24.33
mmol/l
8.21
808
3969
395
1321
3.12
90.57
6.2
4.6
8.08
8.36
kpa
3.05
383
1292
394
1316
3.12
90.54
6.2
4.6
2.87
2.65
mmol/l
0.71
308
877
394
1317
3.12
90.42
6.2
4.6
5.05
5.00
kpa
0.53
382
1289
3882
30200
1.69
89.93
14.1
9.2
4.82
4.35
e9/l
22.08
3487
25989
309
896
3.57
89.14
2.8
2.7
—
—
—
0
0
3330
24924
1.67
89.12
8.7
6.2
62.13
58.58
%
51.09
3223
23685
2526
17633
1.70
87.75
3.5
2.7
58.17
65.39
u/l
0.89
2372
16361
675
3013
2.38
87.71
6.4
4.0
—
—
—
0
0
1093
5912
2.02
87.51
11.2
7.0
1.44
1.38
mmol/l
1.02
1070
5750
3769
29253
1.67
86.60
11.5
7.5
1.20
1.21
mmol/l
7.38
3190
25158
574
2408
2.51
85.38
4.0
3.0
25.62
24.63
mmol/l
6.27
560
2363
191
401
4.87
84.97
2.0
1.3
1.19
1.18
promille
0.02
150
322
560
2329
2.53
84.82
2.8
2.2
454.82
667.02
ug/l
1.18
525
2230
828
4083
2.17
84.64
12.0
7.7
25.30
24.75
mmol/l
3.66
816
4055
459
1740
2.76
83.74
5.0
3.2
7.83
7.89
kpa
0.36
445
1695
3070
22781
1.65
82.72
6.3
4.4
48.89
91.14
ng/l
1.43
2569
17681
914
4738
2.08
81.84
2.5
2.3
361.19
382.00
nmol/l
1.98
840
4375
134
211
6.46
81.19
22.1
20.3
6851.57
1395.98
nmol/l
0.50
128
205
105
126
8.45
80.93
3.9
1.7
—
—
—
0
0
1395
8406
1.83
79.83
2.4
2.0
—
—
—
0
0
491
1974
2.61
79.65
5.8
4.1
7.42
7.41
ph
3.56
480
1949
126
200
6.40
75.75
16.1
15.4
818.44
812.63
nmol/l
0.04
121
192
398
1479
2.80
75.29
3.7
3.0
88.61
88.84
%
0.25
386
1437
778
3953
2.10
73.00
13.6
8.8
24.63
24.20
mmol/l
2.51
753
3818
531
2311
2.41
72.57
7.0
4.1
25.40
24.65
mmol/l
5.84
491
2082
4086
33180
1.60
71.31
9.8
5.3
6.98
6.87
mmol/l
2.29
3951
31632
1002
5641
1.91
70.10
2.7
2.2
0.19
0.20
g/l
4.00
907
5221
124
215
5.86
68.22
1.9
2.1
108.36
125.69
umol/l
0.20
53
127
294
981
3.09
67.47
2.7
1.9
1.70
1.73
mmol/l
0.21
286
958
3337
26074
1.56
66.95
6.9
5.2
32.60
34.78
g/l
73.71
3096
24299
1770
11902
1.66
66.86
3.8
3.1
515.61
543.14
mosm/kgh2o
6.94
1589
10475
1123
6647
1.83
66.83
4.9
3.7
2.34
1.72
mmol/l
6.25
1004
5709
1141
6809
1.82
66.03
4.9
3.7
5.98
5.81
kpa
5.21
1107
6607
242
727
3.42
65.99
6.2
2.9
—
—
—
0
0
395
1573
2.61
65.09
2.8
2.3
127.43
127.78
g/l
0.09
317
1218
1475
9512
1.71
64.98
2.2
2.0
30.15
30.12
s
0.05
1422
9234
265
852
3.20
64.75
4.7
2.1
—
—
—
0
0
1146
6911
1.80
63.83
4.9
3.7
7.38
7.38
ph
0.60
738
4109
2406
17624
1.57
63.04
4.4
3.5
—
—
—
0
0
235
718
3.36
62.39
1.8
1.4
—
—
—
0
0
235
718
3.36
62.39
1.8
1.4
—
—
—
0
0
235
718
3.36
62.39
1.8
1.4
—
—
—
0
0
235
718
3.36
62.39
1.8
1.4
—
—
—
0
0
972
5680
1.83
59.74
4.4
3.1
4.58
4.44
kpa
1.32
936
5494
966
5643
1.83
59.42
13.4
8.3
—
—
—
0
0
1710
11711
1.62
58.72
2.1
1.8
1187.80
1146.22
nmol/l
1.02
1278
8803
285
1021
2.87
57.59
4.9
2.1
—
—
—
0
0
2366
17538
1.54
57.35
5.4
4.3
7.40
7.40
ph
2.76
1865
12770
293
1087
2.77
55.44
5.0
2.0
—
—
—
0
0
2641
20174
1.51
54.97
4.0
3.5
2078.36
1925.21
ng/l
0.71
2346
17672
173
476
3.70
53.90
1.2
1.2
—
—
—
0
0
291
1096
2.73
53.47
5.0
2.0
—
—
—
0
0
504
2446
2.15
52.66
1.4
1.6
13.44
17.19
iu/ml
0.20
11
64
290
1100
2.71
52.55
5.1
2.0
—
—
—
0
0
711
3958
1.89
50.44
3.2
2.8
10.36
10.72
g/l
0.94
642
3621
1065
6713
1.70
49.54
2.2
1.8
—
—
—
0
0
2193
16427
1.50
48.53
2.8
2.4
3.25
2.92
mg/l
6.41
1906
14050
728
4133
1.85
48.48
16.5
9.2
0.65
0.63
%
0.54
719
4098
453
2185
2.15
47.99
6.7
3.8
1.58
1.42
mmol/l
1.74
439
2148
275
1074
2.63
47.01
4.9
2.0
—
—
—
0
0
4167
35479
1.47
47.00
7.0
5.1
1207.30
1648.53
e6/l
0.39
118
621
661
3675
1.89
46.93
15.2
9.5
15.55
15.92
%
2.84
625
3547
736
4263
1.82
45.80
16.3
9.0
1.44
1.31
%
2.82
727
4231
51
50
10.27
45.72
1.1
1.3
—
—
mmol/l
—
0
0
2244
17101
1.47
44.64
4.7
3.2
36.13
37.20
u/l
0.26
2109
16026
788
4702
1.77
44.27
5.7
4.1
1.22
1.22
mmol/l
1.87
716
4060
424
2080
2.11
42.91
1.3
1.2
—
—
—
0
0
1592
11406
1.52
42.51
2.1
1.7
1.61
1.51
mg/l
0.44
1306
8955
1863
13805
1.49
42.18
3.7
2.8
5.28
4.44
e6/l
2.42
1737
12582
568
3124
1.89
41.51
1.9
2.0
1.25
1.38
g/l
0.69
509
2820
56
72
7.83
40.79
1.3
1.2
60.17
45.68
mg/l
0.94
47
62
661
3853
1.79
40.03
4.6
3.7
24.66
24.04
mmol/l
5.03
651
3790
1202
8249
1.56
38.61
2.9
2.5
1.83
1.75
%
1.65
1037
7266
1518
10975
1.50
38.16
6.5
4.8
—
—
—
0
0
1497
10851
1.49
36.99
2.9
2.7
10.57
12.29
umol/l
20.17
1357
10059
1339
9506
1.51
36.55
2.9
2.7
19.62
21.92
%
9.04
1215
8799
808
5114
1.66
36.16
4.7
4.3
0.97
0.96
%
0.05
372
1698
375
1872
2.06
36.15
9.3
5.5
1.38
1.38
mmol/l
0.04
317
1662
2283
17985
1.41
35.89
3.3
2.7
—
—
—
0
0
262
1136
2.36
35.81
4.0
3.3
61.32
58.86
%
2.09
262
1136
770
4833
1.67
35.55
4.4
4.2
1.04
0.71
%
2.24
347
1586
1411
10208
1.49
34.91
2.9
2.7
2.22
2.24
g/l
0.64
1279
9394
995
6683
1.57
34.79
1.9
1.7
—
—
—
0
0
118
340
3.51
34.41
1.9
2.1
16.07
15.88
%
0.05
113
330
262
1156
2.32
34.40
1.7
1.4
62.25
61.90
mmol/l
0.04
209
934
2434
19528
1.39
33.81
4.7
3.7
78.54
104.36
e6/l
0.52
2019
15287
672
4125
1.70
33.66
4.4
3.2
125.87
127.76
g/l
1.36
647
4007
112
317
3.58
33.56
1.5
1.3
1.48
2.10
u/ml
0.27
66
185
121
361
3.40
33.45
2.0
2.1
72.37
71.92
%
0.10
113
339
867
5691
1.60
33.33
2.5
2.6
65.26
65.91
g/l
1.40
772
5146
354
1785
2.04
33.18
7.7
4.1
3.93
3.93
mmol/l
0.10
347
1764
32
25
12.86
33.13
2.8
2.2
—
—
—
0
0
687
4264
1.68
32.98
5.6
4.2
—
—
—
0
0
535
3112
1.78
32.40
4.8
3.5
25.70
25.07
mmol/l
3.97
513
3003
253
1129
2.29
32.36
1.4
1.2
66.67
228.80
titre
—
6
25
198
792
2.55
32.26
6.9
16.6
7.05
7.43
mmol/l
1.05
169
648
490
2789
1.82
31.90
1.5
1.3
258.67
254.28
u/ml
0.03
439
2568
4575
40816
1.39
31.78
12.4
8.4
85.01
82.29
u/l
2.67
4385
38619
756
4854
1.63
31.73
4.9
4.5
0.06
0.20
%
1.53
307
1352
244
1082
2.30
31.68
1.4
1.3
4.14
3.85
mmol/l
2.18
230
1014
251
1127
2.28
31.64
1.4
1.2
526.32
272.50
titre
0.71
19
88
221
939
2.40
31.63
1.5
1.3
14.03
13.56
u/ml
—
6
17
514
2988
1.78
31.16
7.9
4.7
1.66
1.58
%
1.33
478
2834
756
4886
1.62
30.85
4.8
4.3
0.09
0.12
%
0.71
317
1477
2011
15816
1.39
30.77
4.5
3.5
1.85
180.82
estimate
0.61
11
85
516
3021
1.77
30.52
8.4
4.4
36.94
36.91
°c
1.05
511
2982
136
461
2.99
30.44
2.0
2.2
963.72
1125.27
e6/l
1.36
127
410
2112
16780
1.38
30.26
4.5
3.6
0.58
0.48
e6/l
1.18
1731
12698
476
2737
1.80
29.92
8.4
4.9
0.88
0.86
%
0.52
441
2594
66
138
4.82
29.63
2.0
2.2
—
—
—
0
0
933
6412
1.53
29.02
1.4
1.3
450.04
495.19
titre
0.36
231
1380
259
1225
2.16
28.75
1.5
1.3
760.26
589.71
mg/l
0.75
246
1162
848
5731
1.55
28.43
2.9
2.4
8.63
7.19
ug/l
0.63
709
4951
930
6413
1.52
28.43
3.3
2.8
9.80
9.57
umol/l
0.11
797
5660
203
876
2.36
28.08
6.2
6.2
11.63
12.22
mg/l
1.07
183
803
124
422
2.97
27.59
2.5
2.1
15.40
16.04
%
1.26
124
422
2364
19395
1.34
26.65
4.0
3.5
2.33
2.35
mmol/l
8.13
2140
17471
2570
21375
1.33
26.27
5.5
4.3
113.70
112.01
e6/l
0.03
2054
15769
1782
14042
1.37
26.03
6.3
4.4
82.73
83.58
%
0.70
1737
13744
76
199
3.85
25.58
6.0
6.6
25.88
24.51
mmol/l
1.61
70
183
42
66
6.40
25.58
2.5
3.8
40.31
39.65
umol/l
0.06
37
53
897
6277
1.50
25.35
1.8
1.5
—
—
—
0
0
1561
19645
0.73
24.57
2.1
1.9
1.45
1.33
mmol/l
3.67
1283
16319
70
178
3.96
24.55
3.5
2.8
31.65
29.29
umol/l
0.42
49
132
908
6409
1.48
24.53
2.7
2.5
70.11
67.15
e9/l
1.64
699
4737
255
1284
2.03
24.01
11.2
6.4
10.81
11.51
mmol/l
2.76
225
1150
255
1285
2.02
23.95
11.2
6.4
104.36
105.08
mmol/l
1.33
225
1152
61
143
4.30
23.84
2.6
2.4
187.37
143.31
nmol/l
0.84
54
127
153
638
2.43
22.91
1.4
1.3
277.49
277.22
mosm/kgh2o
0.04
116
470
220
1069
2.09
22.82
1.6
1.5
697.50
950.82
e6/l
0.36
181
850
72
197
3.68
22.80
2.0
2.0
29.25
31.62
%
0.67
72
197
2901
24859
1.30
22.75
3.6
2.9
—
—
estimate
—
0
0
218
1059
2.09
22.63
1.6
1.4
31.28
27.18
e6/l
0.08
165
794
227
1120
2.06
22.61
1.5
1.5
31.82
30.74
g/l
0.63
204
998
712
4862
1.52
22.48
1.8
1.6
—
—
—
0
0
109
389
2.83
22.33
1.7
1.3
2.43
2.19
mmol/l
0.76
98
364
31
13
23.93
22.11
1.1
1.0
13.64
15.06
mg/l
—
23
7
220
1083
2.07
22.05
3.2
3.8
1.74
1.51
%
0.36
199
944
298
1639
1.86
21.62
1.5
1.4
6.78
14.36
iu/ml
—
9
28
1567
12410
1.34
21.41
1.9
1.8
12063953.86
27588333.53
pmol/l
0.94
1260
10124
330
1881
1.79
21.31
2.4
1.6
0.38
0.32
mg/l
0.93
184
853
3600
31875
1.28
21.23
5.0
3.4
66.08
54.76
u/l
5.68
3358
29490
4457
48250
0.77
21.10
5.8
6.1
2.43
2.54
mmol/l
12.60
3991
44242
101
358
2.85
20.98
4.0
3.0
—
—
—
0
0
174
3539
0.48
20.91
1.9
2.1
3.50
3.56
ratio
0.24
145
2831
122
479
2.58
20.78
1.3
1.3
0.39
0.42
g/l
0.40
83
359
122
479
2.58
20.78
1.3
1.3
6.88
6.72
g/l
0.19
83
359
122
480
2.57
20.70
1.3
1.3
2.67
2.94
g/l
0.87
85
361
51
118
4.35
20.31
1.9
1.6
—
—
—
0
0
287
1592
1.84
20.27
2.7
2.4
3.86
3.58
g/l
1.92
276
1520
1502
11915
1.34
20.10
5.4
4.3
351.80
526.79
ng/l
0.96
1268
10199
120
476
2.55
20.03
1.3
1.4
—
—
—
0
0
4360
47200
0.78
19.61
5.2
5.3
4.26
4.41
mmol/l
15.49
3932
43456
1689
13677
1.31
19.46
3.3
2.6
—
—
—
0
0
149
661
2.28
19.44
1.2
1.1
—
20.70
u/ml
—
0
6
4321
46789
0.78
19.17
5.2
5.2
1.36
1.40
mmol/l
9.58
3868
42759
171
808
2.15
19.13
1.5
1.7
0.73
0.87
g/l
0.80
129
644
875
6411
1.42
19.07
4.7
3.3
5.08
4.93
e9/l
0.21
698
5392
737
5232
1.46
19.06
3.2
2.5
33.85
48.32
u/l
0.91
631
4419
674
4720
1.48
18.69
1.5
1.4
—
—
—
0
0
791
5753
1.43
17.91
1.8
1.6
—
—
—
0
0
766
5541
1.43
17.87
4.0
3.2
258.66
256.87
ng/l
0.03
707
5095
2732
23739
1.26
17.46
3.6
3.1
160.46
152.49
ug/l
0.78
2472
21813
27
40
6.77
17.39
1.3
1.0
—
—
—
0
0
236
1293
1.86
17.38
1.3
1.2
—
—
—
0
0
170
833
2.07
17.33
1.5
1.6
—
—
—
0
0
1909
15924
1.28
17.11
5.7
4.3
0.00
0.00
estimate
2.37
716
5298
506
3400
1.53
17.11
1.7
1.7
1.64
1.54
g/l
1.46
421
2914
118
2548
0.45
16.73
1.7
1.8
3.29
3.44
mmol/l
0.71
84
1815
105
427
2.48
16.71
3.0
1.9
8.28
8.10
mmol/l
0.18
105
427
238
1334
1.81
16.30
2.0
1.9
11.36
12.57
mg/l
1.13
223
1231
2584
22439
1.25
16.22
4.8
3.6
6.33
6.24
ph
4.14
1521
12396
280
1649
1.73
16.19
4.4
3.6
1.97
1.87
index
0.12
178
858
277
1627
1.73
16.17
2.6
2.7
62.20
59.99
%
0.81
258
1557
201
1074
1.90
16.03
1.9
2.1
0.92
0.87
%
0.66
161
752
135
2731
0.48
15.95
1.4
1.4
—
—
—
0
0
478
3224
1.52
15.87
1.5
1.4
—
—
—
0
0
2632
22955
1.24
15.73
21.2
12.4
0.00
0.00
e9/l
0.16
2190
18638
4144
37965
1.24
15.63
6.0
4.4
18.04
13.74
mm/h
39.74
3882
35171
246
1423
1.76
15.17
1.8
1.5
0.24
0.24
g/l
0.07
236
1357
1739
14540
1.27
14.87
5.0
3.7
0.79
0.22
estimate
0.55
679
4603
2647
23198
1.23
14.85
2.8
2.4
76.72
78.11
nmol/l
1.57
2320
20587
53
159
3.35
14.73
1.2
1.2
—
—
—
0
0
1334
16248
0.78
14.72
3.8
3.4
—
—
—
0
0
32
66
4.87
14.70
1.8
2.0
16.15
17.36
umol/l
0.22
32
66
311
1939
1.63
14.52
2.4
2.1
22.36
21.30
s
1.06
283
1760
281
1718
1.66
14.17
1.3
1.2
0.35
0.81
u/ml
1.14
24
145
172
911
1.91
14.13
1.7
1.9
19.28
24.40
ug/l
1.16
165
892
177
947
1.89
14.10
1.3
1.4
13.52
16.38
u/ml
—
5
19
177
951
1.88
13.93
1.4
1.4
—
—
—
0
0
149
758
1.99
13.78
1.1
1.1
—
—
—
0
0
246
1467
1.70
13.64
1.8
1.5
1.22
1.17
g/l
1.58
236
1399
2392
20878
1.23
13.59
5.7
4.2
0.73
0.32
estimate
0.25
711
4931
392
2623
1.53
13.51
3.1
3.4
4.19
4.40
pmol/l
3.60
346
2316
380
2533
1.53
13.33
1.4
1.3
—
—
—
0
0
300
1898
1.61
13.22
2.1
1.6
7.78
6.78
iu/ml
0.28
92
444
158
837
1.91
13.01
1.4
1.4
133.18
153.87
au/ml
1.26
38
258
123
597
2.08
12.97
1.4
1.3
11.75
13.63
u/l
0.73
114
540
176
968
1.84
12.90
1.4
1.5
1477.64
2947.17
e6/l
0.88
126
683
50
159
3.16
12.70
2.0
2.2
10.98
10.94
%
0.00
42
144
255
1566
1.65
12.67
3.7
3.3
0.79
0.82
nmol/l
0.64
209
1233
96
426
2.27
12.67
1.5
1.1
32.34
35.57
mmol/l
0.76
84
366
738
5612
1.35
12.59
5.4
4.7
7.38
7.35
ph
3.33
598
4054
208
1215
1.73
12.46
1.3
1.2
—
—
—
0
0
1121
9053
1.29
12.43
1.7
1.5
2.81
2.62
g/l
1.70
715
5406
159
860
1.87
12.30
1.5
1.4
102707.82
70089.84
e6/l
0.33
93
487
55
189
2.93
12.25
1.2
1.1
100.20
424.74
ng/l
1.23
20
50
25
28
8.96
12.20
3.2
1.1
—
—
—
0
0
74
299
2.49
12.06
2.6
2.6
41.00
37.89
%
0.63
41
166
1747
20270
0.81
12.00
4.3
4.9
21.25
22.32
%
2.27
874
10615
610
4537
1.38
11.96
4.2
4.0
92.68
98.48
ng/l
0.82
508
3863
146
777
1.90
11.89
1.3
1.4
6.49
6.37
mmol/l
0.20
137
722
3110
28107
1.20
11.77
5.4
4.1
13.79
4.80
estimate
1.11
851
6156
75
310
2.44
11.65
1.8
2.3
447.69
525.51
e6/l
0.67
59
255
3073
27773
1.20
11.54
5.4
4.1
0.00
0.00
estimate
0.24
829
5990
1224
14706
0.79
11.52
3.0
3.4
0.84
0.83
ug/l
0.06
869
10224
3125
28290
1.20
11.51
5.5
4.1
0.01
0.07
estimate
0.58
802
5693
262
1667
1.59
11.32
1.5
1.5
226.82
268.24
ug/g
2.97
164
1015
222
1356
1.66
11.31
1.2
1.2
90.59
96.10
titre
0.13
34
123
96
451
2.14
11.08
1.2
1.1
—
—
—
0
0
53
189
2.82
11.07
42.9
38.6
7.07
7.41
ug/l
0.51
46
171
4375
46423
0.83
10.96
7.5
7.1
41.24
40.25
mmol/mol
8.14
3924
42896
151
839
1.82
10.78
1.3
1.2
290.88
269.89
u/ml
0.35
95
507
2002
17483
1.21
10.65
2.0
1.8
18.85
19.62
nmol/l
1.39
1740
14856
237
1496
1.61
10.61
1.4
1.6
—
—
—
0
0
141
771
1.85
10.60
1.5
1.5
—
—
—
0
0
47
161
2.93
10.57
1.9
2.2
30.26
30.02
%
0.03
42
151
2865
25861
1.19
10.56
2.5
2.3
91.65
93.28
pmol/l
1.03
1661
14186
910
7298
1.29
10.54
1.4
1.3
—
—
—
0
0
4222
44888
0.84
10.53
4.6
4.4
1.32
1.28
mmol/l
2.94
3777
40559
1837
15928
1.21
10.50
10.0
6.4
—
—
—
0
0
130
698
1.88
10.36
2.8
3.7
62.18
57.85
%
1.51
112
582
321
2186
1.49
10.22
2.9
3.2
5.36
5.49
ratio
0.01
193
1285
124
660
1.90
10.16
4.1
4.2
—
—
—
0
0
130
705
1.86
10.06
3.6
3.0
10.37
10.60
mmol/l
0.26
125
696
71
307
2.33
10.04
2.1
2.4
228.68
225.09
e6/l
0.04
63
269
66
277
2.40
9.98
2.9
4.1
2984.22
66.15
mg/l
0.49
46
190
36
109
3.31
9.96
1.8
2.1
0.33
1.34
e9/l
0.62
18
48
73
322
2.28
9.87
1.8
2.3
0.67
0.65
e9/l
0.07
65
306
16
12
13.36
9.65
1.2
1.3
—
—
mmol/l
—
0
0
135
755
1.80
9.49
3.5
2.4
1.77
0.22
mmol/l
3.92
125
724
58
237
2.46
9.32
1.4
1.3
3.80
3.31
mmol/l
0.56
53
213
53
210
2.54
9.09
2.5
2.4
62.34
53.83
umol/l
0.94
44
178
59
248
2.39
8.93
1.2
1.3
90.62
512.20
ug/l
1.38
31
126
138
792
1.76
8.91
1.1
1.1
—
—
—
0
0
40
139
2.89
8.83
4.6
4.6
—
—
—
0
0
341
2423
1.43
8.75
2.9
3.3
43.44
56.68
mg/l
0.98
259
2055
59
251
2.36
8.71
1.7
1.5
2.95
2.32
%
0.23
51
211
795
6414
1.27
8.71
3.4
4.1
38.46
21.41
ug/l
0.23
665
5332
50
199
2.52
8.52
44.7
27.8
129.79
115.43
ug/l
0.76
42
163
340
2427
1.42
8.51
2.9
3.3
69.27
83.83
mg/l
0.26
259
2056
123
694
1.79
8.44
1.1
1.1
1.64
1.53
g/l
1.55
110
625
67
308
2.19
8.27
1.6
1.5
67.43
67.57
%
0.01
54
249
84
424
1.99
8.12
1.2
1.3
7.43
7.41
ph
0.41
63
291
206
1347
1.55
8.02
1.2
1.2
806.67
1063.43
titre
—
6
35
3718
39573
0.86
7.91
42.9
24.7
330.00
331.94
g/l
27.85
3679
39245
35
121
2.90
7.83
1.4
1.3
—
—
—
0
0
54
233
2.33
7.76
1.6
1.3
62.83
65.26
%
—
6
31
1439
12523
1.19
7.50
5.7
4.4
1.98
1.14
kg/l
0.41
1052
8539
247
1703
1.47
7.48
4.4
3.4
1.69
1.68
mmol/l
0.05
237
1651
35
125
2.81
7.40
2.4
1.4
—
—
—
0
0
85
449
1.90
7.25
1.6
1.6
—
—
—
0
0
97
535
1.82
7.24
2.0
2.0
2.00
1.29
u/field
0.70
55
293
71
353
2.02
7.21
1.0
1.1
—
—
—
0
0
247
1730
1.44
6.92
4.4
3.1
1.75
1.73
mg/l
0.10
211
1543
48
208
2.32
6.88
1.2
1.1
—
—
—
0
0
76
395
1.93
6.83
1.1
1.2
86.67
139.12
titre
—
9
68
58
274
2.13
6.76
1.4
1.2
140.35
136.81
nmol/l
0.18
58
274
211
1449
1.47
6.57
4.8
3.5
7.78
7.71
mmol/l
0.14
206
1407
126
772
1.64
6.52
2.7
2.1
34.46
25.02
mg/l
0.80
48
266
80
1422
0.56
6.43
1.5
1.7
—
—
—
0
0
227
3173
0.71
6.21
1.4
1.4
—
—
—
0
0
1340
11810
1.17
5.84
3.5
3.1
2.48
2.46
mmol/l
6.97
1168
10495
69
368
1.88
5.80
4.1
4.1
43.12
55.87
u/ml
0.45
69
361
72
390
1.86
5.77
1.3
1.3
—
—
—
0
0
48
225
2.14
5.76
1.3
1.2
0.66
0.55
ratio
0.32
25
130
78
436
1.80
5.66
2.4
2.4
26.18
30.54
iu/ml
—
10
65
1117
9727
1.18
5.64
4.2
3.4
2.04
1.80
e6/l
0.58
635
5069
276
2055
1.36
5.49
3.6
3.2
1448.94
482.25
mg/l
0.44
141
945
190
1328
1.44
5.47
1.4
1.2
17.69
42.23
u/ml
1.11
11
59
30
117
2.57
5.44
1.2
1.6
—
—
—
0
0
4533
47130
0.88
5.43
5.7
5.5
6.17
6.08
mmol/l
3.24
4025
42586
69
377
1.84
5.41
1.3
1.2
49.98
63.00
u/ml
—
6
18
99
601
1.66
5.38
1.3
1.2
—
—
—
0
0
56
1044
0.53
5.37
1.1
1.2
0.62
0.64
ratio
0.15
12
150
194
1376
1.42
5.18
1.3
1.2
—
—
—
0
0
180
1261
1.44
5.14
1.4
1.2
2.04
6.15
u/ml
0.85
20
112
58
305
1.91
5.13
2.1
1.8
1.41
2.97
u/field
1.42
44
218
180
1264
1.44
5.08
1.4
1.2
6.91
6.61
u/ml
0.03
32
190
96
588
1.64
5.07
4.8
3.4
13.00
11.97
index
0.53
77
319
31
128
2.43
5.03
1.0
1.1
—
—
—
0
0
178
1253
1.43
4.97
4.2
3.8
30.11
30.56
mg/l
0.06
127
911
140
941
1.50
4.95
1.2
1.3
172.19
219.67
miu/ml
0.66
36
370
19
61
3.12
4.90
1.3
1.2
—
—
—
0
0
19
61
3.12
4.90
1.3
1.2
—
—
—
0
0
19
61
3.12
4.90
1.3
1.2
—
—
—
0
0
26
100
2.61
4.88
1.1
1.1
—
—
—
0
0
57
306
1.87
4.77
2.2
2.3
11.49
24.03
umol/l
—
10
30
15
42
3.58
4.76
2.1
1.7
1.15
1.55
umol/l
1.81
15
29
31
132
2.35
4.72
1.6
1.5
5.15
7.44
%
0.61
20
64
14
30
4.67
4.67
1.5
1.1
1.11
0.95
u/field
—
9
20
32
139
2.31
4.67
7.8
7.0
6.08
5.96
kpa
0.23
26
123
620
5210
1.21
4.67
3.3
2.7
0.44
0.49
e6/l
0.26
602
5035
50
259
1.94
4.66
1.1
1.0
—
—
—
0
0
31
133
2.34
4.65
1.0
1.0
—
—
—
0
0
100
635
1.58
4.60
1.1
1.1
—
—
—
0
0
7
5
14.01
4.57
5.1
2.8
—
—
—
0
0
1178
10465
1.15
4.54
4.0
3.3
1.33
1.12
e6/l
0.60
701
5821
58
319
1.83
4.52
1.2
1.1
99.66
46.08
mg/l
0.66
45
258
13
28
4.65
4.36
6.8
3.0
1.95
2.23
mg/l
0.24
13
23
55
303
1.82
4.28
1.1
1.1
414.96
311.45
mg/l
0.34
48
258
40
198
2.03
4.26
2.0
3.0
25.35
20.95
mu/l
0.19
34
189
5080
49285
1.13
4.25
37.4
19.2
32.21
27.80
mg/l
18.02
4796
41978
212
1598
1.34
3.99
5.2
4.4
—
—
—
0
0
56
948
0.59
3.92
1.3
1.6
—
—
—
0
0
156
1125
1.40
3.89
1.4
1.4
11.88
8.97
u/l
1.67
124
907
20
76
2.64
3.89
1.1
1.2
190.43
1126.72
ng/l
0.44
13
53
24
100
2.40
3.88
1.5
1.3
19.22
21.73
%
0.18
18
70
2371
25282
0.90
3.81
5.2
5.9
3.69
3.86
ug/l
0.12
2030
22592
140
997
1.41
3.76
1.3
1.2
—
—
—
0
0
155
1129
1.38
3.66
1.6
1.5
—
—
—
0
0
19
73
2.61
3.63
2.7
2.7
57.36
31.55
mg/l
—
7
15
36
183
1.97
3.61
1.1
1.1
1420.81
1576.47
miu/ml
0.38
36
183
305
2448
1.26
3.60
2.8
2.3
10.36
10.35
g/l
0.00
258
2150
94
1377
0.68
3.49
1.1
1.1
—
—
—
0
0
1756
18948
0.90
3.49
3.6
3.5
74.71
54.39
mg/l
2.06
1182
12600
84
550
1.53
3.48
1.2
1.2
—
—
—
0
0
35
179
1.96
3.47
1.3
1.4
24.00
22.85
%
0.08
25
144
26
119
2.19
3.43
1.1
1.1
—
—
—
0
0
18
70
2.58
3.37
1.1
1.3
75.20
111.83
ug/l
—
10
41
148
1090
1.37
3.31
1.8
1.7
336.63
294.41
mu/l
0.59
140
1009
17
65
2.62
3.29
1.6
1.9
1.12
1.01
mmol/l
0.06
12
42
6
7
8.58
3.26
3.7
5.4
—
—
—
0
0
119
849
1.41
3.22
1.5
1.3
—
—
—
0
0
38
206
1.85
3.20
2.3
1.5
31.26
28.26
umol/l
0.94
38
194
912
8151
1.14
3.20
1.3
1.3
33.03
35.42
iu/ml
0.26
294
2433
26
123
2.12
3.19
6.3
7.3
5.24
5.40
kpa
0.24
26
123
14
49
2.86
3.18
4.9
6.4
74.18
38.22
mg/mmol
0.47
14
43
67
426
1.58
3.18
2.1
1.8
—
—
—
0
0
7
11
6.37
3.18
1.0
1.0
2.00
1.00
u/field
—
7
11
34
179
1.90
3.13
1.1
1.4
13.47
13.86
g/l
0.08
21
135
342
2827
1.22
3.13
1.3
1.3
70.63
59.33
au/ml
0.23
14
203
145
1080
1.35
3.05
1.7
1.5
—
1.00
—
0
7
133
1789
0.74
3.04
1.1
1.1
—
—
—
0
0
85
577
1.48
3.02
1.2
1.2
—
—
—
0
0
7
12
5.84
3.02
1.1
7.8
—
—
—
0
0
61
388
1.58
2.92
2.4
2.1
7.85
6.94
mmol/l
0.84
48
261
56
349
1.61
2.92
1.6
2.2
17.03
17.64
nmol/l
0.18
50
323
340
2835
1.21
2.87
2.8
2.3
7.65
7.40
g/l
2.08
297
2564
35
192
1.83
2.87
2.6
2.5
0.61
0.62
mmol/l
0.29
35
192
340
2836
1.21
2.87
2.8
2.3
4.20
4.16
g/l
0.37
297
2571
85
585
1.46
2.84
3.6
3.9
27.23
32.48
u/ml
0.40
78
566
93
652
1.43
2.82
1.2
1.2
6.32
4.95
u/ml
0.28
44
301
368
3098
1.20
2.82
2.4
2.4
22.55
21.28
au/ml
0.06
23
264
28
144
1.95
2.79
1.9
1.9
—
—
—
0
0
338
2829
1.21
2.76
2.8
2.3
3.87
3.72
g/l
0.84
295
2562
315
2624
1.21
2.71
2.8
2.4
3.10
2.92
g/l
2.44
271
2357
24
118
2.04
2.70
1.5
1.2
2.80
1.45
mmol/l
0.24
17
78
112
818
1.38
2.70
1.9
1.8
4.66
4.57
mmol/24h
0.11
99
702
16
66
2.43
2.70
2.0
1.4
47.63
44.77
umol/l
0.19
16
66
6
10
6.00
2.69
3.3
1.9
279.50
313.10
ug/l
—
6
10
5162
52682
0.91
2.66
50.7
28.9
128.07
133.70
g/l
108.03
5089
51931
5162
52674
0.91
2.62
51.8
29.3
38.50
40.14
%
20.13
5085
51860
5162
52673
0.91
2.62
50.1
28.7
4.28
4.43
e12/l
64.36
5039
51210
5162
52671
0.91
2.61
50.0
28.6
91.69
91.65
fl
0.23
5091
51887
5161
52661
0.91
2.61
50.2
28.7
246.72
239.20
e9/l
11.56
5060
51386
5162
52670
0.91
2.60
50.0
28.6
30.28
30.46
pg
9.49
5092
51888
5164
52687
0.91
2.59
50.2
28.7
7.54
6.96
e9/l
30.57
5049
51218
147
1127
1.31
2.59
1.6
1.9
5.67
9.32
iu/l
0.26
44
421
1830
19465
0.92
2.56
4.4
4.2
13.81
9.81
mg/mmol
2.00
1196
12566
181
1430
1.27
2.54
2.5
2.3
118.66
114.38
ug/min
0.05
106
839
58
379
1.53
2.52
1.1
1.1
293.53
285.87
mg/l
0.28
53
345
30
165
1.82
2.48
1.2
1.0
—
—
—
0
0
30
165
1.82
2.48
1.2
1.0
—
—
—
0
0
30
165
1.82
2.48
1.2
1.0
—
—
—
0
0
53
341
1.56
2.47
2.4
2.1
479.03
494.54
min
0.37
34
242
55
358
1.54
2.44
1.7
1.4
—
—
—
0
0
96
697
1.38
2.44
1.2
1.2
—
—
—
0
0
127
1657
0.76
2.42
1.1
1.2
—
—
—
0
0
55
359
1.54
2.41
1.9
1.7
575.28
343.82
mu/l
1.48
39
284
97
710
1.37
2.36
2.8
2.3
2400.88
4070.94
u/l
0.38
32
273
163
1286
1.27
2.34
3.4
3.4
235.44
786.72
u/ml
1.50
144
1186
17
344
0.49
2.31
1.4
1.4
108.04
190.47
pmol/l
1.68
17
344
20
98
2.04
2.31
1.1
1.1
—
—
—
0
0
297
2504
1.19
2.30
1.2
1.2
115.62
130.68
u/ml
0.26
102
863
29
164
1.77
2.22
1.7
1.3
151.56
130.69
nmol/l
0.19
20
121
73
515
1.42
2.21
1.2
1.2
—
—
—
0
0
10
35
2.86
2.20
1.0
1.1
—
—
—
0
0
76
542
1.41
2.18
1.5
1.2
110.59
42.32
u/ml
—
7
25
1601
15034
1.09
2.16
3.5
3.0
363.63
362.41
umol/l
0.16
1369
13014
69
487
1.42
2.10
2.4
2.2
631.72
650.50
ml
0.14
43
302
1091
10086
1.10
2.10
1.3
1.3
1.16
1.79
u/ml
1.91
266
2583
44
667
0.66
2.08
1.3
1.6
1203.97
1005.44
mu/l
0.52
34
553
5023
51180
0.92
2.08
18.1
12.7
26.52
26.17
u/l
0.31
4882
49391
355
3069
1.17
2.07
2.6
2.5
—
—
—
0
0
87
644
1.36
2.02
1.1
1.1
27.86
18.05
au/ml
—
8
135
1384
12956
1.09
2.01
5.0
3.9
0.27
0.17
0.31
22
167
93
700
1.33
1.95
1.5
1.3
—
—
—
0
0
336
2912
1.16
1.92
2.7
2.9
—
—
—
0
0
403
3545
1.15
1.88
1.2
1.2
—
—
—
0
0
54
373
1.45
1.88
1.2
1.5
—
—
—
0
0
118
925
1.28
1.86
1.4
1.2
35.16
45.91
u/ml
0.38
13
85
26
152
1.71
1.82
1.3
1.2
1.22
1.48
mmol/l
1.02
19
97
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
21
115
1.83
1.82
1.4
1.6
—
—
—
0
0
67
486
1.38
1.80
1.8
1.7
3.92
4.64
mg/l
1.17
61
461
75
555
1.36
1.78
1.0
1.1
—
—
—
0
0
6
18
3.33
1.74
1.3
1.4
339.28
430.87
nmol/l
—
6
18
462
5163
0.89
1.74
2.6
2.3
11.76
12.81
nmol/l
2.08
393
4570
46
314
1.47
1.72
1.8
1.3
—
—
—
0
0
7
24
2.92
1.72
5.3
7.8
103.86
103.79
g/l
—
7
24
55
389
1.42
1.71
1.0
1.0
334.44
314.67
ng/l
0.20
39
264
24
140
1.72
1.71
1.1
1.5
94.00
491.42
nmol/24h
1.13
24
140
42
282
1.49
1.71
2.1
1.5
6.01
6.75
u/l
0.28
35
245
11
48
2.29
1.70
1.5
1.1
—
—
—
0
0
81
612
1.33
1.69
1.4
1.3
0.24
0.22
nmol/l
0.18
55
508
11
226
0.49
1.64
1.2
1.3
5.88
6.06
mmol/l
0.26
11
212
819
7566
1.09
1.63
1.3
1.3
17.84
12.68
u/ml
0.80
270
2746
296
2582
1.15
1.60
1.6
1.7
—
—
—
0
0
22
128
1.72
1.60
1.2
1.2
—
—
—
0
0
10
44
2.27
1.55
1.0
1.1
0.02
0.02
u/ml
—
10
44
141
1159
1.22
1.52
1.4
1.3
47.18
40.83
u/l
0.18
120
989
38
257
1.48
1.52
2.0
2.4
2216.09
1899.91
ml
0.44
32
217
702
6466
1.10
1.51
4.7
5.2
33.42
32.88
%
0.60
493
4209
11
51
2.16
1.50
1.5
1.6
68.17
60.36
%
—
6
33
60
443
1.36
1.49
1.2
1.2
—
—
—
0
0
226
1947
1.17
1.46
1.1
1.1
94.00
170.58
titre
—
5
45
11
52
2.12
1.44
24.0
11.6
0.41
0.23
%
0.54
11
52
605
5550
1.10
1.43
2.2
2.3
197.05
155.51
ug/g
1.39
467
4429
10
46
2.18
1.39
2.0
2.7
—
—
—
0
0
53
390
1.36
1.37
1.0
1.0
755.40
695.46
ng/l
0.38
35
257
18
299
0.60
1.36
1.3
1.5
1.18
1.28
mm
0.86
11
210
18
104
1.73
1.36
1.3
1.2
27.33
379.76
u/l
0.58
12
70
44
314
1.40
1.36
1.2
1.1
—
—
—
0
0
50
365
1.37
1.36
2.2
2.1
2.61
2.14
ug/l
0.31
42
301
34
231
1.47
1.36
1.2
1.5
13.61
12.76
ug/l
0.04
34
206
474
4309
1.11
1.35
3.3
2.9
6.17
6.04
ph
2.56
355
3061
77
600
1.29
1.35
1.5
1.3
—
—
nmol/l
—
0
0
137
1140
1.21
1.34
1.6
1.4
31.65
27.02
iu/l
0.81
114
972
9
42
2.14
1.33
1.3
1.2
—
—
—
0
0
11
54
2.04
1.32
2.2
2.5
—
—
—
0
0
47
342
1.38
1.31
1.2
1.1
—
—
—
0
0
24
152
1.58
1.31
1.4
1.3
25.52
26.11
g/l
0.06
17
117
61
463
1.32
1.30
2.2
2.3
—
—
—
0
0
5
18
2.78
1.28
1.0
1.1
0.02
0.04
u/ml
—
5
18
25
161
1.55
1.28
2.0
2.0
43.21
51.45
u/l
0.12
25
148
23
354
0.65
1.28
1.6
1.9
114.33
126.06
ng/l
0.27
23
354
20
122
1.64
1.27
2.0
1.5
10.29
9.44
ug/l
0.33
20
122
285
3206
0.88
1.27
1.2
1.3
—
—
—
0
0
55
414
1.33
1.25
1.1
1.1
1.34
4.31
u/ml
2.50
27
186
19
303
0.63
1.24
1.3
1.5
—
—
—
0
0
13
70
1.86
1.23
1.8
1.2
62.29
53.38
%
—
7
29
87
699
1.25
1.22
1.5
1.3
0.65
3.18
nmol/l
0.50
81
672
10
49
2.04
1.21
1.0
1.0
—
—
—
0
0
20
310
0.64
1.17
1.3
1.6
—
—
—
0
0
340
3069
1.11
1.15
4.5
3.6
1.02
1.02
ratio
0.04
316
2779
13
72
1.81
1.14
1.1
1.2
86.62
64.03
ug/l
2.21
13
72
12
65
1.85
1.13
1.0
1.1
13.33
14.85
iu/ml
—
6
27
48
361
1.33
1.12
1.3
1.3
28.23
25.98
u/l
0.15
42
300
88
716
1.23
1.12
1.5
1.3
0.18
0.29
nmol/l
—
8
47
41
301
1.36
1.12
1.2
1.3
1.14
1.18
nmol/l
0.07
28
212
13
73
1.78
1.10
1.2
1.5
—
—
—
0
0
98
1181
0.83
1.09
1.1
1.1
—
—
—
0
0
67
532
1.26
1.07
1.7
1.4
27.58
27.34
%
0.02
43
329
5
22
2.27
1.03
1.2
1.2
307.00
238.36
nmol/l
—
5
22
7
35
2.00
1.00
1.1
1.3
—
—
—
0
0
53
415
1.28
0.96
1.3
1.2
89.91
101.66
pmol/l
1.00
53
415
9
50
1.80
0.96
1.1
1.1
1.44
1.82
umol/24h
—
9
50
5147
52026
0.95
0.94
42.3
25.5
85.39
86.00
umol/l
0.40
5065
51220
7
37
1.89
0.94
1.4
1.8
—
—
—
0
0
83
689
1.21
0.92
1.6
1.5
60.42
62.49
%
0.17
50
439
20
134
1.49
0.91
1.1
1.1
—
—
—
0
0
26
185
1.41
0.89
1.9
1.6
—
—
—
0
0
191
1699
1.13
0.89
3.5
3.7
68.94
78.31
u/ml
0.21
185
1638
53
421
1.26
0.88
3.6
2.7
33.53
32.83
mg/l
0.05
43
322
22
152
1.45
0.87
1.0
1.1
1.28
6.15
u/ml
—
7
22
3761
36990
1.04
0.82
4.7
4.1
15.02
14.98
pmol/l
0.44
3359
33391
12
73
1.64
0.81
3.6
2.4
0.08
0.40
u/field
2.00
12
73
141
1599
0.88
0.80
1.9
1.9
41.59
42.80
nmol/l
0.26
133
1544
21
147
1.43
0.79
1.1
2.4
0.69
1.21
ug/l
0.98
21
138
6
33
1.82
0.79
1.2
1.0
—
—
—
0
0
16
106
1.51
0.78
1.0
1.2
338.09
246.62
pmol/l
0.59
11
78
1472
14239
1.04
0.75
3.9
3.2
0.14
0.06
0.63
56
460
3542
35986
0.97
0.73
5.7
4.6
0.18
1203.04
0.49
11
84
32
246
1.30
0.71
3.8
3.8
—
—
—
0
0
28
211
1.33
0.71
1.1
1.1
1.07
1.07
ratio
0.07
23
170
35
273
1.28
0.71
1.5
1.4
5.67
3.45
%
0.52
12
60
5
27
1.85
0.68
1.6
1.6
12.80
27.40
nmol/l
—
5
27
80
685
1.17
0.68
1.8
2.0
—
—
—
0
0
83
713
1.17
0.68
2.0
1.4
52.96
72.37
mu/l
0.66
73
634
30
231
1.30
0.67
1.3
2.0
1213.79
4567.15
e6/l
0.47
19
162
54
447
1.21
0.67
1.1
1.1
1.57
2.31
u/ml
0.52
26
228
119
1052
1.13
0.66
1.1
1.1
1.11
7.98
eliau/ml
—
8
95
79
678
1.17
0.66
1.2
1.1
1.68
2.30
u/ml
0.24
41
370
26
197
1.32
0.65
1.0
1.1
—
—
—
0
0
16
112
1.43
0.63
1.7
2.1
9.12
8.89
mg/l
0.04
11
99
61
516
1.18
0.62
1.1
1.1
0.38
1.35
u/ml
2.72
29
271
67
572
1.17
0.61
1.1
1.1
2.89
4.70
u/ml
0.41
30
300
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
76
659
1.15
0.58
1.3
1.3
1598.82
287.18
pmol/l
0.51
67
547
37
300
1.23
0.58
2.5
3.2
204.54
206.82
u/l
0.07
37
294
13
89
1.46
0.57
14.2
13.1
4.69
5.42
mmol/l
0.74
13
89
86
754
1.14
0.57
1.0
1.1
3.77
1130.28
iu/ml
0.71
13
148
245
2273
1.08
0.57
3.2
3.3
231.22
2647.65
u/ml
1.28
209
1969
6
36
1.67
0.56
4.3
3.4
—
—
—
0
0
8
55
1.45
0.56
2.3
1.3
—
—
—
0
0
34
275
1.24
0.55
3.7
3.6
—
—
—
0
0
37
303
1.22
0.54
1.5
1.6
—
—
—
0
0
178
1636
1.09
0.53
16.5
12.0
—
—
—
0
0
46
387
1.19
0.52
1.0
1.1
0.29
0.28
u/ml
0.02
18
139
4460
45010
0.97
0.52
5.8
5.1
2.11
2.01
mu/l
0.56
4017
40960
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
9
65
1.38
0.50
1.1
1.1
—
—
—
0
0
65
565
1.15
0.50
1.3
1.2
—
—
—
0
0
10
67
1.49
0.49
5.1
2.8
75.94
113.27
ng/l
—
5
34
42
353
1.19
0.49
1.7
1.8
—
—
—
0
0
115
1268
0.91
0.48
2.3
1.9
194.24
205.91
pmol/l
0.65
107
1186
25
199
1.26
0.47
1.3
1.9
—
—
—
0
0
64
559
1.15
0.47
1.1
1.1
0.43
1.15
u/ml
1.17
23
250
120
1093
1.10
0.45
1.6
1.6
0.90
0.87
nmol/l
0.18
96
918
25
201
1.24
0.44
1.3
1.9
37662.46
17384.77
e6/l
0.25
13
109
1392
13598
1.03
0.44
1.4
1.4
—
—
—
0
0
16
121
1.32
0.44
1.1
1.1
—
—
—
0
0
66
582
1.14
0.44
1.5
1.3
1.26
1.49
nmol/l
1.04
57
521
160
1480
1.08
0.44
1.8
1.6
15755.90
15007.21
e6/l
0.08
116
1023
23
184
1.25
0.43
1.3
1.6
—
2.00
—
0
5
5
31
1.61
0.43
1.0
1.2
—
—
—
0
0
5
32
1.56
0.42
1.6
1.3
4.66
3.86
nmol/l
—
5
32
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
0.26
—
0
9
12
160
0.75
0.39
1.3
1.2
14.00
11.38
mm/h
0.37
12
160
93
846
1.10
0.38
2.2
2.3
1.43
1.22
g/24h
0.25
54
495
1929
19604
0.98
0.37
3.8
3.5
6.92
7.51
mmol/l
7.75
1589
16353
69
621
1.11
0.35
1.2
1.1
—
—
—
0
0
5
77
0.65
0.35
4.4
6.5
10.00
8.05
%
—
5
77
5
77
0.65
0.35
2.2
3.3
55.20
44.31
%
—
5
77
22
181
1.22
0.34
1.3
1.2
8.12
12.19
pmol/l
—
6
69
5102
50746
1.02
0.33
41.5
23.4
139.12
139.60
mmol/l
26.55
5007
49669
17
137
1.24
0.32
1.1
1.3
25.47
28.78
s
3.46
17
137
38
333
1.14
0.31
1.7
1.9
6.41
10.83
umol/l
1.26
31
235
68
619
1.10
0.30
1.2
1.1
—
—
—
0
0
11
141
0.78
0.29
1.2
1.3
34.00
30.06
%
—
6
93
233
2227
1.05
0.28
1.2
1.1
—
1.25
—
0
22
46
413
1.11
0.27
1.1
1.1
—
—
titre
—
0
0
22
257
0.86
0.26
1.1
1.7
37.13
39.30
g/l
0.91
22
257
234
2441
0.96
0.26
1.2
1.2
—
—
—
0
0
28
244
1.15
0.25
1.3
1.2
—
—
—
0
0
5103
50823
1.02
0.23
41.4
23.6
4.00
4.01
mmol/l
1.19
5005
49672
40
361
1.11
0.22
2.3
1.8
82.55
94.56
umol/l
1.59
40
361
3942
39640
0.99
0.22
41.6
23.5
14.35
13.85
%
74.03
3903
39037
0
13
0.00
0.21
0.0
1.1
—
169.62
—
0
13
46
501
0.92
0.20
1.1
1.1
3.53
3.11
eliau/ml
0.17
14
183
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
29
260
1.12
0.19
1.1
1.1
13.71
10.03
iu/ml
—
7
72
11
91
1.21
0.17
1.1
1.0
0.25
10.95
u/ml
—
5
58
23
206
1.12
0.16
2.9
1.6
4.76
4.52
ug/l
0.04
14
171
15
130
1.15
0.15
2.2
2.7
4.73
323.47
ug/l
0.81
15
130
9
82
1.10
0.15
1.0
1.2
11.80
8.32
mg/l
—
9
76
519
5278
0.98
0.14
2.5
2.1
0.04
0.00
estimate
0.41
82
1014
13
112
1.16
0.14
7.1
6.0
9.92
8.43
mmol/l
0.81
13
112
23
208
1.11
0.14
1.1
1.2
187.65
164.39
mmol/24h
0.61
23
208
262
2559
1.02
0.13
2.4
2.0
—
—
—
0
0
18
201
0.90
0.13
1.6
1.2
35.83
39.85
g/l
—
6
93
46
432
1.07
0.13
1.5
1.5
0.42
0.28
nmol/l
0.54
26
326
52
492
1.06
0.12
1.4
1.2
316.41
333.25
nmol/l
0.27
35
386
15
168
0.89
0.11
1.1
1.1
0.18
1.26
u/ml
—
9
65
34
318
1.07
0.11
1.9
2.1
53.10
180.42
ug/min
—
10
85
35
328
1.07
0.11
1.5
1.6
—
—
—
0
0
65
678
0.96
0.10
2.6
2.8
—
—
—
0
0
5
44
1.14
0.10
1.2
1.5
—
—
—
0
0
60
576
1.04
0.09
1.6
1.3
34033.91
126298.82
e6/l
2.32
47
384
35
370
0.95
0.09
3.6
5.4
40.59
46.26
u/ml
—
9
115
6
55
1.09
0.08
2.7
2.2
208.83
523.57
umol/l
—
6
49
49
507
0.97
0.06
3.7
3.1
54.58
37.10
mg/l
0.37
38
387
272
2690
1.01
0.05
2.6
2.1
3.85
0.35
estimate
0.44
66
757
23
242
0.95
0.05
1.2
1.1
29.90
19.18
u/ml
—
5
91
2017
20212
1.00
0.04
2.3
2.3
—
—
—
0
0
64
653
0.98
0.03
1.4
1.3
—
—
—
0
0
13
122
1.07
0.02
1.0
1.1
—
—
—
0
0
19
198
0.96
0.02
1.2
1.1
—
—
—
0
0
10
93
1.08
0.02
1.1
1.3
—
—
—
0
0
16
166
0.96
0.00
3.2
1.8
0.19
0.04
estimate
0.36
16
166
596
5951
1.00
0.00
1.4
1.4
—
—
—
0
0
45
454
0.99
0.00
2.3
2.5
—
—
—
0
0
169
1690
1.00
0.00
1.6
1.6
28.34
22.35
u/ml
0.14
14
342
734
7337
1.00
0.00
1.4
1.4
—
—
—
0
0
5
58
0.86
-0.00
2.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.03
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
3.72
—
0
7
6
67
0.90
-0.00
1.0
1.0
14.28
46.14
iu/ml
—
6
67
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
3220.00
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
40.00
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint J10_EXTERLUNG and mortality.

Females

Parameter HR [95% CI] p-value
J10_EXTERLUNG 3.808 [3.36, 4.31] < 0.001
Birth year 0.998 [0.99, 1.01] 0.541

During the follow-up period (1.1.1998 — 31.12.2019), 6547 out of 12360 females with J10_EXTERLUNG died.

Males

Parameter HR [95% CI] p-value
J10_EXTERLUNG 3.701 [3.25, 4.21] < 0.001
Birth year 0.983 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 11681 out of 21009 males with J10_EXTERLUNG died.

Mortality risk

Mortality risk for people of age

years, who have J10_EXTERLUNG.

N-year risk Females Males
1 0.464% 0.573%
5 2.347% 3.661%
10 5.493% 8.851%
15 9.994% 15.792%
20 18.381% 25.671%

Relationships between endpoints

↥

Index endpoint: J10_EXTERLUNG – Lung diseases due to external agents

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data